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EDTA ethylenediaminotetra-acetic acid





GABA y aminobuteric acid
GBR GABA receptor related
GFP green fluorescent protein
GLC glutamate chloride channel
GluCl glutamate-gated chloride ion channel
HEPES (N-(2-hydroxyethyl)piperazine-N’-2-ethane)sulphoni<
HRP horse-radish peroxidase
IC50 concentration producing 50% inhibition
Ig immunoglobulin
IGluR inhibitory glutamate-gated chloride channel receptor
IPs insitol triphosphate







LGIC ligand-gated ion channels
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MBS m-maleimidobenzoic acid N-hydrosuccinamide ester
MOPS morpholinopropanesulfonic acid
mRNA messenger ribonucleic acid
nACh nicotinic acetylcholine
nAChR nicotinic acetylcholine receptor
NMDA N-methyl-D-aspartate
OD optical density
PBS phosphate buffered saline
PCP phencyclidine
PCR polymerase chain reaction
PH -logio (hydrogen ion concentration)
P 2X P2 purinoceptors
RACE rapid amplification of cDNA ends
RDL resistant to dieldrin
RMED ring motor neurons, dorsal
RMEV ring motor neurons, ventral
RNA ribonucleic acid
RNase ribonuclease
rpm revolutions per minute
SCAM scanning-cysteine-accessibility method
SDS sodium dodecyl sulphate
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unc-49 uncoordinated movement phenotype
UV ultraviolet
V volts
v/v volume to volume
W watts
w/v weight per unit volume
X-gal 5-bromo-4-chloro-3-indoyl-p-D-galactoside
GENE NOMENCLA TV RE
The uniform system for naming C. elegans genes consist of using three italicised letters and a 
hyphen, with the last digit of the name being numeral to describe the order of their discovery. 
The protein product of a gene can be referred to the relevant gene name. Some authors have 
decided not to use this nomenclature approach. Nomenclature for genes and gene product 
relevant to this are summarised below.





gbr-2/avr-14 AVR-14 Gbr2-A & B/GluCla3
•  Genes defined by mutation are assigned names containing three italicised letters and a 
Roman numeral referring to the detected mutant phenotype: 
avr-14 resistant to avermectin
unc-49 uncoordinated movement phenotype
•  For genes defmed by cloning, on the basis of sequence similarity, the gene name refers to the
predicted protein or RNA product:
glc glutamate chloride channel
gbr GABA receptor related
Where more than one protein product is predicted for a gene (e.g. as a result of alternative 
splicing), the different proteins are distinguished by additional capital letters, for example the 
gbr-2/avr-14 gene encodes for two spliced products GBR-2A and GBR-2B.
•  Sequences that are predicted to be genes (Caenorhabditis elegans sequencing Consortium, 
1998) are named on the basis of the sequence cosmid plus a number, for example, ZC317.3.
v
SUMMARY
Glutamate-gated chloride ion channels (GluCl) are a family of ligand-gated ion channels 
structurally related to mammalian glycine and GABAa receptors, but pharmacologically distinct 
from all vertebrate ionotropic receptors. In nematodes and insects GluCls are the probable sites 
of action of the avermectin/milbemycin family of anthelmintics and insecticides, although the 
exact mode of action of the drugs, the anatomical localisation and native stoichiometry of the 
receptors remains unknown. This thesis provides a brief synopsis of our current understanding of 
the avermectin-sensitive channels in the free-living nematode Caenorhabditis elegans (C. 
elegans), in addition to addressing some of these fundamental questions.
The first aim of this study involved localising an existing GluCl clone (GBR-2) and examining 
the exact anatomical position in relation to other C. elegans subunits (G1uC1<X2 and (3). A 
polyclonal antiserum raised against the GBR-2 receptor subunits showed a specific expression 
pattern in the extrapharyngeal nerve ring and within three neuronal cell bodies in the metacorpus, 
corpus and terminal bulb regions that represent the M3 pharyngeal neurons. The completion of 
the C. elegans genome-sequencing project revealed a novel gene, ZC317.3, predicted to encode a 
polypeptide with high sequence identity to the previously cloned GluClai and a 2 subunits. Using 
a PCR-based strategy, the second objective of this thesis was the full-length amplification of this 
novel cDNA subunit. Successful isolation of a 1.4Kb cDNA subunit displayed 73-77% amino 
acid identity with other GluCla subunits and only 30-40% with GABA and glycine, indicating 
that this protein is also a member of the same amino-acid family of receptor proteins. The 
Xenopus oocytes expression system in conjunction with the two-electrode voltage clamp was 
used in the final objective of this study to investigate the functional expression of ZC317.3 
cDNA. The pharmacology of these subunits resembled that of recombinant GluCla2 receptors in 
a number of respects and as such is distinct from that of vertebrate G A B A a and glycine 
receptors. As with all GluCl a  subunits (with the exception of GluClai), when ZC317.3 cRNA 
was injected into Xenopus oocytes, a robust inward current in response to applied L-glutamate 
was observed. The agonist pharmacology of the ZC317.3 homo-oligomer produced robust, dose- 
dependent inward currents to L-glutamate yielding an EC50 of 1.9±0.03mM and a Hill coefficient 
of 1.46±0.1. Peak currents were approximately l|iA and desensitised rapidly. Application of 
ImM GABA, glycine, NMDA or histamine all failed to activate the ZC317.3 homo-oligomers. 
The L-glutamate-gated analogue, ibotenic acid activated the homo-oligomer producing weak 
non-desensitising currents resembling the GluCla2 and GluClp homomers. As with all GluCla 
subunits cloned to date, the ZC31.7.3 channels were irreversibly gated by lOOnM ivermectin, 
however, low concentrations of ivermectin failed to potentiate sub-maximal concentrations ofL-
glutamate. The modes of action of convulsant antagonists (3,3-bis-trifluoromethyl- 
bicyclo[2,2,1 ]heptane-2,2-dicarbonitrile (BIDN), a novel bicyclic dinitrile, picrotoxinin and 
insecticide fipronil) were investigated on GLC-3 homomers recorded from oocytes. Picrotoxinin 
failed to inhibit L-glutamate agonist responses at concentrations up to ImM. The present study 
provides the first evidence that a L-glutamate-gated chloride channel may be a molecular target 
for BIDN and the novel insecticide, fipronil, which reversibly inhibited glutamate-gated currents 
through the ZC317.3 receptor with an IC5o 0.22±0.07 and 11.53±0.11pM respectively. Further 
study of this receptor may provide insights into the molecular basis of non-competitive 
antagonism by these compounds. Based on the sequence of the polypeptide and functional 
expression data we conclude that this gene, designated glc-3, encodes a further GluCl subunit, 
GLC-3, from C. elegans.
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Abstract
The alternatively-spliced Caenorhabditis elegans gbr-2/avr-14 gene encodes two subunits of the nematode ligand- 
gated chloride channel family which forms an important molecular target for the avermectin and related an- 
thelminthics. We used reverse transcriptase-polymerase chain reaction (RT-PCR) techniques to isolate cDNAs 
encoding the products o f the gbr-2/avr-14  orthologues from the parasitic nematodes Haemonchus contortus and 
Ascaris suum. The predicted polypeptides possess all the characteristics o f subunits of the ligand-gated chloride 
channels, sharing greater than 80% amino-acid identity with their counterparts in C. elegans and with partial 
sequences from the filarial species Onchocerca volvulus and Dirofilaria immitis. The pattern of alternative splicing of 
the gbr-2/avr-14 gene observed in C. elegans is conserved in H. contortus but may not be in A. suum. Affinity-purified 
anti-GBR-2 antibodies were used to study the expression of these subunits in adult worms and they reacted 
specifically with the nerve ring, the ventral and dorsal nerve cords, the anterior portion of the dorsal sub-lateral cord 
and motor-neuron commissures in H. contortus. Specific immunofluorescence of the nerve cords was confirmed in A. 
suum; isolated muscle cells did not react with the antibody. © 1999 Elsevier Science B.V. All rights reserved.
Keywords: Ivermectin; Glutamate receptor; Nervous system; cDNA cloning
Abbreviations: CSPD, disodium 3-(4-methoxyspiro{l,2-dioxetane-3,2'-(5'-chloro)tricyclo[3.3.1.13,7]decan}-4-yl) phenyl phosphate; 
DIC, differential interference contrast; DIG, digoxigenin; Glu-Cl, glutamate-gated chloride channel; MOPS, 3-[7V-mor- 
pholino]propanesulphonic acid; RACE, Rapid amplification of cDNA ends; R T-PCR , reverse transcriptase-polymerase chain 
reaction.
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1. Introduction
The avermectins are a group of highly effective 
anthelminthics, insecticides and acaricides. The 
probable site of action of these compounds has 
been identified as a family of glutamate-gated 
chloride channels (Glu-Cl) [1], related to, but 
distinct from, the GABAa receptors, but which 
are not present in the vertebrate nervous system 
[2]. These channels have all the properties of the 
ionotropic receptor superfamily and are therefore 
presumably composed of five subunits. Each sub­
unit possesses a characteristic structure consisting 
of a long N-terminal extracellular domain and a 
C-terminal domain with four membrane-spanning 
regions (TM 1-4) with an intracellular loop be­
tween the third and fourth of these membrane- 
spanning regions. To date, the majority of 
published studies on these receptors have concen­
trated on those from the free-living nematode, 
Caenorhabditis elegans. Given the importance of 
the avermectins for the control of animal and 
human parasites, it is clear that the receptors from 
these organisms also need to be well understood. 
The relative difficulty and expense of obtaining 
sufficient parasite material to allow pharmacologi­
cal characterisation of the native receptors led us 
to adopt a molecular cloning approach with the 
ultimate aim of reconstituting these proteins in 
vitro.
Cully et al. [3] originally reported the cloning of 
two subunits of the Glu-Cl from C. elegans; an 
a-subunit which, when expressed in Xenopus 
oocytes formed chloride channels irreversibly 
gated by ivermectin, and a [3-subunit which 
formed channels gated by glutamate. The se­
quences of the polypeptides showed all the charac­
teristic motifs expected for inhibitory ligand-gated 
ion channels and possessed significant homology 
with vertebrate and invertebrate GABAa- and 
glycine-receptor subunits. When expressed to­
gether, the two subunits formed an ivermectin-po­
tentiated, glutamate-gated chloride channel. 
Subsequent work revealed that the a-subunit pos­
sessed a binding site for glutamate, but this was 
not coupled to opening of the ion channel [4]. 
Since then, the avr-15 gene has been demonstrated 
to encode, via alternative splicing, two forms of an
ol2 subunit; the longer of the two polypeptides can 
be expressed to form ivermectin and glutamate- 
gated chloride channels [5,6]. The avr-15 gene is 
expressed in the pharyngeal muscle cells pm4 and 
pm5, along with a number of neurons [5], though 
it is not clear which of the alternative gene prod­
ucts is present in these cells. The sequence of a 
putative a-subunit cDNA has been reported from 
Haemonchus contortus [7]; as yet no expression 
data are available. The C. elegans Glu-Cl (3 gene is 
also expressed in pm4 pharyngeal muscle cells [8]. 
A putative H. contortus orthologue of this gene 
was found to be expressed on motor neuron com­
missures and not in the adult pharynx [9]. This 
result suggests that the function of orthologous 
subunits may vary between nematode species and 
underlines the need for further characterisation of 
the Glu-Cl from parasites.
A further pair of cDNA clones encoding the 
alternatively spliced subunits GBR-2A and GBR- 
2B have also been isolated from C. elegans [10]. 
The pattern of alternative splicing probably results 
from a partial duplication of the original gene to 
produce two subunits with a common N-terminal 
extracellular domain that contains the agonist 
binding site. The differing C-terminal domains 
containing the transmembrane regions are likely 
to form the ion channel. Recently it has become 
that the gbr-2 gene is identical to avr-14, a gene 
involved in avermectin-resistance that is expressed 
in some neurons of the nerve ring and a couple of 
neurons in the tail (J. Dent & L. Avery, personal 
communication). Closely related sequences have 
been cloned from the filarial species Onchocerca 
volvulus and Dirofilaria immitis [11], but it is not 
clear whether or not the partial gene duplication is 
conserved. We report here the cloning of cDNAs 
encoding what we believe to be the H. contortus 
and Ascaris suum orthologues of the GBR-2/ 
AVR-14 subunits of C. elegans.
2. Materials and methods
2.1. Nematodes and genomic DNA
H. contortus eggs were supplied by Dr Gerald 
Coles, University of Bristol. Adult A . suum were a
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tion of 100 ng/ml and applied to the blot at 
68°C overnight. Following hybridization the blot 
was washed twice in 2 x wash buffer (2 x SSC, 
0.1% (w/v) SDS) at room temperature. This was 
followed by two washes in 0.5 x wash buffer 
(0.5 x SSC, 0.1% (w/v) SDS) at 68°C for 15 min 
each. The bound probe was detected by washing 
in 100 mM maleic acid, 150 mM NaCl; 0.3%(v/ 
v) Tween 20, pH 7.5 for 1 min. The membrane 
was incubated in blocking solution (Boehringer) 
by gentle agitation at room temperature for 1 h. 
This was then discarded and the membrane in­
cubated at room temperature in blocking solu­
tion containing the Anti-Digoxigenin antibody 
diluted 1:10000 for 30 min. This was followed 
by 2 x 1 5  min washes in 100 mM maleic acid, 
150 mM NaCl; 0.3%(v/v) Tween 20, pH 7.5. 
Following removal of washing buffer the mem­
brane was equilibrated in detection buffer (100 
mM Tris-HCl, 100 mM NaCl; pH9.5) for 2 min 
at room temperature. Meanwhile, a 25 mM 
stock solution of CSPD was diluted 1:100 in 
detection buffer. The membrane was then placed 
between two plastic sheets and 0.5 ml of the 
chemiluminescence substrate scattered dropwise 
on the surface. The top sheet was then lowered 
and wiped with a damp tissue to remove bub­
bles and the bag was sealed and incubated at 
room temperature for 5 min. To decrease time 
taken for the chemiluminescence substrate to 
reach equilibrium the membrane was incubated 
at 37°C for 15 min. The membrane was then 
exposed to X-ray film overnight.
2.4. Preparation o f anti-GBR-2 antibodies
Two 13 amino acids long peptides, LRTR- 
MVLRREFSC (GBR-2A) and ARVVLRLR- 
REYSC (GBR-2B), were synthesized on a 
Milligen 9050 Pep-synthesizer and purified by 
HPLC. The GBR-2B peptide was coupled to 
thyroglobulin by the ra-maleimidobenzoic acid 
A-hydroxysuccinimide ester (MBS) method [17] 
and New Zealand white rabbits subsequently 
immunized with the thyroglobulin-peptide conju­
gate as described [18]. Polyclonal anti-peptide 
antibodies were purified on an antigen column
prepared by covalently coupling the peptide to 
cyanogen bromide-activated Sepharose 4B. The 
column was extensively washed with 20 mM 
phosphate buffer (pH 7.3) and specific antibod­
ies eluted by 0.05 M diethylamine (pH 10.7). 
Antibody elution was monitored by measuring 
absorbance at 280 nm. 35 ml of eluant was di- 
alysed overnight against PBS and concentrated 
to 1.6 ml using PEG-20000.
2.5. Immunolocalisation o f GBR-2
Adult H. contortus were fixed and perme- 
abilised using the paraformaldehyde and 2-mer- 
captoethanol treatments described [18], followed 
by treatment with 115 collagenase digestion 
units/ml for 8 h. Affinity purified antibodies 
were diluted 1:5, 1:10 and 1:50 in 0.1% (w/v) 
BSA, 0.5% (v/v) Triton X-100, 0.05% (w/v) 
sodium azide and added to permeabilised worms 
for 24-72 h at 4°C. Unbound antibodies were 
removed by extensive washing with PBS and the 
worms treated with a 1:200 dilution of TRITC- 
conjugated goat anti-rabbit IgG (Sigma) 
overnight at 4°C. This was followed by exten­
sive washing with PBS/0.1% (v/v) Triton X-100 
after which the worms were mounted as de­
scribed [9] and viewed under a Zeiss LSM 510 
confocal microscope. The immunostaining exper­
iments were repeated on four separate occasions, 
each time using 10-12 worms.
Adult A. suum muscle cells and body wall tis­
sue were prepared for immunolocalisation by 
collagenase digestion and fixed in 3.7% (w/v) 
paraformaldehyde [17]. Collagenase treatment 
was with 115 collagen digestion units/ml (Sigma 
Type 1A) in 1 mM CaCl2, 100 mM Tris-HCl, 
pH 7.5 for 8-16 h at 37°C. The exact length of 
time the collagenase treatment was allowed to 
continue varied from batch to batch of worms 
and enzyme: the reaction was terminated when 
the cuticle was largely digested and the worms 
became very fragile. The preparations were 
washed in PBS and incubated in 1:10 and 1:50 
dilutions of anti-peptide antibody as described 
above. Washing and detection of bound anti­
body was as described for H. contortus.
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HPLC. The GBR-2B peptide was coupled to 
thyroglobulin by the m-maleimidobenzoic acid 
A-hydroxysuccinimide ester (MBS) method [17] 
and New Zealand white rabbits subsequently 
immunized with the thyroglobulin-peptide conju­
gate as described [18]. Polyclonal anti-peptide 
antibodies were purified on an antigen column
prepared by covalently coupling the peptide to 
cyanogen bromide-activated Sepharose 4B. The 
column was extensively washed with 20 mM 
phosphate buffer (pH 7.3) and specific antibod­
ies eluted by 0.05 M diethylamine (pH 10.7). 
Antibody elution was monitored by measuring 
absorbance at 280 nm. 35 ml of eluant was di- 
alysed overnight against PBS and concentrated 
to 1.6 ml using PEG-20000.
2.5. Immunolocalisation o f GBR-2
Adult H. contortus were fixed and perme- 
abilised using the paraformaldehyde and 2-mer- 
captoethanol treatments described [18], followed 
by treatment with 115 collagenase digestion 
units/ml for 8 h. Affinity purified antibodies 
were diluted 1:5, 1:10 and 1:50 in 0.1% (w/v) 
BSA, 0.5% (v/v) Triton X-100, 0.05% (w/v) 
sodium azide and added to permeabilised worms 
for 24-72 h at 4°C. Unbound antibodies were 
removed by extensive washing with PBS and the 
worms treated with a 1:200 dilution of TRITC- 
conjugated goat anti-rabbit IgG (Sigma) 
overnight at 4°C. This was followed by exten­
sive washing with PBS/0.1% (v/v) Triton X-100 
after which the worms were mounted as de­
scribed [9] and viewed under a Zeiss LSM 510 
confocal microscope. The immunostaining exper­
iments were repeated on four separate occasions, 
each time using 10-12 worms.
Adult A. suum muscle cells and body wall tis­
sue were prepared for immunolocalisation by 
collagenase digestion and fixed in 3.7% (w/v) 
paraformaldehyde [17]. Collagenase treatment 
was with 115 collagen digestion units/ml (Sigma 
Type 1A) in 1 mM CaCl2, 100 mM Tris-HCl, 
pH 7.5 for 8-16 h at 37°C. The exact length of 
time the collagenase treatment was allowed to 
continue varied from batch to batch of worms 
and enzyme: the reaction was terminated when 
the cuticle was largely digested and the worms 
became very fragile. The preparations were 
washed in PBS and incubated in 1:10 and 1:50 
dilutions of anti-peptide antibody as described 
above. Washing and detection of bound anti­
body was as described for H. contortus.
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HC-GBR2A MRNSVPLATR IGPMLALICT VSTIMSAVEA KRKLKEQEII QRILNNYDWR VRPRGLNASW PDTGGFVLVT VNIYLRSISK IDDVNMEYSA QFTFREEWVD
Ce-GBR2A ....................... M WHYRLTTILL IIS IIH S IR A  KRKLKEQEII QRILKDYDWR VRPRGMNATW PDTGGPVLVT VNIYLRSISK IDDVNMEYSA QFTFREEWTD
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OV-GBR2 . MNSFPIVCW ......................................................................................  QRTLKDYDWR VRPRGNNLSW PDTGGPVLVS VNIYLRSISK IDDVNMEYSA QFTFREEWND
Di-G BR2 ...........................................................................................................................................................................................................................................................................................................











































































2 0 1 TM1 30 0
HC-GBR2A AYTTQDIKYE WKEQNPVQQK DGLRQSLPSF ELQDWTKYC TSKTNTGEYS CLRTQMVLRR E . FS YYLLQL YIPSEMLVIV SWVSFWI DKD S VPARVTLGV
Ce-GBR2A AYTTQDIKYE WKEKKPIQQK DGLRQSLPSF ELQDWTDYC TSLTNTGEYS CLRTRMVLRR E . FS YYLLQL YIPSFMLVIV SWVSFWI DKD S VPARVTLGV
HC-GBR2B AYTTQDIKYE WKEQNPVQQK DGLRQSLPSF ELQDWTKYC TSKTNTGEYS CARVKLLLRR E . YS YYLIQL YIPCIMLLW SWVSFWI DKD AVPARVSLGV
AS-GBR2 AYTTDDIKYE WKLTNPIQQK EGLRQSLPSF ELQDVLTDYC TSKTNTGEYS CARVKLLLRR E .Y S YYLIQL YIPCIMLVW SWVSFWI DKD A VPARVSLGV
OV-GBR2 AYTTDDIKYE WKVKNPIQQK EGLRQSLPSF ELQDVLTEYC TSKTNTGEYS CARVLLLLRR EYFS YYLIQL YIPCIMLVW SWVSFWI DKD AVPARVSLGV
Di-GBR2 AYTTDDIKYE WKLKNPIQQK EGLRQSLPSF ELQDVLTDYC TSKTNTGEYS CLRTKMILRR E .F S YYLLQL YIPSFM LV ..
Ce-GBR2B AYTTQDIKYE WKEKKPIQQK DGLRQSLPSF ELQDWTDYC TSLTNTGEYS CARWLRLRR E .Y S YYLIQL YIPCIMLVW SWVSFWI DKD A VPARVSLGV








TM3 •  ' 400
ANVPPV SYTKlAIDVWI GVCLAFIFGA LLEFAWVtNYA ARKDM....................................................   . SCG QRMMKQLPQD GYRPLADSQP
ANVPPV SYTKAIDVWI GVCLAFIFGA LLEFALVNYA ARKDMTQ.........................................................VSQR IRQMKQLPTE GYRPLSASQG
SKLPPV SYIKAVDVWI GVCLAFIFGA LLEYAWNYY GRKEFLRKEK KKKTRLDDCV CPSE.....................RPALRLDLS NYRRRGWTP .
AKLPPV SY IK AVDVWI GVCLAFIFGA LLEYALVNYH GRQEFLKKEK KK
SKLPPV SYIKAVDVWI GVCLAFIFGA LLEYALVNYH GRQEFLKKEK KKKTGLQECL CPNDQPLTQG AHPITRLDMS VYRKRKLLN.
 TKLPPV SYIKAVDVWI GVCLAFIFGA LLEYAWNYY GRKEFLRKEK KKKTRIDDCV CPSD.....................RPPLRLDLS AYRSVKRLPI
4 0 1  ■  TM4 4 5 0
HC-GBR2A RTSFCCRIFV RRYKERSKRI D W SRLVFPI GYACFNVLYW AVYL M...........
Ce-GBR2A RSSFCCRIFV RRYKERSKRI DW SRLVFPI GYACFNVLYW AVYL M...........
HC-GBR2B LNRL. . LDML GRNADLSRRV DLMSRITFPS LFTAFLVFYY SVYV KQSNLD
AS-GBR2 MPGL. . RAWF SSTSEVSKRV DLISRFTFPS FFTCFLVFYY VTYV K...........
OV-GBR2
Di-GBR2
Ce-GBR2B IK R I. . SEIL STNIDISRRV DLMSRLTFPL TFFSFLIFYY VAYV KQSRD.
Fig. 2. Alignment o f nematode GBR-2 subunit sequences. The H. contortus (He) and A. suum (As) sequences described in this manuscript are shown aligned with 
orthologous sequences from C. elegans (Ce) [10], O. volvulus (Ov) and D. immitis (Di) [11]. Conserved residues are in bold face and the predicted membrane-spanning 
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Di-GBR2 ............................................................................................................................



























































































WKEQNPVQQK DGLRQSLPSF ELQDWTKYC TSKTNTGEYS CLRTQMVLRR E . FS YYLLQL YIPSFMLVIV SWVSFWI,DKD S
WKEKKPIQQK DGLRQSLPSF ELQDWTDYC TSLTNTGEYS CLRTRMVLRR E . FS YYLLQL YIPSFMLVIV SWVSFWI,DKD S
WKEQNPVQQK DGLRQSLPSF ELQDWTKYC TSKTNTGEYS CARVKLLLRR E. YS YYLIQL YIPCIMLLW SWVSFWLDKD A
WKLTNPIQQK EGLRQSLPSF ELQDVLTDYC TSKTNTGEYS CARVKLLLRR E. YS YYLIQL YIPCIMLVW SWVSFWI DKD A
WKVKNPIQQK EGLRQSLPSF ELQDVLTEYC TSKTNTGEYS CARVLLLLRR EYFS YYLIQL YIPCIMLVW SWVSFWLDKD A
WKLKNPIQQK EGLRQSLPSF ELQDVLTDYC TSKTNTGEYS CLRTKMILRR E . FS YYLLQL YIPSFM LV ..





















SYTKAIDVWI GVCLAFIFGA LLEFAWVNYA ARKDM........................... SCG QRMMKQLPQD
SYTKAIDVWI GVCLAFIFGA LLEFALVNYA ARKDMTQ....................... VSQR IRQMKQLPTE
SYIKAVDVWI GVCLAFIFGA LLEYAWNYY GRKEFLRKEK KKKTRLDDCV CPSE........ RPALRLDLS
SYIKAVDVWI GVCLAFIFGA LLEYALVNYH GRQEFLKKEK KK






TKLPPV SYIKAVDVWI GVCLAFIFGA LLEYAWNYY GRKEFLRKEK KKKTRIDDCV CPSD........ RPPLRLDLS AYRSVKRLPI
401 ■ TM4 450
HC-GBR2A RTSFCCRIFV RRYKERSKRI DWSRLVFPI GYACFNVLYW AVYL M ....
Ce-GBR2A RSSFCCRIFV RRYKERSKRI DWSRLVFPI GYACFNVLYW AVYL M ....
HC-GBR2B LNRL.. LDML GRNADLSRRV DLMSRITFPS LFTAFLVFYY SVYV KQSNLD
AS-GBR2 MPGL.. RAWF SSTSEVSKRV DLISRFTFPS FFTCFLVFYY VTYV K ....
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Fig. 2. Alignment of nematode GBR-2 subunit sequences. The H. contortus (He) and A. suum (As) sequences described in this manuscript are shown aligned with 
orthologous sequences from C. elegans (Ce) [10], O. volvulus (Ov) and D. immitis (Di) [11], Conserved residues are in bold face and the predicted membrane-spanning 
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Fig. 4. Confocal images o f anti-GBR2 antibody staining o f whole mounts o f adult H. contortus: (A) Staining o f the nerve ring (r), 
motor neuron commissures (m) traversing the body to join the dorsal cord (d). Projecting towards the nerve ring is the structure 
discussed in the text (1); (B) Staining of the motor neuron commissures in the central region of the body; (C) High resolution image 
of motor neuron commissures; (D) Negative control using antibodies pre-adsorbed with 4 pM o f the peptide. Affinity purified 
anti-GBR2 peptide antibodies were used at a 1:5 dilution. Scale Bar =  50 pm
form a similar analysis on mRNA from A. suum 
were frustrated by a low yield of RNA from the 
available tissue.
3.3. Localisation o f  GBR-2 expression
The GBR-2A and -2 B  subunits possess identi­
cal N-terminal amino-acid sequences until just 
prior to the first transmembrane domain. This 
made the design of synthetic peptides for the 
production of antibodies that could distinguish 
between the two subunits problematic. We synthe­
sised a peptide that corresponded to amino-acid 
residues 243-254 of the C. elegans GBR-2A and 
-2B subunits and used the GBR-2B peptide to 
immunise rabbits. When the resulting antiserum 
was tested by ELISA it recognised both peptides 
equally well (data not shown) and was therefore 
unlikely to distinguish between the GBR-2A and 
-2 B  subunits in immunolocalisation experiments. 
In C. elegans, these antibodies showed that GBR- 
2 polypeptides were present in the head region (L. 
Horoszok and A.J. Wolstenholme, unpublished). 
Given the high level of sequence conservation
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-2B subunits and used the GBR-2B peptide to 
immunise rabbits. When the resulting antiserum 
was tested by ELISA it recognised both peptides 
equally well (data not shown) and was therefore 
unlikely to distinguish between the GBR-2A and 
-2 B  subunits in immunolocalisation experiments. 
In C. elegans, these antibodies showed that GBR- 
2 polypeptides were present in the head region (L. 
Horoszok and A.J. Wolstenholme, unpublished). 
Given the high level of sequence conservation
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showed no neuronal staining, though background 
fluorescence of fragments of the cuticle of both 
species was seen.
4. Discussion
The sequences presented in this paper demon­
strate that the gbr-2favr-14 gene and its products 
are conserved and expressed in a variety of para­
sitic nematodes. This suggests that the subunits 
encoded by this gene, and the receptors that they 
help to form, play an important role in the ner­
vous system. The sequences of the H. contortus 
gbr-2 cDNAs are very similar to those of C. 
elegans, as would be predicted by the molecular 
phylogeny [19]. The pattern of alternative splicing 
to produce the GBR-2A and -2B polypeptides is 
also conserved and two mRNAs were detected on 
Northern blots. By contrast we were unable to 
find any evidence for alternative splicing of the A. 
suum gbr-2 gene and only a single cDNA could be 
amplified, though our inability to produce suffi­
cient mRNA for Northern blot analysis in this 
organism prevents us making any definitive state­
ment concerning the number of mRNAs tran­
scribed from the As-gbr-2 gene. This cDNA 
lacked the 5' terminal region of the mRNA pre­
dicted by sequence alignments. The A. suum gbr-2 
cDNA is probably truncated, since no suitable 
initiation codon and signal peptide could be iden­
tified in the sequence. We believe the most likely 
reason for this truncated product is that the SL1 
oligonucleotide primer was hybridising to similar 
internal sequences in the cDNA during the 5’ 
RACE reaction. The absence of evidence for any 
alternative splicing of the A. suum gene might 
indicate that the partial gene duplication that is 
responsible for the two mRNAs in C. elegans and 
H. contortus took place fairly late in the evolution 
of the nematodes. It is also possible that our 
detection of only a single gbr-2 mRNA in A. suum 
is a reflection of the tissue used in these experi­
ments. Attempts to resolve this issue by isolating 
the gene using PCR experiments on genomic 
DNA were inconclusive. The single A. suum 
cDNA we did amplify was clearly more closely
related to gbr-2B than gbr-2A, which might sug­
gest that this was the original gene product. A 
comparison of the sequences of the GBR-2 sub­
units from the filarial species O. volvulus and D. 
immitis (Fig. 2) with those reported here showed 
that the O. volvulus subunit was more similar to 
GBR-2B. There is insufficient sequence of the D. 
immitis subunit to be certain, but the short se­
quence of TM1 that is present in the database is 
more similar to that found in the GBR-2A than 
the -2B subunits.
At present, there have been no reports of the 
successful expression of any GBR-2 subunit in an 
in vitro system. Based on sequence similarities and 
the avermectin resistance associated with muta­
tions in the C. elegans gene [20] we believe that it 
is most likely that these subunits form part of the 
nematode Glu-Cl, but confirmation of this awaits 
successful expression studies.
We were able to produce antibodies against a 
synthetic peptide corresponding to a portion of 
the GBR-2B subunit that reacted specifically with 
neuronal structures in both parasitic species. 
ELISA experiments using peptides derived from 
the same part of the GBR-2 A and -2B sequences 
indicated that the antibody was not able to distin­
guish between the two gene products. Given the 
level of sequence conservation between the or- 
thologous subunits from all nematodes, we believe 
the antibodies are recognising the H. contortus 
and A. suum GBR-2 subunits in the immu­
nofluorescence experiments. The results suggest 
that one or both subunits are expressed widely in 
the nematode nervous system, including the nerve 
ring, but are not present on pharyngeal or body- 
wall muscle cells. The localisation results are con­
sistent with our ability to amplify gbr-2 cDNAs 
from dissected muscle strips of A. suum that 
would include the nerve cords. Reporter gene 
experiments have shown that the C. elegans gbr- 
21 avr-14 gene is expressed in neurons of the nerve 
ring and tail (J. Dent & L. Avery, personal com­
munication), and these results are also consistent 
with our observations. Mutations in avr-14 can, if 
combined with a mutation in a second subunit 
encoded by the avr-15 gene, lead to a high level of 
ivermectin resistance in C. elegans [20]. AVR-15 is
138 S. Jagannathan et al. /  Molecular and Biochemical Parasitology 103 (1999) 129—140
showed no neuronal staining, though background 
fluorescence of fragments of the cuticle of both 
species was seen.
4. Discussion
The sequences presented in this paper demon­
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encoded by this gene, and the receptors that they 
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gbr-2 cDNAs are very similar to those of C. 
elegans, as would be predicted by the molecular 
phylogeny [19]. The pattern of alternative splicing 
to produce the GBR-2A and -2B polypeptides is 
also conserved and two mRNAs were detected on 
Northern blots. By contrast we were unable to 
find any evidence for alternative splicing of the A. 
suum gbr-2 gene and only a single cDNA could be 
amplified, though our inability to produce suffi­
cient mRNA for Northern blot analysis in this 
organism prevents us making any definitive state­
ment concerning the number of mRNAs tran­
scribed from the As-gbr-2 gene. This cDNA 
lacked the 5' terminal region of the mRNA pre­
dicted by sequence alignments. The A. suum gbr-2 
cDNA is probably truncated, since no suitable 
initiation codon and signal peptide could be iden­
tified in the sequence. We believe the most likely 
reason for this truncated product is that the SL1 
oligonucleotide primer was hybridising to similar 
internal sequences in the cDNA during the 5’ 
RACE reaction. The absence of evidence for any 
alternative splicing of the A. suum gene might 
indicate that the partial gene duplication that is 
responsible for the two mRNAs in C. elegans and 
H. contortus took place fairly late in the evolution 
of the nematodes. It is also possible that our 
detection of only a single gbr-2 mRNA in A. suum 
is a reflection of the tissue used in these experi­
ments. Attempts to resolve this issue by isolating 
the gene using PCR experiments on genomic 
DNA were inconclusive. The single A. suum 
cDNA we did amplify was clearly more closely
related to gbr-2B than gbr-2 A, which might sug­
gest that this was the original gene product. A 
comparison of the sequences of the GBR-2 sub­
units from the filarial species O. volvulus and D. 
immitis (Fig. 2) with those reported here showed 
that the O. volvulus subunit was more similar to 
GBR-2B. There is insufficient sequence of the D. 
immitis subunit to be certain, but the short se­
quence of TM 1 that is present in the database is 
more similar to that found in the GBR-2A than 
the -2B subunits.
At present, there have been no reports of the 
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in vitro system. Based on sequence similarities and 
the avermectin resistance associated with muta­
tions in the C. elegans gene [20] we believe that it 
is most likely that these subunits form part of the 
nematode Glu-Cl, but confirmation of this awaits 
successful expression studies.
We were able to produce antibodies against a 
synthetic peptide corresponding to a portion of 
the GBR-2B subunit that reacted specifically with 
neuronal structures in both parasitic species. 
ELISA experiments using peptides derived from 
the same part of the GBR-2A and -2B sequences 
indicated that the antibody was not able to distin­
guish between the two gene products. Given the 
level of sequence conservation between the or- 
thologous subunits from all nematodes, we believe 
the antibodies are recognising the H. contortus 
and A. suum GBR-2 subunits in the immu­
nofluorescence experiments. The results suggest 
that one or both subunits are expressed widely in 
the nematode nervous system, including the nerve 
ring, but are not present on pharyngeal or body- 
wall muscle cells. The localisation results are con­
sistent with our ability to amplify gbr-2 cDNAs 
from dissected muscle strips of A. suum that 
would include the nerve cords. Reporter gene 
experiments have shown that the C. elegans gbr- 
2/avr-14 gene is expressed in neurons of the nerve 
ring and tail (J. Dent & L. Avery, personal com­
munication), and these results are also consistent 
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combined with a mutation in a second subunit 
encoded by the avr-15 gene, lead to a high level of 
ivermectin resistance in C. elegans [20], AVR-15 is
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Chapter 1
Introduction
1.1 Ligand-gated ion channel family
1.1.1 Synaptic transmission within the ligand-gated ion channel family
Chemical synaptic transmitters mediate a flow of information allowing cells to communicate with 
each other throughout the body. The first evidence that neurotransmitters served as chemicals released 
from nerve terminals was presented in 1921 when a substance was released from the vagus nerve it 
acted on the heart preparation below, to cause a reduction in the rate of its beating. This substance was 
later shown to be acetylcholine. With the later discovery of neurotransmitters, their antagonists, and 
precursors the underlying mechanisms in which these transmitters activated distinct classes of 
receptors was established. Since then neurotransmitter receptors have been divided into two classes: 
(1) ionotropic receptors, that elicit a rapid opening of an ion channel only when the receptor is 
occupied by an agonist; and (2) metabotropic receptors, which mediate a response indirectly via a G- 
protein and/or other intermediate secondary messengers.
In this and subsequent sections I explored the structure, pharmacological and functional classification 
on ionotropic receptors with particular relevance to the L-glutamate-gated anion channels.
1.1.2 Structural relationship of ligand-gated ion channels
Initial biochemical and pharmacological studies on ligand-gated ion channels utilised highly enriched 
nicotinic receptor synapses isolated from the electric ray, Torpedo. Subsequent cloning of nicotinic 
acetylcholine and related receptor subunits (nAChR) (Changeux, 1993) have revealed an extensive 
family of ionotropic neurotransmitter receptor subunits, which are forever increasing in size. 
Comparison of these protein subunits to y-aminobutyric acid (G A B A a&c), glycine, 5- 
hydroxytryptamine (5-HT3) and glutamate-gated cation channels revealed considerable sequence 
homology (sharing 20-40% identity) and protein similarities, indicating strong evolutionary 
conservation. Information obtained by hydrophobicity and membrane topology studies (Karlin and 
Akabas, 1995) has lead to the identification of four main structural families of ligand-gated ion 
channel; glutamate-gated cation channels, P2 purinoceptors (P2x), tyrosine-kinase-linked type and the 
“cys-loop” receptor family (which includes nACh, 5-HT3, G A B A a&c, glycine and inhibitory 
glutamate-anionic channels (GluCl) (Fig. 1.1).
The cys-loop receptor family at present consists of five receptor types; GABA(a+q, glycine, 5HT3, 
GluCl and the archetypal example nACh. Structural studies have determined that these receptors are a 
multimeric complex composed of five cylindrical subunits that traverse the membrane (Brisson and 
Unwin, 1985; Unwin, 1995) creating a narrow central pore that acts as a pathway for specific ions, 
(Fig. 1.2, Miyazawa et ol., 1999). The membrane pore is lined by five a-helical M2 domains (one
from each subunit) (Changeux et al., 1992) containing the gate of the channel in the absence of the 
ligand (Unwin, 1993).
Each subunit consists of a large extracellular N-terminal domain, which contains consensus sequences 
for N-linked glycosylation (Karlin and Akabas, 1995) and amino-terminal signal peptides. Signal 
peptides are cleaved co-translationally and after inserted into the membrane of the endoplasmic 
reticulum. A constant motif found in the amino-terminal of these receptors is two cysteine amino 
acids that form a disulphide bridge separated by 13 amino acids. The consensus sequence 
(CPMxLxxYPxDxQxC) for this feature has led to the designation “cys-loop” receptor family and is 
involved in assembly of the receptor subunit (Green and Wanamaker, 1997).
The carboxyl half of the subunits contains four extended hydrophobic domains, 19-27 amino acids in 
length, which form the transmembrane regions M1-M4 (Popot and Changeux, 1984). By traversing 
the plasma membrane they allow the receptor to be exposed to both internal and external chemical 
signals. Short regions of hydrophilic amino acids separate the first three transmembrane domains, with 
a longer cytoplasmic loop separating M3 and M4. The intracellular loop is of a mixed hydrophilicity 
and may contain consensus sequences for protein phosphorylation. Most ligand-gated ion channels are 
subjected to phosphorylation, which may have great importance for regulating receptor function 
(Moss et al., 1995; Moss and Smart, 1996; Tanaka and Nishizuka, 1994).
Initial hydropathy studies (Karlin and Akabas, 1995) indicated that excitatory glutamate subunits were 
considered to transverse the membrane four times (Hollmann and Heinemann, 1994), as seen typically 
with the cys-loop receptor subunits. This allows the N-terminal and the carboxyl-terminus regions to 
face the extracellular space, with the predicted binding site on the N-terminal domain. Further 
observation of endogenous glycosylation sites attached to the intracellular loop inside the lumen of the 













Figure 1.1 Schematic drawings of ligand-gated ion channels, (a) The cys-loop receptor family composed of four hydrophobic transmembrane regions (M l-4), with a long 
intracellular loop (M3-M4) and an extracellular amino-terminal, (b) Proposed structure of glutamate-cation receptor family, consisting of a large amino-terminal that 
combines with the extracellular M3-M4 loop to form an agonist-binding site. The C-terminus is intracellular and the M2 domain does not transverse the membrane. 
Drawings based on proposed electron diffraction imaging and hydropathy studies (Unwin, 1993; Karlin and Akabas, 1995).
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Following much conflicting evidence (McGlade-McCulloh et al., 1993; Yakel et al., 1995), it has 
been currently accepted by most researchers (Bennet and Dingledine, 1995; Hollmann, 1997; Kuner et 
al., 1996) (Fig. 1.1b) that the pore forming glutamate receptor subunits consist of three 
transmembrane regions (Ml, M3 and M4), suggesting that the M2 sequence does not traverse the cell 
membrane but forms a re-entrant loop within it. Other dissimilarities from the cys-loop receptors soon 
emerged. The overall sequence homology of this class with the cys-loops is very low, especially 
within the M2 region. The amino-terminal domain of the glutamate-cation subunit is approximately 
twice as long (400 amino acids) (Barnard, 1992; Unwin, 1993) as the cys-loop receptor family and 
fails to contain the conserved cys-loop feature (Hollmann et al., 1994b). The amino acid region 
separating the M3 and M4 domains is extracellular and appears to form part of the agonist binding site 
with the TV-terminal domain (Hollmann, 1997), as opposed to the C-terminal which is intracellular 
(Fig. 1.1b). By comparison, the topology of the P2x channels is substantially different from both the 
cys-loop and the glutamate-sensitive receptors. The P2X receptors consist of two hydrophobic domains 
that transverse the membrane and are separated by a hydrophilic extracellular loop of approximately 
270 amino acids (Brake et al., 1994; Vallera et al., 1994).
1.1.3. Structural-assembly o f the cys-loop receptor subunits
Images derived from electron microscopy of the nAChR postsynaptic membranes from the Torpedo 
marmorata electroplax have outlined three dimensional structures for open and closed channel forms 
(Unwin, 1993, Unwin, 1995;) whilst retaining the receptor within its native environment. The 
experiment consists of spraying droplets of ACh whilst rapidly freezing the membranes in a low-salt 
solution trapping the structural response (Unwin, 1995). Comparison of the receptor open-channel 
structure with that of the resting state has allowed conclusions to be drawn concerning the mode of 
action.
Unwin’s (1993, 1995) observations of the nAChR resolved the structure to be cylindrical with an 
overall length of 125A and a diameter of 80A (Fig. 1.3). The N-terminal region of the receptor 
reaches 60A from the membrane surface and contains two cavities thought to be the acetylcholine 
(Ach) binding pockets. Furthermore, the cavities appear to be the correct size and shape to 
accommodate the acetylcholine molecule (Miyazawa et al., 1999). In a recent study (Miyazawa et al., 
1999) narrow openings in the wall of the receptor from the vestibule to the extracellular acetylcholine 
binding sites have been observed and are proposed to be the primary route for acetylcholine molecules 
to gain access to the agonist binding site (Fig. 1.2).
5
Figure 1.2 Schematic drawing summarising certain aspects o f receptor structure (courtesy of
Miyazawa et al. 1999).
1. Acetylcholine molecules enter the extracellular region o f the vestibule before passing through 
narrow tunnels that lead towards binding pockets
2. Gate-forming amino acid residues line the M2 region two-thirds down the channel.
3. Upon gating the channel wall pores within the cytoplasmic domain act as ion filters regulating the 
movement o f ions that enter or leave the cell. Rapsyn molecules and the cytoplasmic loop region 





Figure 1.3 Electron diffraction imaging outlined a three-dimensional structure for the nAChR from the 
postsynaptic membranes of the Torpedo marmorata (Image courtesy o f Karlin and Akabas, 1995). 
The cylindrical receptor was found to be 80A in diameter and 125A in length, with most o f the protein 
mass (55%) on the synaptic side of the membrane and 20% on the cytoplasmic side. The extracellular 
portions o f the nAChR molecule extends 60A into the synapse, with the ACh binding site roughly 
33A above the membrane, while the intracellular domain extends 15A into the cytoplasm (Unwin, 
1995). At the synaptic face the pore is 20-25A in diameter but narrows to 7 A where the receptor 
traverses the membrane bilayer. Image courtesy o f Changeux, 1993).
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The water-filled channel pore passes longitudinally extending the full length of the receptor. At the 
surface of the pore the diameter of the lumen is 20A, but narrows rapidly to approximately 7 A two- 
thirds of the way through bilayer and then widens out as it approaches the cytoplasmic portion 
(Unwin, 1993). The narrow strip of density that bridges the pore in the closed state is thought to 
correspond to the receptor gate (Miyazawa et al., 1999; Unwin, 1993). The pore lining is thought to be 
composed of five rod-shaped columns (corresponding to the M2 domains of each subunit), which 
form the pore lining. In a closed configuration the midpoints of the rods appear kinked and slope 
towards the centre of the channel. The pore is therefore exposed to ions in the extreme extracellular 
region but become closed off as the centre of the channel kinks. Upon gating small clockwise 
rotations of three rod-shaped proteins within the a-subunit binding domains produce conformational 
changes causing the disappearance of the a  subunit-binding cavity (Miyazawa et al., 1999). The 
disturbance becomes propagated down the shaft of the receptor resulting in distortion of all five rod­
shaped columns that surrounds the central pore (Unwin, 1995). Clockwise rotation of these kinked 
sections lining the pore’s lumen causes them to be swung sideways from the axis of the channel, 
opening the lumen by 9-10A, whilst the cytoplasmic portion rotates inwards (Unwin, 1995).
The cytoplasmic base of the receptor in the closed formation also restricts the passage of ions by a 
central mass of clustering rapsyn protein (Miyazawa et al., 1999). Ion flow from both directions has to 
traverse narrow openings (pores approximately 10A in diameter protrude from each subunit) from 
inside the channel wall before entering or leaving the pore (Fig. 1.2) (Miyazawa et al., 1999). It is 
plausible that the pores act as filters excluding anions and cations into the channel facilitating 
transport (Miyazawa et al., 1999). In addition the cytoplasmic loop structure (M3-4) lies at the base of 
the subunit and has also been proposed to act as a filter (Popot and Changeux, 1984). The intracellular 
loop is made up of mixed hydrophilicity and is able to discriminate between ions of different charge. 
For cation conducting channels (ACh, 5-HT3) the net charge of the loop would be negative, and for 
the anion channels (GABA, glycine, IgluCl) positive. This proposed structural model of the nACh 
receptor is thought to be similar to that of each of the five receptor types of the cys-loop family.
1.1,4. Ion selectivity within the pore
Unwin’s structural data is in agreement with experimental data obtained from chemical labelling and 
mutagenesis (Unwin, 1995; Unwin, 1993). Early indications that the M2 domain may contribute to the 
lining of cys-loop receptors came from photoaffinity labelling studies. Non-competitive nACh 
blocking reagents such as the neuroleptic chlorpromazine, the anticonvulsant MK801, the dissociative 
hallucinogenic, anaesthetic phencyclidine (PCP) and the anaesthetic lidocaine derivative (Karlin and 
Akabas, 1995; Revah et al., 1990) bound at various depths within the pore. At different levels five 








Figure 1.4 Model o f the amino acid ring structure within the channel pore (adapted from Galzi and 
Changeux, 1995).
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The seven rings identified govern the pharmacological and ion transport properties o f the pore, three 
in particular have been classified as the major determinants o f the rate of ion transport through the 
nAChR channel (Imoto et al., 1988). The three most important ionic rings are composed o f clusters of 
either negative or positive charged residues that are situated in between the transmembrane regions 
(Fig 1.5). The extracellular ring in the M2-M3 portion is located close to the external mouth o f the 
channel and is thought sufficient to determine ion selectivity (Imoto et al., 1988). The intermediate 
ring is positioned between the two other rings, towards the cytoplasm end. Anionic channels differ 
from cationic receptors in the charge of the intermediate ring (Fig. 1.5, Imoto et al., 1988). The third, 
cytoplasmic ring in all nAChR and some GABA receptors contains a negative charge, which is based 
at the intracellular end (in the M l-M2 region) and has a weak effect on ion flow (Imoto et al., 1988).
Positively charged groups (arginine and lysine residues) cluster at the mouth o f the channel of the M2 
domain o f anion channels and determine ion selectivity into the cell (Barnard, 1992). Similarly cation 
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Figure 1.5. Alignment o f M2 amino acid sequence from nACh, rat GABA a i and glycine a i receptor 
subunits indicating the locations o f the three ionic rings, intracellular (|, position -4 ), intermediate (|, 
position -1 )  and extracellular ( , position 20); (alignment taken from Noda et al., 1982). The 
conserved equatorial ring of leucine residues ( | position 9), has been hypothesised to form the receptor 
gate (Unwin, 1993). This figure uses the terminology o f Miller, which assigns position 1’ to the amino 
terminus o f the M2 domain (the cytoplasmic end, Miller, 1989).
1.1.5 The channel ‘gate9
During resting or desensitised states the channel ‘gate’ prevents the flow of ions traversing the ion 
channel. To date there is some debate as to the location of the gate. Structural studies have suggested 
that conserved equatorial ring of leucine (Fig. 1.5, the number 9’leucine l »  side-chains projecting 
towards the lumen from the kink of each subunit may form a tight hydrophobic ring, occluding the 
channel to ions and therefore serving the purpose as a receptor gate (Unwin, 1993). In addition, 
leucine residues have been measured to project 7-8A (Richmond and Richards, 1978) confirming that 
a barrier occluding the centre of the pore could be formed. Mutation of the leucine residue to amino 
acids of different size and polarity have been found to affect the functional properties of the channel 
(Bertrand et al., 1992; Revah et al., 1991) causing noticeable modifications to ion flow when 
responding to acetylcholine. Substitution of the leucine amino acid with a smaller, serine or alanine 
residue resulted in a receptor that still gates (Bertrand et al., 1992; Labarca et al., 1995; Revah et al., 
1991), suggesting the leucine residue may influence the ion transport of the receptor, but does not 
occlude the pore. In addition, residues deeper than the leucine were labelled in SCAM analysis in both 
GABA (Xu and Akabas, 1993) and nACh (Akabas et al., 1994) channels in the closed formation, 
indicating the channel gate is more likely to be located on the intracellular end of the M2 (closer to the 
M l-M2 loop), rather than two-thirds down the M2 as originally proposed. This data indicates that the 
activation of a receptor is complex and the exact location of the channel gate is still clearly disputed 
by some authors.
1.2 Ligand-gated chloride channels
Despite the fact that vertebrate and invertebrate species fundamentally use the same neurotransmitters, 
distinct pharmacological differences in key target sites have been identified at the physiological and 
molecular level. In particular, the increasing knowledge in ligand-gated chloride channels seems to be 
particularly beneficial for attempts to exploit these sites for future drug development. The remaining 
components of this chapter explore a brief pharmacological profile of the ligand-gated chloride 
channels, which is relevant to inhibitory GluCls and experimental chapters to follow.
1.2.1 GABA and glycine receptors
The discovery of GABA was made in the early 1950s and the first report of GABA receptors was 
from invertebrate preparations of lobster and crayfish, where GABA exerted an inhibitory response 
that was later found to be blocked by picrotoxin (Bazemore et al., 1957).
To date, vertebrate GABA receptors have been classified into three distinct subtypes: the ionotropic 
GABAa and GABAc receptors, which are members of the cys-loop ion channel family (Olsen and 
Tobin, 1990) and the metabotropic GABAb receptors which link to an effector channel via G-proteins 
(Andrade et al., 1986) coupled to a second messenger system. The GABAa subtype forms a hetero- 
oligomeric protein composed of seven distinct polypeptide subtypes ai-cc6, Prp4 Y1-Y4, 6, n and 0 
(Sinkkonen et al., 2000). The application of GABA leads to a rapid, reversible change in the chloride 
conductance of the cell membrane. Various combinations of these subunits are combined to form 
receptors of differing pharmacology and location within the nervous system (Betz, 1990; Macdonald 
and Olsen, 1994). Sequence comparisons of these polypeptides subtypes indicate they show 20-40% 
amino acid identity with each other, 10-20% amino acid identity with subunits of the nACh, glycine 
and IGluCl receptors and 60-80% amino acid identity amongst the individual members of the subunit 
family (Olsen and Tobin, 1990).
Pharmacologically the vertebrate GABAa and the GABAc receptor subunits can be distinguished by 
the antagonist bicuculline. The vertebrate GABAa receptors are competitively antagonised by 
bicuculline, whereas GABAc are insensitive (Feigenspan et al., 1993; Sieghart, 1995). Conversely the 
majority of insect and nematode GABA receptors are insensitive to bicuculline, pharmacologically 
distinguishing them from their vertebrate counterparts (Sattelle, 1990). The GABAa receptor complex 
contains a large number of binding sites for drugs, notably the benzodiazepines (BZDs), barbiturates 
and steroids (Olsen and Tobin, 1990; Sieghart, 1995) which is outside the scope of this thesis, and 
only a few aspects of particular relevance to the experimental chapters that follow will be mentioned.
More extensive reviews on GABAa pharmacology can be found in: Sattelle, 1990; Sieghart, 1995; 
Krogsgaard-Larsen, 1994; Macdonald, 1994 and on glycine receptors in Becker, 1992; Vannier, 1997.
Recently the first full-length Drosophila melanogaster GABA-gated chloride channel RDL (resistant 
to dieldrin) was cloned (ffrench-Constant et al., 1993a), which surprisingly showed higher overall 
sequence homology to vertebrate glycine receptors (31-32%) than GABAa or GABAc subunits (27- 
29%), revealing that RDL is a member of a novel class of GABA receptor subtypes (Zhang et al., 
1994). In addition, unlike most vertebrate GABAa receptor subunits, the RDL forms a highly 
functional homomeric receptor. To date, insect GABA-gated chloride channels are not readily 
classified as GABAa or GABAc type, but their antagonist profile is clearly distinct from their 
vertebrate counterparts (Sattelle, 1990) and potentially provides opportunities to exploit this receptor 
site for the development of selective, inhibitory neuromuscular drugs (Rauh et al., 1990).
Vertebrate glycine-gated chloride channels tend to predominate in the spinal cord and brain stem 
regions, compared to GABA receptors, which are abundant in the cortex and cerebellum regions 
(Becker, 1992). Molecular cloning and affinity purified glycine receptor preparations have revealed 
four subtypes of the glycine receptor a  subunits (denoted a  1-4), but as yet no variations on the p 
subtype have been identified. Analysis of the amino acid sequence revealed these receptor subtypes to 
be highly homologous to inhibitory L-glutamate-gated anion channels found in invertebrates 
(approximately 40%), but was shown to differ in terms of both pharmacology and localisation. 
Glycine receptors are confined to vertebrate tissues and are gated by glycine, where as GluCls have 
only been identified in invertebrates and are mostly influenced by L-glutamate. Consistent with 
GluCls, the glycine receptors contain a second pair of cysteine residues within the N-terminal that 
does not exist in GABA or cation channel. Expression of a  subunits form glycine-sensitive currents, 
which are blocked both by strychnine and picrotoxinin (Becker, 1992).
1.2.2 L-glutamate-gated chloride channels
The L-glutamate-gated chloride channels (GluCls) are an important group of ionotropic receptors, so 
far only known to be present on invertebrate nerve and muscle cells. The GluCls are closely related to 
GABAa and glycine receptors, and are presumed to possess the same pentameric structure (Section 
1.1.2) (reviewed by Cleland, 1996), sharing about 40% identity with glycine receptor subunits and 30- 
35% identity with GABAa receptor subunits at the amino-acid level. Phylogenetic analysis of GluCl 
subunit sequences has led to the suggestion that they may be a distinct class of ionotropic receptors 
orthologous to vertebrate glycine receptors (Vassilatis et al., 1997a).
Studies on the physiology and pharmacology of cloned and expressed GluCls has provided further 
insights into the properties and functions of inhibitory ionotropic receptors and opportunities for the
development of novel anti-parasitic drugs. There is now strong evidence that the 
avermectin/milbemycin family of endectocides and insecticides targets the GluCls (Arena et al., 1995; 
Arena et al., 1992a; Cully et al., 1996a; Cully et al., 1994), although not all GluCl subunits are 
sensitive to these compounds in vitro.
In the free-living nematode C. elegans, six cDNAs encoding two classes of putative GluCl subunits 
have been identified. The first two subunits to be cloned from C. elegans have been designated 
GluCla and GluClp and were isolated using an expression cloning strategy (Cully et al., 1994). The 
glc-1 and glc-2 genes encode these two subunits respectively. Later, Dent et al. (1997), reported the 
cloning of a subunit encoded by the avermectin resistance gene, avr-15, with a high level of sequence 
identity (75% at the amino-acid level) to GluCla but only 45% identity to GluClp and it was therefore 
designated GluCla2. Alternative splicing of avr-15 resulted in two gene products -  a short (G luCls) 
and a long (GluCla2L) form, that share ligand-binding and transmembrane domains (Dent et al., 
1997). The long form, GluCla2L, included a long, 171 amino acid, N-terminal extension unrelated to 
any other ionotropic channel subunit sequence. In a later study Laughton et al., (1997b) reported the 
cloning of two further C. elegans subunit cDNAs, GBR-2A and GBR-2B that were closely related in 
sequence to the known GluCl subunits. These two subunits are alternatively spliced products of a 
single gene, gbr-2. The GBR-2A cDNA contains the channel encoding sequence of GBR-2B and both 
subunits possess identical extracellular domains, suggesting that these nematodes will possess 
receptors with identical ligand binding sites but slightly different channel properties.
Dent et al., (2000) demonstrated that the avr-14 ivermectin resistant gene encodes the GBR-2 
subunits, which have now been designated GluCla3A and ^b- A more distantly related ionotropic 
receptor subunit cDNA, C27H5.8, was cloned using information from the genome sequence project 
(Cully et al., 1996b), however, to date no functional data are available for this subunit. In the 
Drosophila melanogaster species a single GluCl subunit has been cloned from the insect heads 
(DrosGluCla) sharing ~48% sequence identity to the C. elegans GluCla subunits and 43% with the 
GluClp subunit (Cully et al., 1996a).
BLAST searches of the C. elegans genome sequence revealed a further predicted polypeptide, 
ZC317.3, with a high amino-acid identity to the cloned GluCl subunits. We report here the 
amplification and expression of the cDNA encoding this polypeptide. Based on the sequence of the 
polypeptide and functional expression data we conclude that this gene, designated glc-3, encodes a 
further GluCl subunit, GLC-3, from C. elegans (see chapter 4 and 5).
1.2.3 Ligand-binding sites o f GluCl receptors
Studies of agonist binding sites to date have been particularly dependent upon photoaffinity labelling 
and mutagenesis studies. The formation of chimaeric homo-oligomers subunits has been advantageous 
in locating the essential agonist-binding site within the N-terminal domain. Evidence of discrete, 
homologous regions within the N-terminal of the cys-loop receptor and the extracellular loop between 
M2 and M3 have been found to influence the binding site in all ligand-gated ion channels. In a 
previous study (Etter et al., 1996), chimaeras composed of the N-terminal of C. elegans GluCla 
receptor subunit (glutamate-insensitive subunit), with the channel domain of GluClp (glutamate- 
sensitive subunit) yielded receptors with greater glutamate sensitivity than seen with the wild type 
GluClp alone. This indicates that the GluCla homo-oligomer contains the necessary binding site 
within the N-terminal domain, but the C-terminal does not couple ligand binding to channel gating. 
Consequently, not only providing further evidence for the location of the agonist binding site in the N- 
terminal domain, but in addition, showing that the ligand binding region is coupled to channel gating 
within the C-terminal.
The GABA and nACh binding sites are formed by the interface of two adjacent subunits (Middleton 
and Cohen, 1991). If we assume similar protein folding occurs in all the cys-loop family it is possible 
that for the agonist binding sites of L-glutamate and ibotenic acid to exist it will require the co­
assembly of two structurally distinct regions at the subunit interface. Thus, for the L-glutamate 
binding site to exist it will require the interface of two distinct a  subunit classes (for example, two 
GluCla2 subunits or one a 2 and one p subunit). The structural location of the amino acids from the 
Torpedo nACh receptor has led to the proposal of a multiple loop model-binding site. Three agonist- 
binding domains have been identified from the nACha subunits (corresponding to A, B and C), (Kao 
et al., 1984; Middleton and Cohen, 1991) and three from the non-a subunits, corresponding to D, E 
and F, (Czaijkowski and Karlin, 1995; Kao et al., 1984; Middleton and Cohen, 1991).
Certain key amino acids that have been identified as potential binding sites in GABA receptor 
subunits have also been found to be conserved in GluCl receptor subunits (Wolstenholme, 1997). The 
residues that appear particularly conserved are at positions 212 (Q), 221-224 (YaxT) and 
268-271 (TGxY), which correspond to 157-160 and 202-205 of the rat GABAa p2 subunit (Fig. 1.6 
and Fig. 1.7b). The conservation of these sites indicates their lack of participation in differentiating 
between amino acid ligands (Wolstenholme, 1997). A number of residues were also common to all 
cys-loop receptor subunits (WxDxxL and WxPD, Fig. 1.7a) and have been predicted to play some role 




Figure 1.6 Potential amino acids involved in the glutamate-binding site o f the GluCl receptor 
subunits. Key amino acids involved in the GABAa receptor binding sites (Olsen and Tobin, 1990) 
were also conserved in the glutamate-binding site of the GluCl receptor subunits (Wolstenholme, 
1997). Schematic diagram courtesy of S. Wonnacott (adapted from a slide presentation). Key; C= 
cysteine loop, P= phosphorylation site, M (1 to 4)= transmembrane domains, F= phenylalanine, Y= 
Tyrosine, T= threonine, Q= Glutamine, not to scale.
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Figure 1.7 Ligand-gated ion channel receptor subunit alignment showing conservation about the 
GABA binding regions, a) The two highly conserved regions include WxDxxL and WxPD (high 
lighted in black) (reviewed in Smith and Olsen, 1995). GABA, glycine and nACh sequences are from 
rat, whereas the GluCl sequences are taken from C. elegans. b) Residues indicated for GABA agonist 
binding site are conserved in C. elegans GluCl subunits (highlighted in black) indicating they are not 
involved in discriminating between GABA and glutamate ligands (Wolstenholme, 1997).
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1.3 Ligand-gated chloride channel pharmacology
1.3.1 L-glutamate and structurally related analogue, ibotenic acid
Recent studies have indicated that the classical excitatory ligand L-glutamate also now functions as an 
inhibitory ligand in invertebrates. The agonist profile of the L-glutamate-gated chloride channel is 
quite distinct from that of the excitatory channels. In general both classes of subunits are activated by 
L-glutamate and ibotenic acid, but the anionic receptors are insensitive to quisqualic acid, kainic acid 
and N-methy 1-D-aspartate (NMDA) (Cull-Candy, 1976; Duce and Scott, 1985; Lea and Usherwood, 
1973a). The excitatory glutamate agonists, kainate, NMD A, a-amino-3-hydroxyl-5-methyl-4- 
isoxazole propionic acid (AMPA), and quisqualate all failed to gate the inhibitory glutamate-gated 
chloride channel expressed from total C. elegans mRNA (Arena et al., 1992a).
Ibotenic acid, a structural analogue of glutamate, gates the native glutamate-sensitive chloride 
channels present in locust muscle, locust neurons and lobster muscles (Cull-Candy, 1976; Lea and 
Usherwood, 1973b; Lea and Usherwood, 1973a; Wafford and Sattelle, 1989) in addition to expressed 
in vitro GluCl receptors (Cully et al., 1992a, 1994; Dent et al., 1997, 2000). However, ibotenate was 
found to be four times more potent than glutamate (EC50 of 70pM compared to 300pM for L- 
glutamate) in oocytes injected with total mRNA (Arena et al., 1991; Cully et al., 1994). In contrast, 
oocytes expressing homomeric GluCl channels yielded Cl" currents of greater amplitude to L- 
glutamate than those observed with ibotenic acid. This observation has also been apparent in most 
arthropod and nematode native preparations, indicating that the probable in vivo subunit combinations 
have not been established with in vitro expression and additional subunits may be necessary to make 
up the wild-type channel.
1.3.2 Avermectins
Avermectin was first described as an anthelmintic in 1979, when nematode-infested mice were 
accidentally fed a fermentation broth generated from soil samples containing a bacterium, 
Streptomyces avermitilis (Campbell, 1981). The naturally occurring avermectins can be separated into 
four main components (AiA, A2A, Bia and B2a) of which only a synthetic derivative of the Bi (22,23- 
dihydroavermectin, known as Bi ivermectin) series will be described here. Ivermectin, a semi­
synthetic mixture (consisting of 80% synthetic 22,23-dihydroavermectin Bia and 20% natural Bib 
products) of and is based on the natural product avermectin, produced by Streptomyces avermilitis 
(Campbell, 1981), with potential insecticidal and anthelmintic actions. These compounds have an 
excellent activity against nematodes, several ectoparasites, arthropods and plant pathogens (Putter et 
al, 1981).
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The success of these compounds has mostly been attributed to their ability to kill parasites without 
affecting the host organism. Vertebrate studies on rat brain observed that avermectin binding sites 
have approximately one-hundred-fold lower affinity than in C. elegans (Turner and Schaeffer, 1989) 
indicating that the concentration required to gate vertebrate channels would be far in excess of that 
required to kill the parasite. In contrast to this, studies have also indicated that in a similar manner to 
L-glutamate channels, ivermectin potentiated the response to low concentration of GABA in oocytes 
injected with rat brain mRNA (Rohrer et al., 1995), consequently decreasing the EC50 from 42 to 3pM 
and reducing the effective concentration of ivermectin necessary to gate the mammalian GABAa 
receptor.
The anthelmintic mode of action of avermectins still remains unclear. In vitro experimental evidence 
indicates that avermectins act by disrupting neuromuscular transmission and increasing cellular 
permeability to chloride ions (Arena, 1994; Turner and Schaeffer, 1989). However, their behaviour in 
whole nematode preparations varies extensively. Incubation of the non-parasitic nematode, C. elegans 
on avermectin agar plates (20ng/ml), (Arena et al., 1995) produced inhibition of pharyngeal pumping 
and a slow-onset of rigid paralysis. In contrast, its parasitic homologue Haemonchus contortus 
showed no obvious effects when submerged in the drug away from its natural environment (Avery, 
1993; Turner and Schaeffer, 1989). Direct injection into the pig nematode Ascaris suum resulted in 
blocking signal transmission from excitatory motomeurons (Kass et al., 1980) causing rapid paralysis 
that is neither rigid nor flaccid (Turner and Schaeffer, 1989). However, for blood sucking nematodes 
like Haemonchus the consumed blood containing the anthelmintic considerably contributes to the 
uptake of drug.
1.3.3 Ivermectin-sensitive chloride channels
When expressed in Xenopus laevis oocytes, the C. elegans a  subunit formed functional homomeric 
channels, which are slowly activating and essentially irreversibly gated by ivermectin. The p subunit 
is not gated or potentiated by avermectin, but does form non-desensitizing channels gated by L- 
glutamate when expressed in the same system. When co-expressed in oocytes, the two subunits 
formed channels gated by L-glutamate and potentiated by very low (5nM) concentrations of 
ivermectin that have no direct effect on membrane current when applied alone. At higher 
concentrations, avermectin has the additional effect of directly activating the channel (Arena et al., 
1991). Furthermore, co-expression of the two subunits shifted the EC5o for glutamate from 380|uM 
(for p) to 1360pM (for a  & p), reducing the receptor sensitivity to the ligand, however, the EC50 
values for ivermectin-induced currents were very similar (140nM for a  and 190nM for a  & P). These 
heteromeric channels resembled those formed following injection of total C. elegans mRNA into
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Xenopus oocytes (Arena et al., 1992a), however, there is no direct evidence that these subunits co- 
express in C. elegans.
The avermectin sensitive currents produced from oocytes injected with C. elegans total mRNA 
yielded irreversible, inward responses with an EC50 of 90nM and a reversal potential of -19.3± 
1.3mV, strongly suggesting an avermectin-sensitive chloride channel (Arena et al., 1992a). In 
addition, the L-glutamate-sensitive current is potentiated by submaximal concentrations of ivermectin, 
as demonstrated with GluCla2 and heteromeric GluClai and p subunits. All oocytes expressing either 
C. elegans mRNA or GluCl cDNA failed to be gated by GABA, benzodiazopines or bicuculline, 
which is consistent with data observed from binding assays (Schaeffer and Hains, 1989), however, 
avermectin current was antagonised by picrotoxin (Cully et al., 1994; Cully et al., 1996b). Later work 
demonstrated that the GluCla subunit possessed a binding site for L-glutamate but was unable to 
functionally gate the receptor when expressed alone in Xenopus oocytes (Etter et al., 1996). This was 
initially discovered when a chimera between the N-terminal, extracellular region of GluCla and the C- 
terminal domain of GluClp produced fully functional channels in oocytes that were gated by 
glutamate (Etter et al., 1996). Secondly, when an engineered mutation was formed at position 308 in 
the M2 domain of GluCla, replacing a threonine with proline, glycine or alanine, homomeric channels 
became sensitive to glutamate (Etter et al., 1996). However, the functional correlation of these 
binding sites in native tissues still remains to be determined.
Expression of the GluCla^ subunit in oocytes formed homomeric channels gated both reversibly by 
L-glutamate and irreversibly by ivermectin (Vassilatis et al., 1997b). The EC50 for L-glutamate was 
208.3 pM and 21.4pM for ivermectin, with Hill coefficients of 2.1 and 1.6 respectively. The Hill 
coefficient for most GluCl receptor subunits is approximately two, indicating that at least two 
molecules of glutamate must bind for the receptor to open. GluCla2-induced avermectin currents were 
approximately 30-fold bigger than that observed with glutamate-sensitive currents (Dent et al., 1997). 
Interestingly, co-expression of GluCla2 and GluClp resulted in channels that responded with a higher 
affinity to both L-glutamate and ivermectin, with EC50’s of 62juM and 103nM respectively (Vassilatis 
et al., 1997b) than when expressed alone. The increased sensitivity of the heteromeric combinations of 
GluCla2 and GluClp to L-glutamate and ivermectin may indicate they are naturally occurring 
(Vassilatis et al., 1997b). Furthermore, the heteromeric channels were insensitive to GABA, glycine, 
aspartate, kainate and picrotoxin.
Recent data by Dent et al., (2000) have shown that avr-14 gene encodes an alternatively spliced GluCl 
related protein (previously called GBR-2A/2B) which has now been designated GluCla3A & a 3B. 
When expressed in oocytes, GluCla3B formed a ivermectin and glutamate-sensitive channel, however,
a response was only observed with homomeric G1uC1cc3B channels and not with GluCla3A subunits 
(Dent et al., 2000). Interestingly, the two subunits are products of alternative splicing indicating that 
they should contain identical ligand binding domains, with only two amino acid residue differences in 
their M2 regions, these are a threonine (a2A) to serine (a2B) substitution at positions 286 and a 
serine (a2A) to alanine (a2B) switch at 299. The amino acid substitution at position 286 is at the 
same position that is responsible for dieldrin and picrotoxin resistance in Drosophila Rdl subunits 
(ffrench-Constant et al., 1993a).
A Drosophila glutamate-gated chloride channel was successfully expressed in oocytes forming 
homomeric glutamate- and ivermectin-sensitive currents. Unlike the GluClcti, ct2 and p subunits from 
C. elegans, DrosGluCla exhibited robust, rapid, desensitised glutamate currents, which were not 
inhibited by picrotoxin or potentiated by avermectins (Cully et al., 1996a). The EC5o for glutamate- 
gated currents was 23pM and 41nM for ivermectin-sensitive channels (Cully et al., 1996a). It is 
therefore plausible that GluCl subunits represent targets of avermectins and may mediate some of the 
effects observed in whole nematode preparations.
1.3.4 Ivermectin binding studies
Specific, high affinity avermectin binding has now been established in at least two nematode species, 
C. elegans and Haemonchus contortus, and several insects {Drosophila melanogaster, Schistocerca 
americana and Spodoptera frugiperda). Surprisingly, the density of binding sites across the species 
range was quite variable. Both Drosophila melanogaster head preparations and Schistocerca 
americana metathoracic ganglia showed a 10- and 100-fold (respectively) difference in binding sites 
in comparison to mixed populations of C. elegans. In addition, specific avermectin binding sites were 
also observed in rat brain but were found to contain approximately one-hundred-fold lower affinity 
than identified in C. elegans (Turner and Schaeffer, 1989).
Presently, ivermectin resistance is presenting itself as an emerging problem, but to preserve its 
efficiency and to gain an understanding of the underlying mechanism of resistance a comparison of 
the target-binding site in resistant and wild type Haemonchus and C. elegans was examined. Studies 
conducted by Rohrer et al. (1994) and Hejmadi et al. (2000) demonstrated that membranes prepared 
from both sensitive and resistant Haemonchus contortus tissues exhibited high affinity ivermectin 
binding and the same number of binding sites per mg of tissue. The probable site of action of 
ivermectin are the L-glutamate chloride channels, suggesting resistance in the Haemonchus strain was 
unlikely to be due to affinity, alterations at the binding site or the number of available receptor 
binding sites (Hejmadi et al., 2000; Rohrer et al., 1994). Density of binding sites between 
Haemonchus and C. elegans nematodes appear to be quite similar, 0.43 and 0.4 pmol/mg, respectively
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(Cully and Paress, 1991; Hejmadi et al., 2000; Rohrer et al., 1994). Competition binding experiments 
indicated the C. elegans [3H] ivermectin binding sites were successfully inhibited by several 
avermectin derivatives, but not by the amino acid transmitter GAB A (Cully and Paress, 1991).
1.3.5 Convulsant antagonists
Channel-blocking antagonists acting on GABA, glycine and GluCl channels are highly toxic 
convulsants that cause hyperexcitation in the nervous system of nematodes, insects and mammals. 
This section summarises the commercial, experimental and botanical toxins that antagonise the 
chloride ion channel and which are relevant to GluCls and the experimental chapters to follow.
All known functional GluCl-gated chloride channels, with the exception of Drosophila melanogaster 
and leech Retzius cells (Cully et al., 1996a; Mat-Jais et al., 1983), are blocked by picrotoxin. This 
plant-derived compound is composed of equimolar amounts of picrotin and picrotoxinin (Etter et al., 
1999), the former has little or no effect (Newland and Cull-Candy, 1992). Inhibition of anion and 
cation flux in vertebrate GABAa (Sieghart, 1995), GABAc (Feigenspan et al., 1993) and glycine 
receptor (Pribilla et al., 1992) as well as invertebrate GABA (Sattelle et al., 1988), L-glutamate (Etter 
et al., 1999) and nicotinic receptors (Benson, 1988; Sattelle et al., 1988) has been attributed to the 
picrotoxinin component. However, invertebrate and vertebrate receptor tissues showed distinct 
variation in affinity for PTX (Hosie et al., 1995a), which was later attributed to the onset and recovery 
of the picrotoxinin response subsequent to gating of the agonist. This implies that an open channel 
increased picrotoxinin affinity, suggesting the ligand-binding site is located within the channel pore 
(Inoue and Akaike, 1988). The functional state of the receptor would therefore reflect on the degree of 
functional block from the toxin (Inoue and Akaike, 1988). However, the site and mode of action of 
picrotoxinin is the subject of some debate and is discussed in more detail in chapter 5.
In Drosophila, a naturally occurring resistance to picrotoxin is caused by the RDL (resistance to 
diekirin) mutation, which is a single amino acid substitution (serine302 for alanine) in the M2 domain 
of a GABA-gated chloride channel (ffrench-Constant et al., 1993a). An equivalent mutation was 
engineered into the C. elegans picrotoxin-sensitive GluClp chloride channel, where the alanine in 
position 279 (the RDL equivalent site) was replaced with the threonine. The GluClp (A279T) single 
amino acid substitution in the M2 domain reduced the picrotoxin sensitivity of homomeric channel at 
least 10,000 fold. The point mutation GluClp (A279T) also altered gating properties to slow the rate 
of desensitisation (Etter et al., 1999) but little effect on other channel properties was noted.
A number of convulsants were also found to block GABA currents at the related Drosophila 
melanogaster RDL ionotropic receptor, including picrodendrins (Hosie et al., 1995a), (3,3- 
bis(trifluoromethyl)bicyclo[2,2,l]heptane-2,2-dicarbonitrile) BIDN (Hamon et al., 1998; Rauh et al.,
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1997b; Shirai et al., 1995a) and fipronil (Cole et al., 1993; Hosie et al., 1995a). Fipronil and BIDN 
antagonism were also affected by the A302S channel mutation (Hosie et al., 1995a; Shirai et al., 
1995b) that also makes the channel resistant to picrotoxinin and dieldrin (ffrench-Constant et al., 
1993a; Hosie et al., 1995a). However, fipronil has not, so far, been reported to have any effect on any 
nematode ligand-gated anion channel and BIDN was found to have no effect on a picrotoxin-sensitive 
insect GluCl (Hamon et al., 1998).
BIDN is a potent, key member of the poly cyclic dinitriles class of insecticides (Buckingham et al., 
1995; Hosie et al., 1995b), which display high potency at the GABA receptor convulsant site (Rauh et 
al., 1997b). In a recent study BIDN failed to inhibit glycine responses from rat brain mRNA when 
expressed in Xenopus laevis (Hamon et al., 1998), similarly nACh receptors currents from cockroach 
motor neuron (Df) were unaffected by the compound (Rauh et al., 1997a). However, following the 
injection of mRNA from either rat brain or RDL GABA receptor subunits, BIDN blocked GABA- 
induced currents at concentrations of lpM and above (Buckingham et al., 1995; Shirai et al., 1995b), 
clearly indicating that BIDN has the ability to antagonise both bicuculline-sensitive receptors from 
vertebrates and bicuculline-insensitive GABA receptors from insects. This suggests that bicuculline 
and BIDN probably act at different locations within the receptor complex (Hamon et al., 1998). In 
comparative binding assays BIDN (lOOpM) bound to distinct sites from 4-n-propyl-4’- 
ethynylbicycloorthobenzoate (EBOB), t-butylbicyclophosphorothionate (TBPS), l-phenyl-4-t-butyl- 
2,6,7-trioxabicyclo[2.2.2] octane (TBOB) and picrotoxin, also suggesting these sites of action within 
the GABA receptor complex are not identical (Rauh et al., 1997b; Sattelle et al., 1995).
In this study we examined the convulsant antagonist action on L-glutamate receptor subunits in C. 
elegans, where future advances of ligand interaction of both BIDN and fipronil may improve 
selectivity between insect and vertebrate receptors with the attempt of reducing organism toxicity 
levels within the host species. In summary, BIDN has previously been found to block only GABA- 
gated chloride channels of invertebrates and vertebrates, but in this study, BIDN was found to block 
recombinant L-glutamate-gated channels of C. elegans, therefore allowing BIDN to be used as a new 
pharmacological tool for L-glutamate receptors.
The phenylpyrazole, fipronil, is an outstanding insecticidal, miticidal (Yanese and Andoh, 1989) and 
herbicidal (Klis et al., 1991b), which has been the first compound of its class to be commercialised. It 
has been observed to exhibit an excellent range of activity against insect pest (aphids, leafhopper, 
planthoppers, cockroaches, fleas, ticks and mites) (Colliot, 1992) and at low concentrations produces 
good selectivity between insects and mammals, allowing it to be used extensively in public and 
animal health. The phenylpyrazoles mode of action involves inhibiting the passage of chloride ions 
through the GABA-gated chloride channel and disrupting CNS electrical activity (Gant et al., 1998).
Interestingly, fipronil has shown distinct differences between insect and vertebrate tissue binding 
affinities, which may indicate why the compound contains selective toxicity to insects over mammals. 
Essentially these differences include convulsant ligands TBPS, EBOB and BIDN binding at the same 
GABA receptor-binding site within vertebrate tissues, whilst fipronil binds with a much lower 
affinity. In addition, in insects, TBPS, EBOB and BIDN bind at three distinct sites, with fipronil 
acting only at the EBOB site (Cole et al., 1993; Gant et al., 1998). However further experiments to 
illustrate whether [3H]EBOB and fipronil share the same binding site in invertebrates or if they just 
overlap needs to be determined.
In oocytes expressing the RDL-resistant GABA receptor, fipronil was also found to reduce the 
amplitude of GABA current. However, the RDL-mutant receptors containing the amino acid change 
A302-S were found to be less sensitive to fipronil than wild type receptors, with corresponding IC50’s 
of lOOpM and 20|iM respectively (Hosie et al., 1995a). This indicates that the point mutation may be 
involved directly or indirectly affecting the binding site for fipronil and/or mechanisms involved in 
GABA-gated chloride currents (Hosie et al., 1995a). Phenylpyrazoles have shown to have no activity 
at the AVM binding site when tested at a concentration of lOOpM (Cole et al., 1993).
The insect GABA-operated chloride channels appear to be important molecular targets of some 
insecticidal active molecules such as picrotoxin, BIDN, avermectins and fipronil. Chapter 5 reports a 
detailed antagonist profile of an expressed GluCl receptor, including for the first time a description of 
the pharmacological actions of convulsant GABAa antagonists bicyclic dinitrile, BIDN and 
insecticide, fipronil on novel C. elegans GluCl, GLC-3.
1.4 Caenorhabditis elegans
Nematodes were first identified in 384-322BC, and are the most numerous animals on earth. From 
around the world 29,500 species have been identified, of which approximately half are free-living and 
the rest are parasitic. Although, it is probable that many more species have yet to be formally 
identified (actual numbers may range from 40,000 to 10 million).
In this study we have used the free-living nematode Caenorhabditis elegans as a convenient, 
experimental model to investigate the pharmacological and molecular biology of anthelmintic receptor 
subunits. The nematode was initially proposed as a model organism by Sydney Brenner in 1974, and 
has since provided a wealth of knowledge in cell biology, neurobiology and genetics and serves as an 
excellent model system for the study of higher eukaryotes (Brenner, 1974). The nematode has several 
features that make it suitable for neurological investigations and in the last two decades has been the 
subject of extensive study, (reviewed by Wood, 1988). C. elegans is the first multi-cellular organism 
to have its entire genome sequenced, of which a detailed genetic map of the nematode can be accessed 
{Caenorhabditis elegans sequencing Consortium, 1998). The genome contains over a 100 million 
base pairs of DNA, approximately thirty times smaller than the human genome and encodes more than 
19,000 genes.
The completion of the Caenorhabditis elegans genome-sequencing project {Caenorhabditis elegans 
sequencing Consortium, 1998) has permitted for the first time, a prediction of the total number and 
diversity of ionotropic receptor subunits present within a single organism. Analysis of the sequence 
predicts that the nematode genome encodes about ninety such receptor subunits (Bargmann, 1998), 
most of which are of unknown function. This includes 37 predicted ligand-gated anion channels 
subunits that will facilitate the cloning of homologous genes from parasitic nematodes. The 
availability of this database with recent advances in pharmacology and molecular biology will help 
provide an insight into new anthelmintic drug discovery.
The simplicity of C. elegans nervous system offers a chance to perform useful genetic and molecular 
manipulation that is attributed to its short life-cycle (generation time from egg to adult is complete 
within 3.5 days), self-fertilising, hermaphrodite form (approximately 300 offspring), small genome 
size and ease of obtaining variety mutant strains. The nervous system of the hermaphrodite consists of 
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Figure 1.8 Stages o f the Caenorhabditis elegans lifecycle. With adequate food supply and at 
standardized laboratory conditions (liquid culture, 20°C), C. elegans eggs develop through four larva 
molts before reaching adulthood; both hermaphrodites and males live for about 17 days. (Key: L I -3= 
Larvae stages 1-3). Photograph courtesy o f Dave Laughton.
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7.5. Project aims
Despite the GluCl proteins being well established as putative targets for avermectin compounds, the 
exact mode of action of the anthelmintic and the stoichiometry of the native receptor in any species is 
unknown. The completion of the C. elegans project provides the first opportunity to explore and 
identify a full complement of GluCl subunits within a single organism, facilitating advances in 
pharmacology and molecular biology.
Consequently, the first aim of this study was to map the expression of existing GluCl clones and 
examine the exact anatomical location in relation to other subunits, which may also determine native 
stoichiometry (Chapter 3). Second, was the isolation of novel cDNA (GLC-3) encoding a putative 
(ot/p-like) GluCl subunit (Chapter 4) that will also facilitate future cloning of homologous ion 
channels from parasitic nematodes. Finally, pharmacological characterisation of the novel cDNA 
clone (GLC-3) will be expressed in Xenopus oocytes to investigate agonist and antagonist profiles that 
can be compared to existing GluCls (Chapter 5). Chapter 5 also describes the actions of novel GABA 
convulsant antagonists in an attempt to distinguish receptor subunit subtype-specific compounds to 
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Restriction enzymes and associated buffers were supplied by New England Biolabs, Hitchin, U.K. All 
enzymes and buffers stored at -20°C as per manufacturer's recommendations. When necessary, 0.01 
volumes o f 1 OOx BSA (1 Omg/ml) was also added to the digest.
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ENZYME REACTION BUFFER (lx) SUPPLIER
C alf Intestinal Phosphatase lOOmM NaCl,
30mM Tris-HCI (pH 7.9), 
lOmM MgCl2,
ImM DTT
New England Biolabs, 
Hitchin, U.K.




50mg/ml BSA (pH 7.8)
Gibco BRL, Paisley, 
U.K.
Taq DNA polymerase 50mM KC1,
IOmM Tris-HCI (pH 9.0), 
0.1% (v/v) Triton X-100
Promega Corporation, 
Madison, WI, U.S.A.
Expand™ High Fidelity PCR 
System
50mM Tris-HCI (pH 9.2), 




T7 RNA Polymerase 400mM Tris-HCI (pH 7.5), 
60mM MgCl2>








0 .0 1 % (v/v)
Boehringer Mannheim, 
Lewes, U.K.
Enzymes and buffers were stored at -20°C or as per manufacturer's recommendations.
2A. 1.3 General laboratory reagents
Chemical reagents (analytical grade) were obtained from Sigma-Aldrich Chemical Co. Ltd., Poole, 
U.K. and Fisons, Loughborough, U.K. except where stated otherwise.
REAGENTS SUPPLIER
Water-saturated phenol Rathburn, Walkerburn, U.K.
Absolute ethanol Hayman Ltd., Witham, U.K.
Nunc plasticware Life Technologies, Glasgow, U.K.
Bovine Serum Albumin Sigma-Aldrich Chemical Company Ltd., Poole, U.K.
Diethylprocarbonate (DEPC) Sigma-Aldrich Chemical Company Ltd., Poole, U.K.
Oligonucleotides Perkin Elmer -  Applied Biosystems, Warrington, U.K.
Falcon plasticware Becton Dickinson Company, Plymouth, U.K.
Dimethylsulfoxide (DMSO) BDH, Poole, U.K.
Dynabeads® 0 1 igo(dt) 2 5 Dynal, Wirral, U.K.
Agarose (Hipure Low EEO) Bio/gene Limited, Cambridge, U.K.
2.1.1.4 General laboratory solutions
SOLUTIONS COMPONENTS
Phenol Obtained distilled and stored in the dark at 4°C.
Before use equilibrated with 2 volumes 50mM Tris-HCI 
(pH 8.0).
Chloroform 24:1 (v/v) Chloroform:isoamyl alcohol
Phenol/chloroform 50% (v/v) Phenol equilibrated with; 
IOmM Tris-HCI, pH 7.6,
49% (v/v) chloroform 
1 % (v/v) isoamyl alcohol 
Stored in the dark at 4°C
Ultrapure Deoxyribnucleoside 
triphosphates (dNTP’s)
Each dNTP was dissolved in H20  at a concentration of 
lOOmM, pH adjusted to 7.0 with 0.5M Tris
1M Dithiothreitol (DDT) 3.09g DDT,
20ml sodium acetate (pH 5.2), 
filter sterilized and stored at -20°C
Ethidium Bromide 1 Omg/ml stock, stored in the dark at 4°C
0.5 M Ethy lenediaminetetra-acetate 
(EDTA) pH 8.0
186.1 g disodium ethylenediaminetetra acetate.2H 20 , 
800ml H2 0 , pH adjusted to 8.0 with NaOH
Diethylpyrocarbonate (DEPC) H20 1% (v/v) DEPC added to dd H 2 0 , mixed vigorously for 
1 0  minutes, left o/n at room temperature and autoclaved
lOmg/ml RNase A lOmg RNase A is mixed in TE buffer, incubated at 95°C 
for 30 minutes and stored at -20°C
Sodium Azide 1 % (w/v) sodium azide
2 . 1 . 1 . 5  G e n e r a l  b u f f e r s
BUFFERS COMPOSITION
Phosphate-buffered saline (PBS) 8 g NaCl 
0.2g KC1 
1.44g Na 2 H P 0 4  
0.24g KH2 P 0 4
dissolve in H 2 0 ,  pH adjusted to 7.4 with HC1 and made up 
tol litre with H20
Sodium citrate/acetate 408. lg  sodium acetate.3H 2 0 , 
pH to 5.2 with glacial acetic acid 
adjusted tol litre with H20
Tris-borate (TBE) 5X 54g Tris-base 
27.5g boric acid
20ml EDTA (pH 8.0), adjusted to 1 litre with H20
Tris-EDTA (TE) pH 7.6 IOmM Tris-HCI (pH 7.6) 
ImM EDTA (pH 8.0)
Morpholinopropanesulfonic acid 
(MOPS) 10X (pH 7.0)
0.2M MOPS buffer 
0.05M Na acetate 
0.01M Na2  EDTA
6 x DNA Loading Buffer 0.25% (w/v) bromophenol blue 
0.25% (w/v) xylene cyanol FF 
30% (v/v) glycerol in H20
6 x RNA loading buffer 71 pi formamide
16pl formaldehyde
4 pi (100%) glycerol
8 .6 pl 10X MOPS buffer
0.24pl ethidium bromide (lOmg/ml)
8 pl o f RNA loading buffer was mixed with 1 pg of RNA
lOx RNA electrophoresis buffer 20.93g MOPS (0.2M)
3.4g Na acetate (0.05M)
1.86g Na2EDTA (0.01 M)
adjusted to 500ml with H20  and stored in the dark at 4°C
2 . 1 . 2  E s c h e r i c h i a  c o l i  s t r a i n s
Escherichia coli strains (XL1 and XL2 blues) were used routinely for cloning and general DNA 
manipulation, while TGI was used for protein expression work.
STRA IN G EN O TY PE SU PPLIE R
X Ll-Blue RecAl endAl gyr96 thi-1 hsdRl7 ( )  
supE44 relAl lac [F’ proAB lacqZAM15 
TnlO (Tet’)]
Stratagene Ltd., Cambridge, U.K.
XL2-Blue RecAl endAl gyr96 thi-1 hsdR17 (rkmk+) 
supE44 relAl lac [F’ proAB lacqZAM15 
Tn 10 (Tet’) Amy CanT]
Ultracompetent Epicurian® XL-2s 
Stratagene Ltd., Cambridge, U.K.
TGI F* traD36 laqlq A(lac)M15 proA+B+/  
supE{hsdM-mcrB)5{rkirik' McrB ) thi A(lac- 
proAB)
Amersham International Pic, 
Little Chalfont, U.K.
OP50 RecAl endAl gyr96 thi-1 hsdR17 {rkmk)  
supE44 relAl lac [F’ proAB lacqZAM15 
T n/0]
Stratagene Ltd., Cambridge, U.K.
2 .1 .3  E s c h e r i c h i a  c o l i  p l a s m i d s
Plasmid vectors used in cloning and expression studies.
PLA SM ID G EN O TY PE AND 
SIZE
SU PPLIE R
PBluescript™ Ampr, 2.96Kb Stratagene Ltd., Cambridge, U.K.
pCDNA3.1 Ampr, 5.4Kb Stratagene Ltd., Cambridge, U.K.
pCR®2 . 1 Ampr, 3.9Kb Stratagene Ltd., Cambridge, U.K.
PGEM®-T Easy Ampr, 3.01Kb Promega, Southampton, U.K.
2 . 1 . 4  R e a g e n t s  u s e d  i n  t h e  c u l t i v a t i o n  o f  C . e l e g a n s  a n d  b a c t e r i a l  s t r a i n s
M ED IUM CO M PO N EN TS (g/L)
LB (Luria-Bertani)-Broth 1 Og bacto-tryptone, 
5g yeast extract, 
lOg NaCl
DYT 2 0 g bacto-tryptone, 
1 Og yeast extract, 
lOg NaCl
LB and DYT agar LB-broth or DYT broth 
1.5% (w/v) agar





5mg K2 P 0 4
M9 buffer 6 g N a 2 H P 04,
3g KH2 P 0 4,
5g NaCl,
0.25g M gS0 4  7H20
S buffer 5.8g NaCl,
6 .8 g KH 2 P 0 4, (pH 6.0)
S medium 1 Litre S buffer,
1 ml ethanol-saturated cholesterol, 





O.lmM Z nS 04,
0 .00ImM C uS 0 4
Freezing medium O .lM N aCl,
0.01 M KH2 P 0 4, 
6 % (v/v) glycerol, 
0.06mM MgCl2
Solutions were sterilised either by autoclaving at 120°C, 1.41 KPa for 20 minutes, or by filtering using 
Millipore 0.22pM syringe filters. All solutions were stored at room temperature in colourless glass or 
plastic bottles, unless otherwise stated.
Salts were obtained from BDH or Sigma-Aldrich Chemical Company Ltd., Poole, U.K. and culture 
media from Difco laboratories, East Molesey, Surrey, U.K.





Ampicillin 50mg/ml in H20 60pg/ml
Carbenicillin 50mg/ml in H20 60pg/ml
Chloramphenicol 34mg/ml in ethanol 170pg/ml
Kanamycin 1 Omg/ml in H20 50pg/ml
2 . 1 . 6  B u f f e r s  u s e d  i n  p l a s m i d  D N A  p r e p a r a t i o n  a n d  a n a l y s i s
Wizard™ Minipreps DNA Purification System kits were purchased from Promega and Sephaglas™ 
Bandprep kit from Pharmacia Biotech, St Albans, Herts. U.K..
BUFFER COMPOSITION
Resuspension Buffer 50mM Tris-HCI (pH 8.0) 
IOmM EDTA 
lOOpM RNase A
Standard Lysis Buffer 





3M potassium acetate 
11.5% (v/v) acetic acid, pH 4.6
Equilibration Buffer 0.75M NaCl 
50mM MOPS (pH 7.0)
15% (v/v) ethanol
0.15% (v/v) Triton X-100
Wash Buffer 1M NaCl
50mM MOPS (pH 7.0) 
15% (v/v) ethanol
Elution Buffer 1.25M NaCl
50mM Tris-HCI (pH 8.5) 
15% (v/v) ethanol
Tetra-EDTA (TE) pH 7.6 IOmM Tris-HCI (pH 7.4) 




2 0 ml formamide
lOx Tris-Borate (TBE) pH 7.5 0.89M Tris-HCI 
0.89M Boric acid (H 3 B 0 3) 
20mM EDTA, pH 8.0
37
2 .1 .6 .1  B u f f e r s  u s e d  i n  D N A  p u r i f i e d  w i t h  S e p h a g l a s  B a n d p r e p ™  K i t
REAGENT COMPONENTS
Gel solubiliser Buffered Nal
Sephaglas 20% (w/v) Sephaglas in aqueous solution
Wash buffer 60% (v/v) ethanol 
20mM Tris-HCI (pH 8.0) 
ImM EDTA 
O.lmM NaCl
Elution buffer IOmM Tris-HCI 
ImM EDTA
2 . 1 . 7  M a t e r i a l s  f o r  a n t i s e r u m  p r o d u c t i o n  a n d  c h a r a c t e r i s a t i o n
Peroxidase conjugated goat anti-rabbit serum, thryroglobulin, tetramethylbenzidine, 
dimethylsulphoxide, dithiothreitol and m-maleimidobenzoic acid jV-hydrosuccinamide ester (MBS) 
were purchased from Sigma-Aldrich Chemical Company Ltd., Poole, U.K. Biorad Ltd., Hemel 
Hempstead, U.K. supplied BIOGEL P-2 and Cyanogen Bromide activated Sepharose™ was obtained 
from Pharmacia, St Aibans, Herts., U.K.
2 .1 .7 .1  E L I S A  ( E n z y m e -  L i n k e d  I m m u n o s o r b e n t  A s s a y )  r e a g e n t s
REAGENT COMPOSITION
Coating buffer 15mM Na2 C 0 3, 
35mM N aH C 03, 
0.01% NaN 3  (pH 9.6)
Washing buffer PBS, 0.1% Tween™
Stock acetate/citrate buffer 1M Sodium acetate (NaOAC),
30mM Trisodium citrate (Na3 C 6 H 50 7) pH 6.0
Stock Tetramethyl benzidine solution lOmgml' 1 TMB in DMSO
Substrate solution 5% stock acetate citrate buffer, 
1% stock TMB solution, 
0.006% hydrogen peroxide
Stop solution 1.84M H2 S 0 4  (1:10 dilution of 98% stock)
2 . 1 . 7 . 2  I m m u n o c y t o c h e m i s t r y  r e a g e n t s
REAGENT SOLUTIONS
Antibody buffer 5ml Triton-X,
2ml 0.5M EDTA, 
lg  BSA,
0.3ml sodium azide pH 7.2 with HC1, 
adjusted to lOOmls with lOx PBS
Antibody dilution solution 1% BSA (w/v),
1% Triton-X (v/v),
0.5% sodium azide (w/v)
BME solution 5% (v/v) {3-mercaptoethanol, 
1% Triton-X (v/v)
Collagenase buffer ImM CaCl2,
lOOmM Tris-HCI pH 7.5
Coupling buffer 0.2M N aH C 03, 
0.5M NaCl, pH 8.5
Inject Alum Insoluble aluminum hydroxide suspension
PBS/Triton-X 1% PBS/Triton-X (v/v)
Poly L-lysine slides 200-400mg poly L-lysine (Sigma PI 524)
200mls dd H20
0.2g Sodium azide (0.1%)
Mix together and store at 4°C
Wipe slides very clean and place back to back in slide 
holder, dry in 60°C oven >5 minutes. Shake in poly L- 
lysine for 5 minutes and dry in 60°C oven >1 hour.
2 . 1 . 8  R e a g e n t s  u s e d  i n  c l o n i n g  o f  t h e  Z C 3 1 7 .3  c D N A  r e c e p t o r  s u b u n i t
2 . 1 . 8 . 1  R e a g e n t s  f o r  i s o l a t i o n  a n d  p u r i f i c a t i o n  o f  R N A  a n d  c D N A  s y n t h e s i s
REAGENTS COMPOSITION
Genomic DNA synthesis preparation
TEN9 buffer
Protein digestion
Separation o f phases 
TE buffer (pH 7.6)
DNA precipitation
50mM Tris-Cl (pH 9.0) 
lOOmM EDTA 
200mM NaCl
lOOg/ml DNase ffee-RNase A 
20% SDS (w/v)
1 Omg/ml proteinase K
20ml equilibrated phenol (pH 8.0)
IOmM Tris-HCI (pH 7.6)
ImM EDTA (pH 8.0)




Monophasic solution o f phenol and guanidine 
thiocyanate for RNA, DNA and protein isolation. 




Superscript II buffer 
dNTPs





2 pl (0 . 1 M) stock 
ljil RNasin (40units)
4pl (5x)
1 pi o f a 1 OmM stock 
1 pi ( 2 0 0  units)
1 pi ( 2  units)
5,G ACT ACGTT AGCAT CT AGAATT CT CGAGfT] 173’ 
(N)6
RNase-free solutions were prepared in 0.1% (v/v) DEPC treated water and sterilised at 1.41 Kpa for 
20 min. SDS solution alone was prepared by addition o f RNase-free SDS to sterilised DEPC water. 
Baked glassware was used for all purposes. cDNA encoding the C. elegans G luCla 2  subunit was 
provided by Dr. Joe Dent, Department o f Molecular Biology and Oncology, University of Texas 
Southwestern Medical Centre at Dallas, 5323 Harry Hines Blvd, Dallas, TX 75235-9146, U.S.A. All 
other reagents were of Analar grade, obtained from the Sigma-Aldrich Chemical Company Ltd.,
Poole, U.K. Drummond glass capillaries were obtained from Laser Laboratories Systems Ltd., 
Southampton, U.K., while borosilicate glass capillaries were obtained from Clark Electromedical 
Instruments, Reading, U.K.
2 . 1 . 9  S o l u t i o n s  u s e d  i n  X e n o p u s  o o c y t e  p r e p a r a t i o n  a n d  e l e c t r o p h y s i o l o g y
2 .1 .9 .1  S t a n d a r d  o o c y t e  s o l u t i o n s
SOLUTIONS COMPOSITION
Standard Oocyte Saline (SOS) 96mM NaCl,
12mM KC1,
108mM MgCl2,
5mM HEPES (pH 7.6)
Incubation Solution 2.5mM sodium pyruvate,
1 pg/ml streptomycin,
1 OOunits/ml penicillin,
50jig/ml Gentamycin made up in SOS solution
Collagenase lOOmg collagenase, 
50ml SOS
2 . 1 . 9 . 2  S o u r c e s  o f  c h e m i c a l s
GABA, histamine, Glycine, L-Glutamate, ibotenate, NMDA and Picrotoxinin were obtained from 
Sigma-Aldrich Chemical Company Ltd., Poole, U.K., whilst fipronil and BIDN were obtained from 
RP Agro-chemicals, North Carolina U.S.A.
2.2 Methods
2.2.1 Biochemical techniques used in the purification o f DNA
2.2.1.1 Agarose gel electrophoresis o f DNA
Gels were prepared by dissolving 1-4% (w/v) agarose in electrophoresis buffer by boiling and then 
allowing to cool to 50-60°C. Ethidium bromide was added to a concentration of 0.5pg/ml and the 
mixture poured into a horizontal perspex gel apparatus. Once set, the comb was removed and gel 
submerged in a tank of lxTBE. DNA samples (0.1-2|ug) were taken up in gel loading buffer (Table 
2.1.1.5) and electrophoresed at 120V until the marker dyes had migrated to the end of the gel. Phage X 
DNA, cut with the restriction enzyme Pst 1, was used as a size marker. The DNA was visualised by 
fluorescent ultraviolet light (UV).
2.2.1.2 Purification of DNA from agarose gel using Sephaglas™
The band of interest was cut out using a clean razor blade and any excess agarose was trimmed away. 
The gel slice was weighed and 250pl (or lpl for each mg of agarose, whichever was the greater) of 
gel solubiliser (2.1.6.1) was added. Incubation at 60°C for 10 minutes dissolved the agarose. 
Sephaglas BP (5 pi, 20% (w/v) Sephaglas in aqueous suspension) was added (or 5 pi per estimated jig 
of DNA present) and the contents of the tube mixed by vortexing. Incubation was continued on the 
bench for a further 5 minutes with additional periodic vortexing. The Sephaglas was spun down at top 
speed in a microcentrifuge for 1 minute and the supernatant aspirated. Wash buffer (40pl or 8 x the 
volume of sephaglas used) was added and the pellet resuspended by vortexing. The Sephaglas was 
spun down again, and the supernatant aspirated. This step was repeated twice and the pellet was air 
dried for 10 minutes. DNA was eluted by adding a suitable volume of elution buffer (2.1.6.1), not less 
than half the volume of Sephaglas used. The sample was vortexed briefly to resuspend the pellet and 
incubated at room temperature for 5 minutes, then centrifuged again for 1 minute at top speed before 
the supernatant was carefully removed and retained.
2.2.1.3 Concentration of DNA by ethanol precipitation
DNA was concentrated by precipitation with 0.1 volumes 3M sodium acetate (pH 5.2) and 2.5 
volumes absolute ethanol at -70°C for 20 minutes or -20°C overnight, centrifuged at high speed for 20 
minutes, washed in 70% (v/v) ethanol and resuspended in sterile water.
2.2.1.4 Purity of DNA preparations
DNA solution (5j l i 1) was diluted to 1ml with water. Spectrophotometer (Perkin Elmer UV/VIS 
Lambda 1 1 ) readings were taken at A26o and A28o. The A26o reading was adjusted and used to estimate 
the concentration of the DNA using the following equations:
1 A 26o =  50 fig/ml double stranded DNA 
1 A 26o =  3  3 fig/ml single stranded DNA 
The ratio (A26o/A28o) provided estimation for the purity of the DNA preparation. A ratio of 1.8 
indicated high purity. A ratio greater than 1.8 suggested RNA contamination while a lower figure 
indicated protein contamination.
2.2.2 DNA modifying techniques
2.2.2.1 Restriction digest techniques
Restriction digests were performed generally in a total volume of lOOjil or less. Plasmid DNA (l-5pg) 
was incubated for 1-3 hours at 37°C with lOunits of restriction enzymes (2.1.1.1) and 0.1 volume of 
the associated lOx reaction buffer. Enzyme reactions were stopped by the addition of 0.5M EDTA 
(pH 8.0) to a final concentration of IOmM.
2.2.2.2 Removal of 59 phosphate group
The 5’ phosphate group was removed from DNA fragments by treatment with alkaline phosphatase. 
The DNA and associated reaction buffer (Table 2.1.1.2) was incubated in a total reaction volume of 
50jil. After 30 minutes incubation at 37°C the reaction was stopped by the addition of 5pi 0.5M 
EDTA and the enzyme inactivated by incubation at 65°C for 10 minutes.
2.2.2.3 Ligation of sticky and blunt ended DNA
In a standard ligation of sticky or blunt-ended DNA, approximately 50ng of vector was used with a 
two-fold molar excess of insert to vector. This was incubated with 2 units of T4 DNA ligase and 
associated buffer (Table 2.1.1.2) in a final reaction volume of 20pl. The reaction was incubated at 
15 °C for 4 to 15 hours prior to transformation into competent cells.
2.2.2.4 Single stranded DNA sequencing
Clones were sequenced directly on an automated Perkin Elmer ABI PRISM™ 377 DNA Sequencer. 
Sequencing was performed in a lOpl reaction volume and set up in a 0.2ml thin-walled 
microcentrifuge tubes. Prior to the addition DNA polymerase enzyme the reaction mix is heated to 
94°C to denature the DNA template.
2.2.3 Standard Microbiological Techniques
2.2.3.1 Bacterial strains, plasmids and antibiotics
All bacterial strains, plasmids and antibiotics used in this report are listed in Table 2.1.2, 2.1.3 and 
2.1.5 respectively.
2.2 3.2 Maintenance of bacterial strains and plasmids
Stocks of bacterial strains and plasmids in the appropriate host cell were prepared for long term 
storage at -70°C by mixing 0.5ml of a fresh overnight culture with 0.5ml of 100% glycerol. For short­
term storage, strains were plated out onto LB-agar, sealed with nescofilm and stored at 4°C.
2.2.3.3 Isolation o f plasmid DNA fromE. coli using Promega “Wizard”™ 
miniprep method
For small-scale preparation, an isolated colony was picked and used to inoculate 5-10ml liquid 
medium containing antibiotics (Table 2.1.6). After overnight growth in an orbital incubator at 37°C, 
210rpm, a 1.5ml sample of the culture was transferred to a micro-centrifuge tube and centrifuged at 
10,000g for 5 minutes. The pellet was resuspended by vortexing in lOOpl of Cell Resuspension 
Solution. Cell Lysis Solution (200jil) was added and the tube’s contents mixed by inverting several 
times. After the addition of 200pl of Neutralisation Solution the tube was again inverted several times 
and spun at 10,000g in a microcentrifuge for 5 minutes. The clear supernatant was retained and the 
pellet of bacterial debris discarded.
A Wizard™ Minicolumn was prepared by attaching the barrel of a 3ml syringe to the Minicolumn and 
lml of resuspended Wizard™ miniprep DNA Purification Resin was added to the Minicolumn/syringe 
assembly. The clear supernatant was transferred to the barrel of the Minicolumn/syringe assembly and 
the plunger pushed gently, after which the syringe was removed from the column and the plunger 
withdrawn. The syringe barrel was then reattached and 2ml of Column Wash Solution passed through 
the Minicolumn. The syringe was again removed and the Minicolumn transferred to a clean 1.5ml 
microcentrifuge tube. The Minicolumn was centrifuged at 10,000g for 2 minutes to dry the resin. 
Following this 50j l i 1 of water was added and the column left to stand for 1 minute, centrifuging at 
10,000g for 30 seconds eluted the plasmid DNA.
2.2.3.4 Preparation of competent cells (strains XL1, XL2 and TGI)
Competent cells were made using the calcium chloride (method adapted from Mandel and Higa, 
1970). A 10ml culture of the desired cell strain was prepared. A 100pi sample of the culture was used 
to inoculate 50ml LB medium. The culture was grown 37°C, 210rpm, until an A550 of 0.3 was 
reached. The cells were cooled briefly on ice (5 minutes) before pelleting at 3000-4000rpm in a Sorval 
H-1000 rotor at 4°C. The cells were resuspended gently in lOmls of sterile, ice-cold, 0.1M CaCl2 and 
incubated on ice for at least 1 hour. The cells were pelleted and resuspended in 2ml of the 0.1M CaCl2 
solution prior to transformation.
2.2.3.5 Transformation o f competent cells with plasmid DNA
Competent cells (100pi) were mixed with the transforming DNA (up to 50pg) in a pre-cooled 
microcentrifuged tube. The mixture was incubated on ice for 30 minutes before incubating at 42°C for 
45 seconds (heat shocking). After 2 minutes on ice, the volume was increased to 1ml with LB broth 
and incubated in the orbital shaker at 37°C, 210rpm for 1 hour. Up to 200pl of the transformed 
mixture was plated out onto LB plates containing antibiotic and incubated, inverted, at 37°C.
2.2.3.6 Denaturing agarose gel electrophoresis
The formaldehyde gel was prepared by melting 1.5% (w/v) agarose in RNase-free water. The agarose 
was allowed to cool to 55°C before the addition of 5x MOPS buffer and formaldehyde to give lx and 
2.2M final concentrations, respectively. The agarose mixture was poured into an RNase-free perspex 
gel cast and allowed to set in a chemical fume hood. RNA samples were then prepared by mixing 8 pi 
of RNA loading buffer (Table 2.1.1.5) in a sterile microcentrifuge tube with 0.5pg RNA. The RNA 
sample was then incubated at 60°C for 15 minutes prior to loading on the gel and electrophoresised at 
70V in MOPS buffer (lx MOPS buffer, Table 2.1.1.5). Restriction fragments of DNA or RNA ladder 
were convenient molecular weight markers. When the RNA had reached the end of the gel the 
ethidium bromide stained RNA was examined and photographed under ultraviolet light.
2.2.4. Maintenance of Caenorhabditis elegans
The Bristol N2 strain of C. elegans was routinely maintained on NGM agar plates seeded with OP50, 
a uracil-requiring mutant of E. coli. Plates were incubated at 15°C and sub-cultured every 10 days. C. 
elegans worms were grown in large scale liquid cultures on dense suspensions of E. coli OP50. An 
overnight culture of OP50 in DYT medium was spun at 300g for 5 minutes at room temperature and 
resuspended in complete S basal medium at a concentration of 20g wet weight per litre. Two litre 
flasks with 500ml of the bacterial suspension were inoculated with 2xl04 worms washed off plates, 
and cultures vigorously aerated at 20°C for 7-10 days until the culture started to clear. The suspension 
was transferred to a 1 litre glass cylinder and nematodes allowed to settle for 1 hour at 16°C. The 
complete S medium suspension was carefully poured away and worms were washed in M9 buffer 
until remaining bacteria was removed. Worms were resuspended in cold 35% (w/v) sucrose and spun 
in a swinging bucket rotor at 700g for 5 minutes. C. elegans worms that floated to the top were 
removed and washed twice with 0.1M NaCl. The yield was ~3-5g wet weight of nematode per litre of 
culture.
2.2.5 Antiserum Production and Characterisation
2.2.5.1 Peptide design and synthesis
Several features of the polypeptide were considered prior to peptide synthesis including:
• Peptides containing hydrophilic amino acids were more likely to be exposed on the surface of the 
native protein.
• Hydrophilic peptides are more likely to be soluble for coupling reactions.
• Presence of proline residues in [3-tums are thought to form portions of known epitopes (Lane, 
1988).
• Carboxy or N-terminal sequences are often exposed.
• Stretches of amino acids that are more flexible are more likely to be epitopes.
• An N-terminal cysteine was added during peptide synthesis to allow conjugation of the peptide to 
thyroglobulin using the m-maleimidobenzoic acid N-hydroxysuccinimide ester (MBS) method.
Ideal antisera possess high titre coupled with specificity (Lane, 1988). High titre can be influenced by 
the use of adjuvant, which allows continued presence of immunogen to allow extensive polyclonal 
proliferation. Avidity and specificity depend critically upon the purity of the immunogen administered 
and the initial design of the peptide. All peptide sequences were automatically synthesised using a 
finoc synthesis on a Milligen 9050 Pepsynthesizer by Sue Phillips (University of Bath). The quality of 
the peptide was checked by reverse-phase HPLC.
2.2.5.2 Peptide coupling and carrier proteins
A 20mg/ml solution of bovine thyroglobulin was dissolved in lOmM potassium phosphate (pH 7.2), 
dialysed overnight at 4°C against lOmM potassium phosphate (pH 7.2) and the final concentration 
adjusted to 16mg/ml. Thyroglobulin was then activated by adding 250jul of the dialysed thyroglobulin 
to 85pi m-maleidobenzoic acid N-hydroxysuccinimide (MBS) and mixed end over for 30 minutes at 
room temperature. The thyroglobulin was then desalted by passing it through a Pharmacia Bio-Gel P- 
30 column, equilibrated with 50mM potassium phosphate (pH 6.0) and collected as three fractions. 
The cysteine residue of the peptide was reduced (enabling the carrier protein to bind) by dissolving in 
lOmM potassium phosphate (pH 7.2) and incubated overnight at room temperature with a final 
concentration of 200mM dithioreitol. The peptide was then desalted by passing it through a Bio-gel 
P2 (Bio-rad, Laboratories, California, U.S.A.) column. The peptide fractions were collected, pooled 
and freezed-dried overnight. Peptide was dissolved in lOmM potassium phosphate (pH 7.2) to a final 
concentration of 5mg/ml.
The three fractions of thyroglobulin were combined with 1ml of peptide, conjugation was allowed to 
proceed allowing the compound to oxidize and produce disulfide bonds. The pH was adjusted to 7.4 
and mixed at room temperature for 3 hours. Solid NaCl was added to a final concentration of 0.9% 
(w/v) to adjust the compound to physiological osmotic potential, prior to injection. The peptide- 
conjugate was used at a concentration of 1 mg/ml (pH to 7.4).
2.2.53 Immunisation
New Zealand white rabbits were immunised with thyroglobulin-peptide conjugate. A typical schedule 
was as follows: for each rabbit 0.25ml (45mg/ml) of adjuvant (Imject Alum), was added dropwise to 
0.25ml of immunogen solution (lmg /1ml). This was mixed thoroughly for 30 minutes, prior to 
injection into two intraperitoneal sites. Additional injections were made every ten days. ELISA tests 
done on trial bleeds after each injection and pre-immune control allowed the monitoring of antibody 
titre. Exsanguination was performed on anaesthetised rabbits; approximately 150-200mls of blood 
was obtained per rabbit.
2.2.5.4 Harvesting serum
Between 5-10mls of blood was collected from each rabbit and allowed to clot for 1 hour at 37°C. The 
clot was then freed from the walls of the container and left overnight for the clot to retract. The serum 
was centrifuged at 4000 r.p.m. for 10 minutes to remove the red blood cells. For long term storage at -  
20°C, 0.1% sodium azide was added at this stage. Preservatives are unnecessary for sera stored at - 
70°C.
2.2.5 5 ELISA protocol
An ELISA test for the specificity of the antisera to the nematode antigen was performed. The plate 
was coated with 100pi of antigen solution (lOpg/ml diluted in coating buffer) and left overnight at 
4°C. Plates were then washed 3 times with PBS/Tween (1% (v/v)) and left for 2 hours at room 
temperature with a casein-blocking agent. Following 2 washes with PBS/Tween, the test antiserum 
was applied in doubling dilutions (starting at 1:50) and left overnight at 4°C. Three washes of 
PBS/Tween removed the unbound primary antibody before applying the (HRP)-conjugated goat anti- 
rabbit IgG peroxidase enzyme (Amersham NA934) diluted 1:1000 in PBS/Tween. The plates were 
then incubated for 2 hours at room temperature before three washes with PBS/Tween and two washes 
with PBS. The hydrogen peroxide substrate was then applied and incubated for 5-15 minutes at room 
temperature. The reaction was stopped with 50pl of 1.84M H2SO4 and the O.D. read at 450nM.
2.2.5.6 Coupling of thyroglobulin to CNBr activated Sepharose
Severe contamination was removed from 3g CNBr activated sepharose by 3 series of repeated washes 
with 300mls of ImM HC1 (pH 2-3), 200mls distilled H20  and 200mls of 0.1M NaHC03 (pH 8.3) on a 
sintered funnel. The ligand (5mg) was dissolved in 5mls of coupling solution and excess ligand 
washed away with 3 bed volumes of 0.1 M NaHC03 mixed with 0.5M NaCl. Remaining active groups 
on the gel were blocked with 0.1M Tris-HCl (pH 8.0). The mixture was rotated end over for 12 hours 
at 4°C. Three wash cycles in alternating pH (0.1M sodium acetate (pH 4.0) mixed with 0.5M NaCl, 
0.1M Tris-HCl (pH 8.0) and 0.5M NaCl), removed excess uncoupled ligand that remained after 
coupling.
2.2.5.7 Affinity purification o f GBR-2B antiserum
Gel slurry was poured into a 10ml column and washed profusely with column buffer via a peristaltic 
pump at 1ml per minute. The serum was re-cycled through the column overnight at 4°C. Excess 
ligand was washed off with 20mM Na2HP04 (pH 7.3) prior to blocking excess active groups which 
remain on the gel after coupling. Diethylamine (pH 11.5) eluted the antibody that was measured using 
UV photospectrophotometer linked up to a chart recorder. Antibody containing fractions were 
dialysed in PBS overnight and then concentrated in polyethylene glycol 20,000 for 2-3 hours. The 
column was regenerated by washing once with 20mM Na2HP04 (pH 7.3) and three times with 0.1M 
Tris HC1 (including 0.5M NaCl pH 8.3) and 0.1M sodium acetate (including 0.5M NaCl pH4.0).
2.2.6 Immunocytochemistry
2.2.6.1 Preparation of C. elegans whole worm tissue preparations
Using the N2 strain of C. elegans, adult worms were grown on several plates and then washed off the 
agar with M9 buffer (2.1.4). Nematodes were then pelleted by centrifugation at 1500rpm for 5 
minutes at 4°C. Worms were incubated overnight at 4°C in 4% paraformaldehyde and 1% 
Glutaraldehyde fixative. Fixed worms were then permeabilised by a 1% Triton-X, 5% 2p- 
mercaptoethanol (2[3-ME)/collagenase (pH 6.9) treatment and incubated overnight at 37°C with gentle 
shaking. The reduction step of 2 (3-ME reduced the disulphide linkages between cuticular collagens 
thereby enhancing the effects of the collagenase in the next step. Following this overnight incubation 
the worms were gently washed five times in PBS (pH 7.2), resuspended in 0.4ml of collagenase buffer 
and incubated at 37°C to allow permeabilisation of the highly cross-linked nematode cuticle and 
penetration of antibodies. Polyclonal serum raised in rabbit against the synthetic peptide was applied 
to the fixed, permeabilised worm at the dilution of 1:10 and 1:100, in antibody buffer. Primary 
antibody was incubated at 4°C for three days. Three 15-minute washes in PBS/Triton-X removed 
unbound primary antibody. The fluorescently tagged secondary antibody (goat anti-rabbit-TRITC) 
was diluted 1:50 in antibody buffer and incubated for five hours at room temperature with gentle 
shaking. Following 6  washes, the stained nematodes were transferred to microscope slides, mounted 
in Vectrashield (Vector Laboratories Inc., Burlingame, CA, U.S.A.) and viewed on the confocal 
microscope (Zeiss LSM 510) under fluorescence.
2.2.6.2 Pre-absorption ofprimary antiserum for negative controls
Purified antisera were incubated with excess, pure peptide to a final concentration of 20mg/ml' 1 and 
incubated at 37°C for a minimum of one hour. The "adsorbed” antibody/antigen complex was used as 
a negative control.
2.2.6.3 Freeze-crack immunocytochemistry
Nematodes were prepared for freeze-crack immunocytochemistry in the same way as described in 
section 2.2.6.1. Poly-Lysine slides were labelled with a diamond glass pen (2.1.7.2. for poly-lysine 
preparation) and placed on the bench-frosted side up. Using a glass pipette, worms were spread on the 
slides and sandwiched carefully by placing an unlabelled poly-lysine slide (frosted side down) on top. 
Slides were then placed on dry ice for at least 20 minutes. At this point, slides could be saved at - 
80°C. Prior to use (following -80°C incubation), slides were warmed up on dry ice for 20 minutes 
before cracking.
2.2.6.4 Cracking, fixing and staining o f nematodes
Frozen slides were cracked by swiftly pulling them apart. The unlabelled top slide was discarded and 
the wormless sides placed back-to-back and placed into a cold slide holder. Worms were fixed by 
immersing them in ice-cold methanol for two minutes, followed by ice-cold acetone for four minutes. 
The slides were air dried for less than a minute and placed into a block for 1 hour at room 
temperature. Immunocytochemistry was carried out as described in section 2.2.6.1. All fluorescence 
microscopy of nematodes was examined using a Zeiss LMS 510 confocal microscope, with a helium 
neon laser and rhodamine filter.
2.2.7 Cloning o f the ZC317.3 cDNA receptor subunit from C. elegans using 
the Polymerase Chain Reaction (PCR)
2.2.7.1 Small-scale worm RNA extraction
Worms were washed off 4 plates (9cm), that were just clearing, using M9 buffer (Table 2.1.4) and 
spun down at 150g. Approximately 200|ul of “packed” C. elegans worms were transferred into 2ml 
microcentrifuge tubes and resuspended with 0.8ml of TRIzole®Reagent (GIBCOBRL) and 0.5ml 
glassbeads (425-600 microns, acid washed, Sigma-Aldridge) and vortexed at high speed for 1 minute. 
The samples were left to stand at room temperature for 10-15 minutes with occasional vortexing. The 
homogenised worms were then centrifuged briefly and the supernatant drawn off the beads and placed 
into clean 1.5ml microcentrifuge tubes. The beads were rinsed with a further 200pl Trizole, vortexed 
briefly and the supernatants combined. Chloroform (200pl) was added to the sample and vortexed for 
30 seconds prior to being incubated at room temperature for 5 minutes. The mixture was 
microcentrifuged at 12,000g for 15 minutes (at 2-8°C), allowing the phases to separate. The upper 
aqueous phase was removed, taking care not to remove any of the interface. Precipitation of the RNA 
was achieved by the addition of isopropanol (0.5ml), vortexing and incubation at room temperature 
for 10 minutes. The RNA was recovered by centrifugation at 12,000g for 30 minutes at 4°C. Once 
pelleted the aqueous layer was removed and the RNA washed with 1ml 75% ethanol, briefly mixed 
and microcentrifuged at 7,500g for 5 minutes at 4°C. Ethanol supernatants were removed and the 
pellets allowed to dry for 5-10 minutes, prior to resuspending in 200|nl nuclease free water and stored 
at -70°C. RNA (5j l i 1) was diluted in lOOOp.1 H20  and the O.D. measured at 260 and 280 to determine 
the concentration and purity. (Note a 260/280 ratio of <1.6 indicates partially dissolved RNA). The 
concentration of the RNA was determined using the following equation:
RNA concentration (pg/ml) = 100/5 (dilution factor) x O.D.26o x 40
Approximately one 9cm petri-dish of healthy worms (0.2ml of worms) yielded about 100-150jig of 
total RNA.
2.2.7.2 Synthesis o f cDNA from total RNA
Total RNA was reversed transcribed into cDNA using Superscript™ reverse transcriptase enzyme. 
Random hexomer primer (4pi, Fig. 4.1) was added to 1 lpl of dH20  and lpg of eluted total RNA, and 
heated to 70°C for 2 minutes to disrupt any secondary structure. The reaction was immediately chilled 
on ice prior to the addition of the following; 2pi of 0.1 M DTT, lpl RNasin (40units, Promega), 4pl of 
superscript (II) buffer (SK) and lpl lOmM dNTP’s. The reaction was heated to 42°C for 2 minutes 
prior to the addition of lpl of Superscript™ reverse transcriptase enzyme (200U, Promega) and the 
incubation continued for a further 50 minutes. The reaction was heated to 70°C for 15 minutes to 
inactivate the enzyme. RNase H (2units, GIBCO BRL) was added and the reaction incubated for 20 
minutes at 37°C. The reaction volume was increased to lOOpl with dH20  before a phenol rchloroform 
extraction was performed. cDNA was precipitated with 0.1 volume of 3M sodium acetate (pH 5.2) 
and 2.5 volumes of ethanol and incubated at -20°C for a minimum of 1 hour. The cDNA was pelleted 
and washed in 70% ethanol before being air-dried and resuspended in H20  (usually lOOpl).
2.2.7.3 Isolation o f genomic DNA from C. elegans
Following the method of Herman and Frischauf [1987 #238], nematodes were ground to a powder 
under liquid nitrogen with a pestle and mortar. The powder was quickly resuspended in 20ml of TEN9 
buffer (2.1.8.1.). The solution was transferred to a 50ml tube and shaken to give an homogenous 
suspension. SDS (1ml of a 20% solution) and lml of proteinase K (lOmg/ml) were added and mixed 
by inverting the tube. Digestion was allowed to continue overnight at 55°C. The solution was 
transferred to a large flat-sided glass bottle (500ml), and 20ml of equilibrated phenol (pH 8.0) was 
added. The bottle was placed flat on a gently rocking platform (30rpm) for 1-3hours. The phases were 
separated by centrifugation at 3000rpm for lOminutes and the aqueous phase drawn off with a wide- 
bore pipette into a fresh bottle. The phenol extraction was repeated twice more, until the aqueous 
phase was clear. Remaining debris was removed by centrifugation at 9000rpm for 20 minutes at room 
temperature. The supernatant was dialysed against a 1000-fold volume of TE (pH 7.6), first at room 
temperature, to avoid SDS precipitation, then at 4°C overnight. DNA was precipitated by the addition 
of 0.1 vol of 3M sodium acetate (pH 5.5) and 0.8 volumes of 2-propanol. The solution was mixed 
gently by inverting the tube several times. The DNA was spooled out with a glass rod and placed into 
TE (lml per g of tissue) in a microcentrifuge tube. The tube was placed on a rotating wheel (lOrpm) 
and the DNA allowed to dissolve overnight at 4°C.
2.2.7.4 Design o f oligonucleotide primers
Blast searches of the C. elegans genome sequence revealed a predicted polypeptide, ZC317.3 with 
high amino-acid sequence identity to the other cloned GluCl subunits. Based on the sequence of the 
polypeptide we were able to design gene specific oligonucleotides primers corresponding to the 5’ (*) 
and 3’ (f) ends of the predicted gene. All oligonucleotides used were custom made by Perkin-Elmer 
and had been HPLC purified and lyophilised.
(.) ZC317J 5 CTTGATGAGTCTCCGTTCACTTC3
(t)Zc317.3 ’ CAATTT CATTT GGCTT CCGGTGCG3
SLI 5 GGTTTAATTACCCAAGTTTGAG3
2.2.7.5 Calculation of primer annealing temperature
Predicted melting temperatures (Tm) of primers were estimated using the equation:
T m=4(GC)+2(AT)
2.2.7.6 The Polymerase Chain Reaction
All PCR’s were performed in the Perkin-Elmer, Model PTC-100™ (MJ Research, Inc) thermo-cycling 
machine. Expand High Fidelity (Boehringer Mannheim) was used that ensures high 3’-5’ exonuclease 
activity for proofreading of the extension product.
The PCR reaction was performed in a 50pl reaction volume and set up in a 0.2ml thin-walled 
microcentrifuge tube by adding:
5 pi 10X Expand High Fidelity DNA polymerase buffer, 15mM MgCl2 included
7.5 pi 4X dNTP’s (2mM)
lpl 2X oligonucleotide primer (20pM)
lpl lOng cDNA template
0.75pl Expand High Fidelity polymerase enzyme (2.6units/0.75pl)
H20  (dd) to 50pl total volume.
2.2.7.7 Temperature cycling conditions
Hot start 2 min 94°C
Denaturation 2 mins 94°C
Annealing 1.5mins 55°C typically 40 cycles
Extension time 2 mins 72°C
The final step involved heating to 72°C and maintaining this temperature for 5 minutes to ensure all 
extension products were double stranded.
2.2.7.8 Subcloning PCR products
PCR products were analysed on 1-3% agarose gels and bands of the predicted size were excised and 
purified with Sephaglas. Primers incorporating unique restriction sites resulted in PCR products that 
were digested with the appropriate restriction enzyme, re-purified and ligated into a suitable digestion 
vector, either pGEM®-T Easy or pBluescript™. PCR primers that did not incorporate restriction sites 
resulted in PCR products that were cloned into a pCR® 2.1 vector (Invitrogen cloning kit®). Freshly 
amplified PCR products (50ng) generated using Taq DNA polymerase have a 5’ A overhang due to 
the terminal transferase activity of this enzyme. The purified, amplified DNA was used for a 1:1 
(vectoninsert) ligation reaction as follows:
For a lOpl ligation reaction:
Fresh PCR product Xpl
1 OX Ligation buffer 1 pi
pCR® 2.1 vector (25ng/pl) 2pl
Sterile water to total of 9 pi
T4 Ligase (4.0 units) lpl
The reaction mixture was incubated at 15°C overnight, after which time the reaction was cooled on 
ice or stored at -20°C until ready for transformation. Transformation and subsequent sequencing were 
performed as above. The cDNA was subcloned into pGEM®-T Easy (Promega, Southampton, U.K.). 
DNA sequencing reactions were carried out by DNASHEF, Edinburgh, U.K. and analysed using the 
GCG package mounted on a Silicon Graphic Unix workstation.
2.2.8 Functional expression o f glutamate- chloride channels in Xenopus
oocytes
2.2.8.1 Preparation of cRNA for In vitro transcription
The cloning of C. elegans GLC-3 receptor subunit was described in section 2.2.7. Plasmid DNA 
encoding C. elegans glutamate receptor subunits were prepared from glycerol stocks as described in 
section 2.2.3. The DNA encoding each subunit (llpg) was linearised with the restriction enzyme Notl 
at 37°C overnight as described in section 2.2.2.1. The resulting linearised template was precipitated 
once with 0.1 volumes sterile 3M sodium acetate and 3 volumes sterile absolute ethanol at -20°C, 
overnight. Linearised template was centrifuged at high speed for 30 minutes, washed with sterile 70% 
ethanol, dried and resuspended in 20pl RNase-free DEPC treated sterile water. The linearised plasmid 
was diluted to a final concentration of 1 ^ ig/pJ with RNase-free water.
Maintaining RNase-free conditions, 20-40jag of 7-methylguanosine capped cRNA was synthesised 
with T7 RNA polymerase transcription kit (mMessage mMachine, Ambion, Austin, TX, U.S.A.) 
using the following protocol:
The following were mixed:
5 pi IO x  Transcription buffer
5pl lOOmM DTT
5 pi of each; ATP, CTP, UTP, and GTP (5mM)
0.5pl lOmg/ml BSA
2.5pl cap analogue (M7G(5’)ppp(5’)G)
lOpl linearised plasmid DNA (lOpg)
2pl 40U/pl RNase Inhibitor
2 jlx1 T7 Polymerase
and the volume made up to 50pl with nuclease-free water and incubated at 40°C for 1 hour. Following 
the incubation time the template was digested with 2 units DNase for 15 minutes at 37°C to minimise 
DNA degradation. The resulting transcripts were treated with phenol, phenol-chloroform and 
chloroform extraction prior to ethanol precipitation and resuspended in nuclease-free water to a final 
concentration of 1 jug/fxl. At this point, appropriate volumes (approximately 10-20pl) of transcript 
from each subunit were mixed, centrifuged at high speed for 40 minutes, washed in 70% ethanol, 
dried and re-suspended in 10-20pl (depending on average concentration of transcripts) of sterile
RNase free water. The concentration and integrity of cRNA produced from in vitro transcription was 
determined by spectophotometry, and on a denaturing gel as described in section 2.2.3.6.
2.2.8.2 Xenopus oocytes preparation and injection
Xenopus laevis females were anaesthetised by submersion in 0.5% Tricaine (3-aminobenzoic acid 
ethyl ester) at room temperature for approximately 40 minutes until leg retraction ceased. Ovarian 
lobes were extracted through an incision made in the skin and abdominal body wall in the posterior 
ventral side of the frog. The incision was sutured using Mersilk™ 4.0 (Ethicon Ltd., U.K.) and the 
frog was left to recover in water before returning to its original colony. The ovarian lobes were sliced 
into smaller clumps of approximately 50 oocytes, where stage V and VI were defolliculated manually 
after a 5-30 min incubation with collagenase (type 1A; 2mg/ml), in a calcium-free version of standard 
oocyte saline SOS (Table 2.1.9.2). Oocytes were then rinsed in several washes of SOS and transferred 
and stored for up to 3 days in incubation medium (Table 2.1.9.2).
Injection needles were pulled from 3.5 Drummond glass capillary tubing (Clark Electromedical, U.K.) 
on a stationary coil Narishige microelectrode puller (Optical Instruments Services Ltd., Croyden, 
U.K.) to produce a tip of approximately lpM which was then gently broken to give a tip with a 
slightly larger diameter. Needles were back filled with sterile mineral oil and attached to the plunger 
of a Drummond “Nanoject” microinjector (Broomhall, PA, U.S.A.). With the aid of a binocular 
microscope oocytes were injected cytoplasmically with either 50ng of in vitro transcripts in a total 
volume of 50nl or for control eggs 50nl of nuclease-free H20. Oocytes were incubated at 16°C for 2-7 
days in changes of incubation medium (Table 2.1.9.2).
2.2.8.3 Electrophysiological recordings
Microelectrodes were pulled from borosilicate glass capillaries on a microelectrode puller (Scientific 
and Research Instruments, Ltd., U.K.) to produce a resistance, when filled with 3M KC1, of between 
0.5 and 5 MQ. Each oocyte was positioned in a perspex-recording chamber, secured with steel pins, 
impaled with two microelectrodes and perfused continuously with SOS (5ml/minute) by gravity fed 
system (5ml/min). Electrophysiological recordings were performed using a two-electrode voltage 
clamp amplifier OC-725C (Warner, Warner Instrument, Corp., U.S.A.) on oocytes with a resting 
membrane potential of greater than -25mV and maintained at a holding potential of Eh= -80mV 
unless otherwise stated. In each case, the change in current (or lack of) across the membrane of the 
oocyte required to keep the oocyte clamped at -80mV was recorded on a Hewlett-Packard chart 
recorder. Data was analysed using the program graph pad prism (Graphpad Software) and presented 
as the mean +/- the standard error of the mean. Hill coefficients were calculated using the following 
equation:
59
I  = /min + /max-Zmin
/max /max [l+ lO ^^so '^^j/m ax
This equation was used to fit a sigmoid curve of variable slope to the normalised data. %Imax and 1 ^  
represent the maximal and minimal currents induced by a particular agonist. The EC50 is the 
concentration of agonist necessary to elicit half the maximum response and nH is the slope (Hill) 
coefficient.
2.2.8.4 Data analysis
In each case, experiments were repeated at least 4 times (n>4). All values are quoted as mean ± 
standard error of the mean. Concentration response curves were fitted using non-linear regression in 
Graphpad Prism (version 3, San Diego, U.S.A.). Data on graphs are shown as a percentage of the 
maximum response.
2.2.8.5 Ligand application protocol
Saline insoluble ligands (IVM, fipronil, BIDN and Ibotenate) were dissolved in DMSO (<1% v/v final 
concentration in saline); this solvent concentration was shown to have no undesirable effects either on 
drug-induced responses or on uninjected oocyte membranes when cells were clamped at Eh =80-mV. 
Only those oocytes which gave stable responses to at least 2 applications of 3mM L-glutamate were 
used, this allowed us to assess the quality of the oocyte and RNA expression. An acceptable inward 
current for 3mM L-glutamate would be between 150 and 250nA. A dose-dependent relationship for L- 
glutamate was generated by challenging the expressed receptor first with 3mM applications of L- 
glutamate followed by increasing concentrations of L-glutamate (lOpM to lOOmM) at 5 minute 
intervals, preventing desensitisation. The response to each concentration of agonist was expressed as a 
percentage of the peak response (%Imax). When investigating the antagonist action of compounds, 
oocytes were pre-incubated for 2 minutes in the antagonist prior to each co-application of L-glutamate 
and the antagonist. The process was repeated with higher concentrations of antagonist following 5 
minutes recovery period in normal saline. All ligands and standard oocyte saline was applied using a 
gravity fed system at a constant rate of 5mls/minute, unless otherwise stated. The amplitude of the 
response to co-application of antagonist and L-glutamate was subtracted from the values obtained in 
the presence of 3mM L-glutamate in physiological saline.
2.2.8.6 Current-voltage relationship o f L-glutamate chloride channels
The L-glutamate induced current was determined by subtracting the current required to clamp the 
oocyte membrane at a given potential in saline, from that required to clamp the membrane at the same 
potential in the presence of a non-desensitising L-glutamate concentration (3mM). To check the ion 
channels selectivity to chloride ions a reduction of external NaCl concentration to 54.9mM and its 
replacement by 45.1mM monosodium gluconate was examined and compared to the predicted 
chloride equilibrium potential Ea  given by the Nemst equation for chloride ions.
ES = RT In rClL In [K]n InfNaL MCaL 
F [Cl]! [K]r [Na]x [Ca^
Here R is the gas constant (8.314 JK — 1 mol — x), T is the absolute temperature (K), F is the Faraday 
constant (96,500 C mol-  *) and Es is the equilibrium potential. The subscripts O and I stand for 
outside and inside, respectively. The Nemst equation allows us to derive ionic equilibrium potential 
(Es) for one or all the permeable ions present within a cell. According to the Nemst equation, how 
large the equilibrium potentials for a living cell will vary linearly with absolute temperature and 
logarithmically with ionic concentration ratio. Equilibrium potentials change sign if the charge of the 











I  mm unocytoch emical localisation o f GBR-2 
subunits from Caenorhabditis elegans
3.1 Introduction
In both free-living and parasitic species of nematodes (Avery and Horvitz, 1990; Geary et al., 1993) 
the mode of action of ivermectin and related analogues is to selectively paralyse the parasite by 
increasing muscle C1‘ permeability. However, the identity of the channel target in whole nematode 
preparations has been controversial (Arena, 1994). Observed behaviour in whole nematode 
preparations varies extensively. Incubation of C. elegans, on avermectin plates (20ng/ml) produced 
inhibition of pharyngeal pumping and slow onset of rigid paralysis. In contrast Haemonchus contortus 
showed no obvious effects when submerged in the drug at similar concentrations (Avery, 1993; 
Turner and Schaeffer, 1989). Furthermore, direct injection into the nematode A scar is suum resulted in 
rapid paralysis that was neither rigid nor flaccid (Bemt et al., 1998; Kass et al., 1980). But nematodes 
examined at pharmacologically relevant concentrations of avermectin (0.1-InM) showed no visible 
effect on motility in any susceptible nematode species (Geary et al., 1992). In contrast, pharyngeal 
pumping in C. elegans (Avery and Horvitz, 1990) and Haemonchus contortus (Geary et al., 1993) 
appeared extremely sensitive to low concentration of avermectin, where paralysis is produced at 10- 
100 fold lower concentrations than those required to inhibit motility (Geary et al., 1992; Geary et al., 
1993; Martin, 1997).
3.1.2. Anatomy o f the C. elegans pharynx
In order for C. elegans to eat, rhythmical contraction and relaxation of the pharynx must occur. The 
pharynx forms a self-contained muscular organ that is composed of three function parts, the corpus, 
the isthmus and the terminal bulb, containing 20 muscle cells of eight anatomical types and 20 
neurons (Fig. 3.1), (Albertson and Thompson, 1975). The eight muscle types, denoted pml-8, line the 
pharynx and are innervated by motor neurons Ml-5 (Fig. 3.1). Bacterial food enters the pharynx 
through the buccal cavity situated at the anterior end of the animal and becomes accumulated within 
the two sub-divisions of the corpus, the procorpus and the meta-corpus. Peristaltic action of the 
isthmus combined with intermittent pumping action of corpus, anterior isthmus and terminal bulb 
delivers the food to the terminal bulb. Contraction of the terminal bulb muscles grinds the bacterial 
food plug, which then passes into the intestines. Pharyngeal relaxation returns the grinder to its 
relaxed position, closes the lumen and expels any remaining liquid leaving the bacteria trapped within 
the corpus (Albertson and Thompson, 1975). The 15 motor neuron synapses onto the M3 and M4 
motor neurons that innervate the pm4 and pm5 muscle cells (of the corpus and isthmus), in addition to 
sensory endings found in the terminal bulb. The neuronal endings of the 15 senses when the terminal 
bulb is becoming full and responds by inhibiting the M3 and M4 motor neurons (Avery, 1993).
Electropharyngeogram (EPGs) recordings have observed inhibitory postsynaptic potentials (IPSPs) 
generated by the M3 and M4 motor neurons which synapse directly onto the pm4 and to a lesser 
extent pm5 muscles cell that are directly responsible for regulating pharyngeal muscle relaxation 
(Dent et al., 1997). The IPSPs generated by the M3 motor neuron have been hypothesised to be o f an 
inhibitory glutamatergic transmission that can be influenced by avermectin analogues (Dent et al., 
1997). Furthermore, removal o f the two M3 motor neurons from the pharynx lead to an absence o f 
IPSPs and consequently increases the duration o f muscle contraction. In view o f such observations, it 
is plausible that for ivermectin to be effective in C. elegans, the compound must irreversibly bind to 
ivermectin sensitive channels, causing lethal increases o f chloride conductance that inhibit essential 
cells o f the pharyngeal pump (Dent et al., 1997).
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Figure 3.1 Anatomy of the C. elegans pharynx.
The pharynx is divided into three functional parts: the corpus, the isthmus and the terminal bulb. The 
corpus is further subdivided into the procorpus and metacorpus. Eight muscle types denoted pm 1 to 8 
line the pharynx, four (pm3 to 6) o f which are individually innervated by five motor neurons (M 1-M5) 
and one sensory neuron (15). Three types of small muscle pm l, pm2 and pm8 are not shown 
(Albertson and Thompson, 1975). Photograph courtesy o f Leon Avery PhD taken from 
http://eatworms.swmed.edu/worm_labs/Avery/.
To date only two glutamate-gated chloride channel receptor subunits of C. elegans have been 
localised to specific cells. In both studies, GluCip (Laughton et al., 1997a) and GluClct2 (Dent et al., 
1997) were localised using reporter gene constructs. Using a LacZ reporter gene construct, GluCip 
was found to be expressed in the three pm4 pharyngeal muscle cells of the metacorpus (Fig. 3.1), with 
additional pattern of expression in nuclei of the terminal bulb in the earlier stages of development (egg 
to L3 stages) (Laughton et al., 1997a). The avr-15 gene which encodes protein, GluClot2, was found to 
be expressed in all the muscles of the metacorpus (pm4) and the isthmus throughout larval and adult 
stages. Expression was also observed in a few neurons in the head, which include RMED (ring motor 
neurons, dorsal) and RMEV (ring motor neurons, ventral). Weak staining was also demonstrated in 
ventral cord neurons near the anus, namely DA9 and VA12, indicating that the GluClct2 promoter is 
active in pharyngeal muscle as well as some extrapharyngeal motor neurons that may be involved in 
movement (Dent et al., 1997). The GluCfeGFP transformed animals exhibited a green fluorescence, 
due to a 6kb DNA fragment encoding the first three exons of GluCla2 fused to green fluorescent 
protein (Dent et al., 1997). Expression of the GluCla2 receptor subunits within the pm4 muscles cells 
was found to have very similar expression patterns to the GluCip subunits, indicating the two may 
form a heteromeric pharyngeal receptor onto which the M3 neuron synapses (Fig. 3.1) (Dent et al.,
1997). Expression of the C. elegans GluClai subunit is not known. The location of an avermectin- 
sensitive GluCl channel, has also been identified using a two microelectrode current clamp technique 
in the parasitic nematode Acaris suum (Martin, 1996). Pharyngeal muscle of this parasite possessed 
glutamate receptors that gate chloride channels and that are sensitive to the avermectin analogue 
milbemycin D (Martin, 1996). Although it appears that avermectins may have more than one site of 
action in nematodes, these results provide further evidence that points to the inhibition of the 
pharyngeal pumping as a major mode of action.
In view of such observations the first aim of the study was to map the patterns of an existing C. 
elegans GluCl clone, GBR-2 and examine the anatomical localisation in relation to GluCip and 
GluCla2. The alternatively spliced gene avr-14 encode two proteins (Figure 3.2), GBR-2A and -2B 
from C. elegans which is also conserved in the parasitic species Haemonchus contortus (Jagannathan 
et al., 1999). Sequence analysis of the GBR-2 from Haemonchus indicates that, like C. elegans, the 
gene encodes two receptor subunits, Hc-GBR2A and Hc-GBR-2B. Orthologues of this receptor 
subunit have also been observed in Ascaris suum (Jagannathan et al., 1999) and Dirofilaria immitis 
(Yates, 2000).
Figure 3.2 Schematic diagram of the alternatively spliced products o f GBR-2 A and -2B  derived 
from the gene avr-14. Both subunits possess a common N-terminal indicated by [ J ]  and 
transmembrane domains are labelled 1-4. The GBR-2A product contains the channel encoding 
sequence of the GBR-2B cDNA, 120nt downstream from the GBR-2A termination codon (not to 
scale).
3 . 2  R e s u l t s
3 .2 .1  P e p t i d e  d e s i g n  a n d  s y n t h e s i s
The C. elegans avrl4 gene encodes alternatively spliced products corresponding to the GBR-2A and 
GBR-2B subunit cDNAs. The cDNA-spliced products possess high homology within the N-terminal 
domains making the design of synthetic peptides in this region troublesome. Several key features were 
considered to check the suitability o f the region prior to peptide synthesis. Structural analysis o f the 
sequence was examined using GCG program PEPTIDESTRUCTURE (Fig. 3.4). From the most 
prominent region o f the N-terminal sequence (amino acids 240-270) several candidate domains were 
examined for specificity, antigenicity and sequence homology to other nematode sequences. Using the 
Genbank database an alignment o f all known nematode sequences were compiled allowing us to 
discriminate between proteins regions that share high homology with the peptide sequence. From 
these results peptides (GBR-2A and GBR-2B) were designed from equivalent regions o f the putative 
extracellular domain just upstream from M l, where heterogeneity o f the two N-terminal sequences 
was greatest (50%). Alignment o f 13 consecutive amino acids appeared highly conserved with two 
orthologue nematode sequences, Haemonchus contortus (Hc-GBR-2) and Ascaris suum (As-GBR-2) 
(Fig. 3.3). Peptide sequences were automatically synthesised using a fmoc synthesis on a milligen 
9050 Pepsynthesizer by Sue Phillips at the University of Bath. The quality of the peptide was checked 
by reverse-phase HPLC.
GBR2-B
C. elegans arv0: S urreys
Haemonchus arv0: 0 .rreys
Ascaris arv0: 0 .rreys
GBR2-A
C. elegans lrtJmvlrrefs 
Haemonchus lrtJmvlrrefs
Figure 3.3 Alignment o f the alternatively spliced GBR-2A and GBR-2B receptor subunits indicates 
sequence conservation from C. elegans, Haemonchus and Ascaris suum nematodes. Peptides designed 
to C. elegans GBR-2A and GBR-2B N-terminal domains show high homology to parasitic 
orthologues. Residues where sequences are not conserved are indicated in black. Peptides correspond 
to amino acid residues 243-254 o f the C. elegans GBR-2A and -2B  subunits.
Figure 3.4 Predicted hydrophilicity of GBR-2B.
Hydrophilicity plot displaying the N-terminal domain followed by four transmembrane regions (marked by solid blue lines). A red solid line indicates 
the GBR-2B sequence chosen for peptide synthesis. This profile was constructed using the GCG computer program PEP flDESTRUCTURE.
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3.2.2 Polyclonal serum analysis
Throughout immunisation the titre of the absorbed antiserum was monitored against the free peptide 
using the ELISA method (Section 2.2.5.5.) to ensure specificity remained and that the maximum titre 
had been obtained prior to purification (Fig. 3.5). Affinity purification of polyclonal serum against the 
free peptide sepharose column was then performed to remove unwanted antibodies against the 
thyroglobulin carrier protein and increase overall specificity of the serum. Addition of the antiserum 
to the column allowed specific antibodies to bind non-covalently to the antigen, whilst non-specific 
antibodies are washed away with phosphate buffer (pH 7.3). Serum eluted from the column under 
high alkaline (pH 10.7) was monitored through an optical ultraviolet unit, calibrated initially with 
lOmg/ml bovine serum albumin (BSA). The eluent was collected as absorbance peaked at 280nM.
An ELISA experiment to examine cross-reactivity between peptides was also performed. This 
involved titre measurements of anti-GBR-2A polyclonal serum against the GBR-2B free peptide and 
vice versa. At various dilution factors and in both experiments the antisera against both subunits could 
not distinguish between the GBR-2A and -2B antigens, indicating cross-reactivity between the 
peptides. Polyclonal antibodies made to the original peptide GBR-2B obtained the highest titre and 
was therefore used for all subsequent localisation experiments to study gbr-2 expression patterns.
3.2.3. C. elegans Immunocytochemistry
Nematodes were prepared for freeze-crack immunocytochemistry as described in section 2.2.6.3. 
Following the cracking of the C. elegans slides, nematodes were fixed in either methanol/acetone or 
paraformaldehyde/glutaraldehyde and permeabilised using acetone (Section 2.2.6.4). In all cases 10% 
goat serum was used as blocking agent and FITC-conjugated goat anti-rabbit IgG was used as the 
secondary antibody. C. elegans treated with rabbit polyclonal antibodies raised against the N-terminal 
of the GBR2 subunit at 1:10 and 1:100 dilutions showed bright, specific staining of four sets of cells 
in the region of the pharyngeal nerve ring (Fig. 3.7). No other specific staining of internal organs or 
muscular tissue was identified. Identical patterns of localisation were observed in the isolated 
pharyngeal preparations as with the whole mount preparations, with the additional specific staining of 
2 neuronal cell bodies observed in the corpus and terminal bulb regions of the pharynx (Fig. 3.8 and 
3.9). Both neuronal cell bodies observed surrounding the pharyngeal muscle cells appear to have 
anterior and posterior processes extending outwardly. Nematodes exposed to “absorbed” 
antibody/antigen complex or pre-immune polyclonal serum, showed no specific fluorescence, only 
small amounts of non-specific staining of external body wall, buccal cavity and intestinal contents due 
to bacterial cross-reactivity with FITC secondary antibody (Fig. 3.10). In general polyclonal serum 
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Figure 3.6 ELISA analysis o f  pre-immune and CNBR purified GBR-2B serum.
Figure 3.7 Confocal images of C. elegans, anterior head sections. Red arrow indicates pronounced, 
immunofluorescent staining of pharyngeal nerve ring using rabbit anti-GBR2 polyclonal serum at 
1:10 dilution. Four distinct sets of cells surrounding the pharynx was observed, no other specific 
staining fluorescence of internal organs or muscle tissue was identified Scale bar indicates lOOpM.
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Figure 3.8 Confocal laser micrograph image o f anti-GBR-2 antibody staining within isolated 
dissected pharynx. The anterior section o f the worm is pointing towards the right hand side o f the 
picture. The arrow indicates the staining o f  an individual neuronal cell body within the corpus o f the 
pharynx and the scale bar indicates lOpM. Purified antibody was used at a dilution concentrations of 
1:20. Scale bar indicates lOOpM.
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Figure 3.9 Neuronal cell body immunofluorescence observed in the terminal bulb o f the isolated 
pharyngeal preparation (red arrow). The C. elegans pharyngeal preparation is orientated with the 
anterior end o f the nematode at the bottom of the micrograph. Affinity purified GBR-2 antibody, was 
used at 1:20 dilution, scale bar indicates lO^M.
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Figure 3.10 Isolated pharyngeal preparation obtained with secondary antibody only, showing an 
absence of punctate staining. The fluorescence on the right of the image is gut autofluorescence. Scale 
bar indicates IOOjiM.
3.3 Discussion
The C. elegans avr-14 gene encodes two subunits, which are members of the glutamate-gated chloride 
channel ion family. Both subunits possess a common N-terminal domain but have two different, 
though closely related, channel transmembrane regions (Laughton et al., 1997b), indicating the 
presence of very similar binding sites coupled to different chloride channels. The C. elegans GBR-2A 
cDNA contains the channel encoding sequence of the GBR-2B cDNA approximately 120 nucleotides 
downstream from GBR-2A termination codon (Fig. 3,2). Parasitic orthologues of the GBR-2A and 
GBR-2B subunits have been found to exist in Haemonchus contortus, sharing approximately 88% and 
83% amino acid identity respectively. However, the pattern of alternative splicing may not be 
conserved in Ascaris suum (Jagannathan et al., 1999) or Dirofilaria immitis (Yates, 2000). C. elegans 
GBR-2A and GBR-2B receptor subunits share 82% identity at the amino acid level. In a recent study 
RNAs corresponding to each of the two spliced variants encoded by avr-14 gene were injected into 
oocytes. Interestingly, oocytes only expressing the GBR-2B protein responded to both L-glutamate 
and ivermectin, transcript 2A did not respond to ivermectin or L-glutamate (Dent et al., 2000).
Despite the inability of the anti-GBR-2 antiserum to distinguish between the C. elegans GBR-2A and 
-2B subunits, immunohistological labelling has proven successful, producing distinct, extrapharyngeal 
immunoreactive cells, indicating that one or both subunits are expressed (Fig. 3.5). In pre-absorbed 
(antigen:anti-GBR-2 serum) and pre-immune controls, no specific staining was examined, although 
non-specific staining of buccal cavity, anus and external body wall was observed. In view of such 
observations the GBR-2B antibodies were used to locate the subunits in isolated pharyngeal 
preparations (Figure 3.8, 3.9 and 3.10). This technique allows lower concentration of anti-GBR-2B 
anti-serum to be used, reducing background fluorescence and allowing more specific detail to be 
observed. In addition, the pharynx can be exposed to the antibodies solutions without the aid of 
permeabilisation techniques, which can often lead to increased background fluorescence. Identical 
patterns of localisation were observed in the isolated pharyngeal as with the whole mount 
preparations, with the additional specific staining of 2 neuronal cell bodies observed in the corpus and 
terminal bulb regions of the pharynx (Fig. 3.8 and 3.9, Holden-Dye, 2000). Both neuronal cell bodies 
observed surrounding the pharyngeal muscle cells appears to have anterior and posterior processes 
extending outwardly. From this pattern of immunoreactive neurons it is reasonable to assume that the 
GBR-2 subunits exists on the M3 motor neurons that innervate pm4 and pm5 muscle cells. Previous 
studies indicate IPSPs generated by the M3 motor neuron have been of an inhibitory glutamatergic 
transmission (Dent et al., 1997). I can therefore hypothesise that GBR-2 channels operate as pre- 
synaptic autoreceptors on the M3 neuron and are maybe indirectly involved in regulating glutamate 
release. Furthermore, Dent et al., (2000) generated a fusion protein between the avr-14 gene and a 
GFP fusion protein, which was found to be expressed within a group of 40 extrapharyngeal ring
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neurons of the head, clearly confirming GBR-2 existence within the nerve ring of C. elegans. The 
GBR-2 protein displayed additional activity in the ventral nerve cord and mechanosensory neurons. 
As reporter gene fusions do not always faithfully reflect the expression pattern of the intact gene, 
perhaps because of the absence of enhancer elements located downstream or within introns, two 
methods of localisation (GFP-fusion proteins and immunocytochemistry) should be conducted to give 
greater confidence in the work. Here I provide additional immunocytochemistry data, which supports 
the conclusion that this subunit is expressed on extrapharyngeal cells and on pharyngeal neurons.
The anti-GBR-2 antibodies were also used to study the pattern of localisation in both male and female 
species of Haemonchus contortus and Ascaris suum (Jagannathan et al., 1999). Specific 
immunofluorescence in motor neuron commissures, nerve cords and the extrapharyngeal region was 
demonstrated. Once again, non-specific binding was observed in samples incubated only with 
secondary antibody and anti-GBR-2 pre-absorbed with a large excess of synthetic peptide. Differences 
in GBR-2 distribution between Haemonchus and C. elegans were observed. In C. elegans the 
extrapharyngeal staining appears to be confined to four subsets of cells and two specific cell bodies 
within the corpus and terminal bulb, whereas in Haemonchus immunofluorescence appears to be 
diffuse across the whole nerve ring region. In addition GBR-2 expression was observed from adult 
Ascaris and Haemonchus dorsal cord and motor neuron commissures, which was absent in C. elegans 
immunofluorescence preparations. This may reflect differences in the expression of GBR-2 
orthologues between the two species. Comparing GBR-2 experiments with that of GluCip and ai 
receptor subunits, it is plausible these subunits are also involved in pharyngeal pumping, but are 
unlikely to co-assemble with GluClot2 and GluClp to form a native receptor.
In summary, GBR-2 receptor subunits formed specific expression patterns over three nematode 
species. This is the first demonstration of inhibitory glutamatergic synapses found in the 
extrapharyngeal nerve ring in any nematode species. In C. elegans and Haemonchus species 
fluorescence in the extrapharyngeal nerve cord region is observed which has also been verified in C. 
elegans G¥Y\avr-14 fusion experiments (Dent et al., 2000). In addition, GBR-2 may have specific 
roles in dorsal and ventral nerve cords of Ascaris suum and Haemonchus species and pharyngeal 
pumping in C. elegans. However GBR-2 physiological roles (if any) in pharyngeal action and in 
location still remain to be determined. To distinguish clearly between the expression of GBR-2 A and 
GBR-2B polypeptides in C. elegans and Haemonchus additional subunit-specific antisera should be 
raised to unique intracellular regions indicating which subunits exist in the extrapharyngeal region and 
if co-expression of GBR-2A and GBR-2B is observed.
Chapter 4
Cloning of a novel glutamate-gated cDNA 
receptor subunit (ZC317.3) from 
Caenorhabditis elegans
4.1. Introduction
When I commenced this Ph.D. the only cloned and fully-functionally expressed GluCl subunits 
known to exist in C. elegans were GluCla and GluClp (Cully, Vassilatis et al. 1994). Although other 
predicted GluCls had been cloned (Chapter 1) and sequence analysis indicated high homology to 
GluCip and GluCla, the absence of expression studies prevented confirmation of this function. The 
GluCla and GluCip subunits were isolated by Cully et al. (1994) using an expression cloning 
strategy. The g/c-1 and glc-2 genes encode these two subunits respectively and, when expressed in 
Xenopus oocytes, the a  subunit formed functional ivermectin-sensitive homomeric channels. The 
GluCip subunit formed non-desensitising channels gated by L-glutamate but was ivermectin- 
insensitive. When co-expressed in oocytes, the two subunits formed channels gated by L-glutamate 
and potentiated by very low (5nM) concentrations of ivermectin. Shortly after, Dent et al. (1997) 
reported the cloning of a subunit encoded by the avermectin resistant gene, avr-15. When expressed in 
Xenopus oocytes, GluCla2 subunits were gated both reversibly by L-glutamate and irreversibly by 
ivermectin. Recent data by Dent et al. (2000) have shown that avr-14 gene encodes an alternatively 
spliced GluCl (previously called GBR-2A/B) which has now been designated GluCla3A and a 3B. 
When expressed in oocytes, GluCla3B formed ivermectin and glutamate sensitive channels, however a 
response was not observed with GluCa3A subunits. Consequently, these studies provided strong 
evidence that GluCls are targeted by the avermectin/milbemycin family of endectocides and 
insecticides (Arena et al., 1995; Arena et al., 1992a; Cully et al., 1994; Cully et al., 1996b). 
Subsequently, studies on the physiology and pharmacology of cloned and expressed GluCls may 
provide an insight into other properties and functions of inhibitory ionotropic receptors and 
opportunities for the development of novel anti-parasitic drugs.
The completion of the C. elegans genome sequence (Caenorhabditis elegans sequencing consortium,
1998) has permitted for the first time prediction of the total number of ionotropic receptor subunits 
present within an organism. The sequence predicted 19,000 genes of which 37 seem to encode ligand- 
gated anion channels most of which are of unknown function. Blast searches of sequence database 
revealed a predicted polypeptide, ZC317.3, with high amino acid identity to the previously cloned 
GluCl subunits. The generation of a full-length ZC317.3 cDNA clone by using PCR-based strategies 
was attempted. This strategy was preferred, as library screening can often be time consuming and can 
depend upon higher expression levels of the gene of interest. Initial amplification attempts were made 
using an alternative PCR technique, RACE (rapid amplification of cDNA ends), (Frohman et al., 
1988), where unknown initiation and termination codons can be obtained after an internal known 
stretch of sequence has been obtained. In numerous free-living and parasitic nematodes a common 5’
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stretch of nucleotide sequence known as the spliced leader (SL) sequence has been demonstrated to 
exist (Nilsen 1993). Many mRNAs from nematodes contain the same 22nt leader sequence at the 5’ 
ends which have been precisely acquired from a separately transcribed (lOOnt) RNA known as the SL 
RNA via /ra/75-splicing (Bektesh, Doren et al. 1988; Nilsen 1993). In all cases examined the SL 
sequence has been perfectly conserved and is invariably located 0-3 8nt upstream of the ATG start 
codon, allowing a specific 5’ exon region to be used for the initial design of a sense strand primer. 
Once the computer-predicted ends of the reading frame has been established, gene specific 
oligonucleotide primers can be designed to yield the desired product.
4.2 Results and Discussion
4.2.1 Amplification of 3 9 and 59 ends of ZC317.3 cDNA using RACE PCR
Using the EMBL database, all known nematode and Drosophila GluCl sequences were extracted and 
aligned (using the GCG program “pile-up”) allowing us to search for high amino acid conservation to 
aid the design of oligonucleotides. A minimum of seven consecutive amino acids was chosen to allow 
for specific amplification. This was used in combination with the predicted ZC317.3 sequence from 
the C. elegans genome-sequencing database. From the sequence alignments an octopeptide motif 
TTLLTMTT in M2 appeared highly conserved amongst most available GluCls, GABAa and glycine 
receptor sequences. Both an antisense (termed ZC:AS2) and a sense (termed ZC:S2) primer were 
designed and synthesised to ZC317.3 M2 region (Fig. 4.1). Our initial attempt to detect mRNA 
transcribed from ZC317.3 gene were made using RACE PCR based strategies (Frohman, et. al., 
1988). Primer designed to the 5’ end spliced leader sequence (SL1) was then used in conjunction with 
the ZC:AS2 M2 octopeptide and a predicted 3’ antisense primer (ZC:ASi) was used with the sense 
octopeptide M2 primer (ZC:S2).
A modified method from the standard PCR technique, “Touchdown” was used to enhance specificity 
during amplification. This involves a stepwise decrease in annealing temperature, starting at or above 
the expected annealing temperature. The amplification of both 5’ and 3’ terminal regions of ZC317.3 
was achieved by performing PCR on single stranded cDNA at an initial annealing temperature of 
65°C for 1.5 minutes, which was then step-wise decreased to 63 and finally 54°C. The ZC317.3 5’ 
RACE reaction produced a single band of 800bp at the 5’ end, which was re-amplified, subcloned and 
sequenced. The 3’ RACE PCR reaction produced several bands, one of which was 550bp. Both 
products matched convincingly with the predicted ZC317.3 sequence obtained from the C. elegans 
genome database. Many structural features, for example M2, M3 and M4 motifs were clearly visible, 
suggesting the computer-predicted ends of the open-reading frame were accurate and allowed us to 















Internal ZC:S2 CT ACTCACAATGACCACACAGG
Internal ZC:AS2 CCTGTGTGGTCATTGTGAGTAG
Table 4.1 Oligonucleotide primer sequences and locations used for the amplification o f full-length 
ZC317.3 receptor cDNA (arrows not to scale), (a) Schematic representation o f ZC317.3 subunit, 
indicating four hydrophobic segments, which are assumed to span the membrane in blue and 
approximate primer locations, represented with an arrow (not to scale), (b) Gene specific primers for 
ZC317.3 are labelled ZC accordingly and given suffix/S to denote a sense primer and /AS to denote 
an antisense primer.
Although theoretically a complete sequence had been obtained for ZC317.3, the sequence data was 
derived from two separate PCR products. To enable the clone to be used for expression studies and to 
ensure the sequence originated from a single receptor subunit it was necessary to amplify a full-length 
ZC317.3 cDNA from a single PCR reaction. The full-length sequence was obtained with a second 
PCR amplification using both the gene specific primers designed to the 5’ and 3’ regions and first 
strand cDNA as the template. After an initial melting at 94°C for 2 minutes, Expand™ High Fidelity 
was added and 40 cycles o f amplification performed at 94°C for 2 minutes, 55°C for 1.5 minutes and 
72°C for 2 minutes, with a final extension time o f 5 minutes. The PCR reaction produced a single 
cDNA band o f approximately 1400bp (Fig. 4.2), which was re-amplified, purified and ligated into 
pGEM*-T-EASY vector using TA overhangs which are produced by the Expand enzyme during the 
PCR reaction. The sequence has been submitted to the EMBL database (Accession number 









Figure 4.1 Agarose gel electrophoresis o f a PCR amplification product predicted to encode the full 
length protein coding sequence of ZC317.3.
4 . 2 . 2  S e q u e n c e  A n a l y s i s
The ZC317.3 cDNA shares many sequence characteristics with other invertebrate L-glutamate-gated 
chloride channel subunits (Section 1.2.3), which are presumed to be hetero-oligomeric complexes of 
five subunits, each of which span the membrane four times. The predicted mature gene product after 
signal peptide cleavage is a 484 amino acids polypeptide. The 5’end o f the open reading frame 
includes a large N-terminal extracellular domain o f 222 amino acids that contains a disulphide bridge 
consisting o f a pair o f cysteines separated by 13 amino acids (Stephenson 1988), leading the 
description of this receptor class to be called “ cys-loop receptors” (Karlin and Akabas 1995). A 
characteristic 2nd pair o f cysteine residues at positions 199 and 210 in addition to the dicysteine loop 
(positions 138 and 152) distinguishes the L-glutamate and the vertebrate glycine-gated chloride 
channels from the GABAa, GABAc and nACh receptors (Fig. 4.3).
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Drosal .KKRRDLEQA SLDAASDLLD TDSNA...TF AMKPLVRHPG DPLALEKRLQ CEVHMQAPKR PNCCKTWLSK FPTRQCSR.. .SKRIDVISR
Gly al ...HKELLRF RRKRKNKTEA FALEKFYRFS DTDDEVRESR LSFTAYGMGP CLQAKDGVVP KGPNHAVQVM PKSADEMRKV FI...... D RAKKIDTISR
GABAa1 ....... VV PEKPKKVKDP LIK..... K NNTYAPTATS YTPNLARGDP GLATIAKSAT IEPKEVKPET KPPEPKKTFN SV....... ..SKIDRLSR
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ZC317.3 VLFPTLFVCF NFVYWTKYSQ YHAPEAK
GluClal ALFPVLFFVF NILYWSRFGQ QNVLF
GluCla2 VMFPVLFLTF NISYWTHYGQ YGVAIST
GluCip FVVPLAFLAF NVIYWVSCLI MSANASTPES LV
Drosal ITFPLVFALF NLVYWSTYLF REEED
Gly al ACFPLAFLIF NIFYWVIYKI LRHEDIHHQQ D
GABAal IAFPLLFGIF NLVYWATYLN REPQLKAPTP HQ
Figure 4.3 Alignment of C. elegans receptor subunit ZC317.3 with invertebrate ligand-gated chloride channels.
Representative members of the ligand-gated chloride channel subunit family from invertebrate rat (GABAa, and glycine a p , C. elegans (GluCls a i, a 2, p) 
and Drosophila (a ) receptor subunits aligned with the full-length receptor subunit, ZC317.3. The putative transmembrane regions (M l-4) are underlined and 
for the ZC317.3 sequence only, the N-linked glycosylation site is indicated by The four cysteine residues in the N-terminal domain is signified by
and the 2 x S residues (consensus site for PKC phosphorylation) highlighted in blue ( J
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Homologous regions within the cys-loop (218CPMxLxxYPxDxQxC‘232, Fig. 4.3) appear to be, 
conserved across invertebrate species to mammals. The cys-loop appears to be essential for events 
during subunit assembly, including subunit folding, obgomerisation and producing correct oligomeric 
stoichiometry (Green and Millar, 1995). Part of the assembly also appears critical for the formation of 
binding sites for agonist, allosteric modulators and antagonists, (for reviews see Galzi and Changeux, 
1995; Karlin and Akabas, 1995; Smith and Olsen, 1995).
Studies with homo-oligomers composed of chimaeric subunits have provided further evidence for the 
location of the agonist-binding site in the N-terminal domain. In a recent study (Etter, Cully et al. 
1996) a homo-oligomer composed of chimaeric subunits provided evidence not only for the location 
of the agonist binding site in the N-terminal domain, but in addition that the ligand binding region is 
coupled to channel gating within the C-terminal domain. A chimaera composed of the N-terminal 
domain of C. elegans GluCla (a glutamate-insensitive channel) with the C-terminal of GluCip subunit 
(glutamate-sensitive subunit), yielded a receptor with greater glutamate sensitivity (EC50 530±90nM) 
than seen with wild-type GluCip homomers (EC50 380pM). This data indicates wild-type GluCla 
contains the necessary binding site within the N-terminal extracellular domain, but the C-terminal part 
of GluCl does not couple ligand binding to channel gating.
The motif WxDxxL (corresponding to residues l37WVDGRL142 in ZC317.3 protein, Fig. 4.3) has been 
found to be conserved in all cys-loop receptor subunits and may contribute to channel gating (Smith 
and Olsen, 1995). It has been reported that most ligand-gated channels need the interface between two 
adjacent subunits to be co-expressed before the agonist will bind, as yet it has not been ascertained 
whether this also holds true in C. elegans GluCls. If we assume that similar protein folding occurs in 
all the cys-loop family, it is possible that the co-assembly of two structurally distinct homologous 
regions at the subunit interfaces may form the agonist binding sites of L-glutamate and ibotenate. As 
most GluCls are capable of forming homo-oligomers and therefore have all the necessary amino acid 
residues within the binding site, for glutamate or ibotenate binding site to exist it may require the 
interface of two distinct a  subunit classes or one subunit from an a  class and one from p.
The cytoplasmic domain between M3 and M4 is the most divergent region of ligand-gated chloride 
channels. Most ligand-gated chloride channels are subjected to protein phosphorylation modification 
and the conservation of these residues may have great importance for regulating receptor function 
(Raymond, Blackstone et al. 1993; Tanaka and Nishizuka 1994), although this role is still poorly 
understood (Vijayaraghavan, Schmid et al. 1990).
Figure 4.4 Hydrophilicity analysis of GluCla4.
The predicted Kyte and Doolittle hydropathy plot of C. elegans receptor cDNA; ZC317.3 was constructed using the GCG program 
PEPTIDESTRUCTURE. The hydropathy plot predicts a proposed extracellular N-terminal, followed by four membrane-spanning 
domains (denoted by a solid red line, M l-4). The predominantly hydrophilic intracellular loop separates the M3 and 4 domains.
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Nicotinic acetylcholine, GABAa (Raymond, Blackstone et al., 1993; Krishek, Xie et al., 1994; Moss, 
Gorrie et al., 1995) and glycine (Song and Huang 1990; Swope, Moss et al., 1992) receptor function 
can all be regulated by phosphorylation of defined serine, tyrosine and threonine cytoplasmic residues. 
Biochemical approaches have demonstrated that phosphorylation of serine and threonine residues by 
PKC and PKA on GABAa receptors decreases chloride conductance (Sigel 1995; Moss and Smart 
1996) inhibiting receptor function. However, others have indicated that PKC (Lin, Browning et al., 
1994) and PKA (Cheun and Yeh, 1992) potentiate a GABA-gated response. Alternatively, tyrosine 
phosphorylation has been considered to be involved in numerous processes, including growth, 
differentiation (Wan, Man et al., 1997), and ischemia (Kindy 1993). In all of these cellular processes 
tyrosine phosphorylation is know to inhibit GABAa receptor function and potentiation. Studies 
indicate that protein kinase catalyse the transfer of a charged phosphate molecule from ATP to a key 
serine, tyrosine or threonine within the M2 and M3 intracellular loop (Swope, Moss et al., 1992; Moss 
and Smart, 1996). However, neither the N-linked glycosylation site nor the protein kinase C sites is 
conserved between ZC317.3 and other C. elegans a  subunits, though a glycosylation site is present at 
a homologous position on the GluClct3 subunits. The significance of the putative phosphorylation sites 
in GluCl is poorly understood. A candidate site for N-linked glycosylation is located in the 
extracellular domain at residue 26 of the mature polypeptide.
The hydropathy profile (Kyte and Doolittle, 1982) of the predicted gene was constructed using the 
GCG protein analysis software (Fig. 4.4) and displays four extended hydrophobic domains 
corresponding to putative a  helices spanning the membrane domains. Both the position and amino 
acid sequence of the four membrane domains are conserved with respect to other known members of 
the ligand-gated chloride family. The plot also indicates a potential intracellular loop of 127 amino 
acids, which separates the M3 and M4 domains. When a comparison of the ZC317.3 cDNA sequence 
was made with the genomic sequence predicted by Genefinder, this revealed that one of the 
intron/exon boundaries was not as predicted, resulting in a longer (43 amino acids) intracellular loop 
between the M3 and M4 domains.
Database searches of the ZC317.3 sequence exhibited a >40% amino-acid identity to other 
invertebrate GluCl subunits (Table 4.1). An alignment illustrating the relationship between the 
GluCla-like subunits is shown in Fig. 4.3. Compared to GluCla and <x2, ZC317.3 is truncated by 
about 30 amino acids at the N-terminus, producing an extracellular domain similar in size to GBR-2, 
and has a slightly longer intracellular loop than any of the other GluCl subunits. All four-membrane 
domains are highly conserved with respect to other GluCla subunits (Fig. 4.3). The M2 domain is 
especially homologous with the exceptions of threonine 335 in ZC317.3 which is substituted for 
serine in GBR2B, alanine 348 in ZC317.3 is replaced with serine in GluClai and qli and finally, serine 
349 in ZC317.3, a2 and GBR2b is an alanine in GluClai.
GluCla GluClp GluCl a2s GluCl a21 GBR2A GBR2B C27HS.8 DROSa GABAaj GLYat
ZC317.3 73% 63% 77% 71% 60% 58% 40% 48% 32% 40%
GluCla 45% 77% 77% 57% 54% 38% 46% 33% 40%
GluCip 47% 47% 48% 47% 39% 44% 33% 40%
GluCl 0 2 S 96% 57% 54% 38% 48% 33% 39%
GluCla2L 57% 55% 38% 47% 33% 38%
GBR2A 79% 41% 52% 31% 37%
GBR2B 40% 50% 31% 37%
C27H5.8 37% 32% 38%
DrosGluCla 37% 43%
GABAaj 35%
Table 4.5 Compilation of the percentage amino acid identities of vertebrate and invertebrate GABAa, glycine and L-glutamate receptor subunits. Receptors 
are given the suffix GluCl to denote glutamate-gated receptor subunit and Dros indicates a Drosophila melanogaster subunit. A more distantly related 
ionotropic receptor subunit cDNA, C27H5.8 was cloned using information form the genome sequencing project.
C. elegans Drosophila melanogaster
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4.3. Summary
We report here the amplification of a full-length, novel subunit from C. elegans. Overall, sequence 
resembles in size, sequence and predicted secondary structure subunits of other cloned invertebrate 
GluCls. However, the ZC317.3 only shows approximately 30% homology with GABA and 40% 
homology with Glycine cDNAs indicating they are not species homologues of the same polypeptide. 
To date, no homologue of this subunit has yet been identified in other nematode species. The C. 
elegans ZC317.3 gene is therefore designated glc-3 and the subunit it encodes GLC-3 (see 
nomenclature page IV). GLC-3 appears to be most closely related to the previously characterised 
GluCla and -a2 subunits where the homology is highest within the transmembrane regions M l-M3.
Future studies will include direct in vitro expression of the gene in Xenopus oocytes, this will not only 
provide further evidence that GLC-3 is part of the GluCl family, but also offers an opportunity in 
identifying the in vivo subunit combinations. With their known sequence and subunit components, 
recombinant receptor studies offer an important tool in identifying the mode of action of insecticides 
and the structural elements involved in toxicity and selectivity.
Chapter 5
Agonist and antagonist pharmacology o f the 
GLC-3 homo-oligomers
5.1 Introduction
The first report identifying the existence of the IGluCls was by Lea and Usherwood (1973), on 
Schistocerca gregaria (locust) leg muscle. Since then, subsequent reports have emerged identifying 
their existence in crustaceans, molluscs and nematodes. Inhibitory ionotropic glutamate receptors 
appear to be confined to invertebrate species and have been demonstrated to be the targets of a wide 
range of avermectin and related anthelmintic.
Electrophysiological studies on Xenopus oocytes injected with mRNA from the C. elegans GluCla 
(ct2s, ot2L an(* a 3B) subunits have produced undisputed evidence that ivermectin directly induces 
chloride currents and was able to potentiate (GluCla and GluCip heteromers) glutamate-induced 
chloride currents at nanomolar concentrations. In addition, all of the functional a  subunits (with the 
exception of GluClai) have also been observed to produce reversible L-glutamate- and ibotenate- 
gated chloride currents at micromolar concentrations (Cully et al., 1994; Dent et al., 1997; Dent et al., 
2000). The GluCip homomer forms reversible, non-desensitising, L-glutamate-sensitive channels that 
are non-responsive to ivermectin (Cully et al., 1994). On co-expression of GluClai and p receptor 
subunits, an ivermectin potentiated chloride channel is formed.
Although the primary structure of the Drosophila GluCla is ~50% identical to the C. elegans GluCls, 
some differences have been identified in their antagonist pharmacology. In contrast to the functional 
C. elegans GluCip, a 2 and a 3 channels, Drosophila GluCla exhibited rapid, robust inward currents in 
response to L-glutamate and ibotenate which were not inhibited by picrotoxin or potentiated by 
avermectin (Cully et al., 1996a). Interestingly, oocytes expressing either DrosGluCla subunits, C. 
elegans total RNA or C. elegans native pharyngeal GluCls produced channels that were significantly 
more sensitive to ibotenate than L-glutamate. This appears contradictory with oocytes expressing C. 
elegans recombinant GluCls (a2, P, and a 3), which produced full agonist responses to L-glutamate, 
but only weak, small chloride currents to ibotenate. However, until more is known of the composition 
of native GluCls of C. elegans, relating pharmacological differences to underlying receptor properties 
will remain difficult. Although the completion of the C. elegans genome sequence (Caenorhabditis 
elegans sequencing Consortium, 1998) has permitted for the first time a prediction on the total 
number of IGluCls present, the functional subunit combination is not known for any nematode muscle 
or neuronal GluCl. Future pharmacological investigation of cloned heteromer-forming GluCls offers a 
better understanding of the anthelmintic drug-receptor interactions in C. elegans and orthologous 
parasitic species.
The polycyclic dinitriles (for example BIDN), phenylpyrazoles (fipronil) and picrotoxin are 
convulsant antagonists that inhibit GABA-mediated chloride currents. The binding site where these 
convulsant drugs interact is still unknown, although some authors (Gant et al., 1998; Hosie et al., 
1995a) have speculated that these compounds act deep within the channel pore that is lined by the M2 
domain. Both fipronil and BIDN have shown effective commercial, insecticidal and pesticidal action, 
which have been discussed further in Chapter 1. In view of the structural similarities between GABA 
and IGluCl receptors, BIDN and fipronil were specifically chosen, as their effects on GluCls have not 
been previously characterised. Furthermore, the pharmacological success of fipronil (as with the 
avermectin class of compounds) has mostly been attributed to their ability to exhibit a range of 
activity against insect pest and mites without affecting the host organism, allowing it to be used 
extensively in public and animal health. The plant derived compound picrotoxin is composed of 
equimolar amounts of picrotin and picrotoxinin (Etter et al., 1999), the former has little or no effect 
(Newland and Cull-Candy, 1992). The site and mode of action of picrotoxinin is the subject of some 
debate and is discussed in detail in the discussion of this chapter.
To date little else is known of the pharmacology of GluCl receptors expressed in vitro, which would 
be necessary to understand the molecular basis of anthelmintic action for which no vertebrate 
counterpart has been described. This chapter reports a detailed description of the agonist and 
antagonist profile of C. elegans GLC-3 receptor subunit providing the first demonstration that GluCl 
RECEPTORSare a molecular target for convulsant antagonists BIDN and fipronil. In addition, the 
actions of L-glutamate, ibotenate and ivermectin are also described, as well as the lack of effects from 
picrotoxinin and several amino acid ligands. The chemical structures of ivermectin, fipronil, BIDN 
and picrotoxinin are shown in Fig 5.1.
The Xenopus oocyte expression system in conjunction with the two electrode voltage clamp recording 
is a convenient means of expressing and recording current across the membrane from exogenous 
LGICs. This system was therefore used for the potential characterization of the GLC-3 receptor 
subunits. Oocytes from the South Africa clawed frog offer a convenient lipid membrane used as a 
heterologous receptor expression system for several reasons. Late staged (V & VI) oocytes are large 
cells (l-2mm in diameter) simplifying both microinjection of cDNA into the nucleus and also the 
insertion of microelectrodes for voltage clamping. Although they possess certain voltage-dependent 
ion channels and G-protein coupled receptors (Snutch, 1988), these offer little interference to 
electrophysiological studies on GluCl ionotropic receptors. Oocytes injected with foreign mRNA into 
the cytoplasm or cDNA into the nucleus, assemble fully functional hetero-oligomers with post- 
translational modifications such as phosphorylation and glycosylation (Snutch, 1988). However, there 
are some disadvantages to the oocyte expression system. These include the short expression period 
compared with stably transfected cell lines (at most, two weeks of expression before oocyte
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deterioration) and the small number of oocytes that can be assessed for function during one 
experiment. Furthermore, oocyte expression systems are often seasonally dependent (oocytes tend to 
be more reliable between the months March and October, Snutch, 1988) and can produce erratic, non­
functional responses.
5.1.1 Aims
The final aims of this study are as follows:
(i) Using electrophysiological techniques, investigate the agonist profile of endogenous 
neurotransmitters (L-glutamate, GABA and glycine) on the GLC-3 homo-oligomer.
(ii) Examine the potential of the anthelmintic ivermectin as an agonist at the receptor.
(iii) Using the current-voltage relationship, determine the ion selectivity of GLC-3 receptors.
(iv) Due to GluCls sequence similarity to GABAa receptor subunits, examine the potential effects 
of known GABAa antagonists and insecticide compounds.
5.2 Results
5.2.1 Actions of L-glutamate and Ibotenate at the GLC-3 homo-oligomer
Xenopus oocytes injected with in vftro-transcribed cRNA encoding the GLC-3 polypeptide responded 
to L-glutamate, yielding robust, dose-dependent inward currents at a holding potential of Eh—80mV 
(Fig. 5.2). Dose-dependent currents elicited by L-glutamate (Fig. 5.2b) generated an EC50 value of 1.9 
± 0.03mM and an estimated peak plateau at concentrations of 8 mM and above. The Hill coefficient of 
1.46 ±0.1 suggested more than one L-glutamate molecule was necessary to gate the channel. Control 
oocytes injected with the same volume of deionised water and non-injected oocytes failed to respond 
to L-glutamate when it was applied at concentrations from 3(jM to lOmM (n=6 , Fig. 5.2b). 
Applications of 3mM L-glutamate were used thereafter as the standardising agonist, allowing 
reproducible responses to subsequent drug applications. The conformationally constrained L- 
glutamate analogue, ibotenic acid, activated the GLC-3 receptor at ImM, but produced non­
desensitising currents of a smaller amplitude and slower onset than L-glutamate (Fig. 5.3b). The 
amplitude and shape of the ibotenate response were similar to those obtained from C. elegans GluClp 
and ci2 homomers (Cully et al., 1994; Dent et al., 1997).
5.2.2 Negative effects o f GABA, glycine, histamine and NMDA
GLC-3 homo-oligomers were insensitive to NMDA, glycine, histamine and GABA at ImM, however, 
a robust inward current was elicited by ImM L-glutamate (Fig. 5.3a). The application of 3mM L- 
glutamate was used prior to the application of the above ligands, to standardise the agonist responses 
to changes seen in both oocytes and mRNA expression. The negative responses seen here appear to be 
consistent with data obtained from other GluCls (Cully et al., 1994; Dent et al., 1997).
5.2.3 Current-voltage relationship determinedfor GLC-3 homomers
The current-voltage relationship was determined using L-glutamate (3mM) to ascertain if the GLC-3 
homo-oligomer was selective for chloride ions. The inwardly evoked L-glutamate-gated responses 
decreased in size as the membrane potential was increased step-wise from -80mV to -20mV. As the 
membrane potential was increased to become more positive (increasing from 0 to +40mV) the L- 
glutamate-gated responses increased in size and changed to an outward direction. L-glutamate induced 
currents were found to reverse near the predicted chloride reversal potential for oocytes (= -20mV, 
Fig. 5.4) (Dascal, 1987). In order to ascertain that the GLC-3 homo-oligomer was selective to chloride 
ions, the external chloride concentration was lowered (from 107.6mM to 54.9mM) and replaced with 
mono-sodium gluconate, allowing equilibrium of Cl' ions.
OH
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Figure 5.1 Chemical structures o f the agonist and antagonist compounds used in this study and/or 
referred to in the text. Ivermectin is composed primarily o f 22,23-dihydroavermectin B la , where 
R=CH3, but also contains some 22,23-dihydroavernectin B ib , where R=C2H5. Chemical structures 
were prepared using Chem 4-D Draw, (ChemJnnovation Software, U.S.A).
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Figure 5.2 Dose-dependent L-glutamate-gated currents in oocytes injected with GLC-3 cDNA.
(a) L-glutamate induced dose-dependent inward currents from Xenopus oocytes injected with 
GLC-3 cRNA and voltage clamped at -80mV. Desensitisation was observed with higher 
concentrations o f L-glutamate, approximately 1 OpM and above. Horizontal bars indicate the 
duration o f agonist application and downward deflection denotes an inward current.
(b) L-glutamate concentration-response curves of oocytes injected with in vitro cRNA encoding 
the GLC-3 subunit J i n>6), and water-injected control oocytes (^n> 6  ), clamped at -80m V .
(a)







Figure 5.3 Comparison o f inward currents induced by 1 mM L-glutamate, ibotenate and the negative 
effects o f NMDA, GABA, glycine, and histamine on the GLC-3 homo-oligomer.
Horizontal bars indicate the duration o f agonist application and downward deflection denotes an 
inward current.
(a) Currents were not observed for the following ImM applications o f GABA, glycine, histamine and 
NMDA, although inward responses were induced by ImM L-glutamate.
(b) Chloride currents induced by ImM ibotenic acid and ImM L-glutamate.
The reversal potential was estimated to be (Ea)—16.6mV for oocytes in the presence of NaCl 
(normal SOS, Table 2.1.9.2) and (ECi)—7.3mV for oocytes in the reduced extra-cellular CT saline, 
shifting the reversal potential (Erev=9.3mV) for the L-glutamate-sensitive currents. The glutamate- 
induced current was determined by subtracting the current required to clamp the oocyte membrane at 
a given potential in saline, from that required to clamp the membrane at the same potential in the 
presence of 3mM L-glutamate.
5.2.4 Agonist actions of ivermectin on GLC-3 homo-oligomers
Oocytes expressing the GLC-3 protein exhibited slowly activating, irreversible, inward current in 
response to ivermectin, that were dose-dependent and not observed in control uninjected oocytes or in 
oocytes injected with distilled water. Large non-desensitising ivermectin-sensitive currents were 
observed following the application of 0.1 pM and ljuM ivermectin, whereas O.OIjliM ivermectin failed 
to gate the channel (Fig. 5.5a, n=3). The time course for maximal activation of ivermectin-sensitive 
currents was 28±18.5 seconds for GLC-3, 10 seconds slower than observed for GluCloti receptors 
(Cully et. al., 1994). A two-phase agonist response was observed following the co-application of 
ivermectin (lpM) and glutamate (3mM). An initial rapid, desensitising response to L-glutamate was 
followed by a slower, non-desensitising, irreversible response characteristic of ivermectin (Fig. 5.5b). 
There was no apparent increase in the amplitude of either the L-glutamate or ivermectin peaks when 
co-applied than observed when applied alone.
5.2.5 Actions of convulsant antagonists on GLC-3 receptors
Picrotoxinin is a potent antagonist of many native and recombinant vertebrate and invertebrate 
GABAa receptors (Becker, 1992; Cull-Candy, 1976; Olsen and Tobin, 1990; Pribilla et al., 1992), and 
of some native and recombinant GluCls (Arena et al., 1992a; Cleland, 1996; Cully et al., 1994; Etter 
et al., 1999; Vassilatis et al., 1997a). However, at concentrations of 0.01 to lOOOpM, it failed to 
inhibit the robust L-glutamate (3mM) agonist response in oocytes expressing the GLC-3 receptor (Fig. 
5.6, n=6 ).
The bicyclic dinitrile convulsant, BIDN and the phenylpyrazole insecticide, fipronil (lOpM), had no 
direct effect on either un-injected oocytes, or oocytes injected with GLC-3 cRNA all of which were 
clamped at Eh—80mV. However, when L-glutamate was co-applied with either fipronil or BIDN the 
L-glutamate response was significantly reduced. Incubation of the oocytes for 2 minutes in saline 
containing one of the L-glutamate antagonists, fipronil or BIDN, at concentrations from 0.1 pM to 
lOOpM, suppressed the amplitude of the L-glutamate response in a dose-dependent manner (n>5, Fig. 
5.6). The amplitude of the L-glutamate responses was restored after 10 min rebathing in normal 
saline, though at antagonist concentrations at and above lOpM recovery was slower and often
incomplete. The estimated IC5o’s for the co-application of L-glutamate with BIDN and fipronil were
0.22 ± 0.07pM and 11.53 ± 0.1 lpM, respectively (Fig. 5.7).
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Figure 5.4 Current-voltage relationship o f L-glutamate-sensitive GLC-3 channels.
The L-glutamate-induced currents mediated by GLC-3 homo-oligomers reversed at -16.6m V in 
normal oocyte saline ( ■ )  and 7.3mV in reduced CL saline ^  ) indicating the receptor was selective to 












1 0 0 -
2 0 0 -







L-Glu 3x10 3M L-Glu 3x10 3M & IVM 10^M
(b)
lOOnA
Figure 5.5 Effects of ivermectin on GLC-3 homo-oligomers.
(a) Ivermectin-induced, dose-dependent inward currents from one Xenopus oocyte expressing GLC-3 
protein. Horizontal bars above the traces indicate a 30-second application of ivermectin and 
downward deflection denotes an inward current.
(b) Inwardly activating, biphasic current in response to the co-application o f L-glutamate (3 x l0 '3M) 
and ivermectin (lO"6!*^ )
(a)
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Figure 5.6 Effects of GABA-channel antagonists picrotoxinin, fipronil and BIDN on L-glutamate- 
elicited (3mM) responses recorded from GLC-3 homo-oligomers. Horizontal bar indicates 
duration of agonist and antagonist ligands.
(a) Picrotoxinin (lOpM) failed to block 3mM L-glutamate-induced currents.
(b) Fipronil (10pM) reproducibly reduced the amplitude o f the 3mM L-glutamate response, 
producing a total block at approximately lOOpM.
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Figure 5.7 Dose-inhibition curves for the GABA-channel antagonists, picrotoxinin ( ^ ), fipronil ( | ) 
and BIDN ( f  ) expressed in Xenopus oocytes injected with GLC-3 cRNA.
5.3 Discussion
5.3.1 Agonist effects o f L-glutamate and ibotenic acid
Inhibitory glutamate-gated chloride channels have been identified in crustaceans, molluscs, insects 
and nematodes, where only a small degree of pharmacological variation has occurred across the 
invertebrate phyla. The amino acid agonist L-glutamate and its structurally related analogue ibotenate, 
gate both native, locust leg muscle, (Cull-Candy, 1976; Duce and Scott, 1985); as well as C. elegans 
pharyngeal preparations, (Holden-Dye, 1998) and recombinant expressed GluCl receptor subunits (C. 
elegans GluClp, GluCl a  & GluClp, (Cully et al., 1994); DrosGluCla, (Cully et al., 1996a)).
The high level of sequence identity between GLC-3 and other C. elegans and Drosophila 
melanogaster GluCl subunits suggested that the novel polypeptide might have a similar function. 
When expressed in Xenopus oocytes the agonist pharmacology of C. elegans GLC-3 homo-oligomers 
mimics a number of aspects of that of the native and in-vitro insect and nematode receptors. The EC50 
for L-glutamate of 1.9 ± 0.03 mM at the GLC-3 receptor was very similar to the reported values of 
1.36 ± 0.05 mM for the GluCl a  + p receptor (Cully et al., 1994) and 2.0 ± 0.3 mM for the GluClcx2 
receptor (Dent et al., 1997). The estimated Hill coefficient for GLC-3 channels was greater than 1, 
indicating that at least 1 molecule of L-glutamate was necessary to gate the channel, in agreement 
with all other expressed C. elegans GluCls (Cully et al., 1994; Dent et al., 1997; Vassilatis et al., 
1997a). A striking feature of the currents activated by L-glutamate on GLC-3 homomers is the rapid 
desensitisation of current back to base-line levels, seen at high concentration of the agonist. Similarly, 
the Drosophila melanogaster (Cully et al., 1996a) L-Glu-sensitive currents desensitised rapidly and 
completely in the continued presence of L-glutamate, however, these effects on other C. elegans 
GluCls (p, (X2L and 012s) have not been so noticeable.
Ibotenic acid, a glutamate analog closely related to muscimol, activates all known C. elegans in vitro 
and in vivo GluCls (Cleland, 1996), with the exception of recombinant C. elegans GluCla. In most 
nematode native preparations, ibotenic acid (Holden-Dye, 1998; Martin, 1996) is known to maximally 
activate chloride currents with greater desensitisation than L-glutamate. However, the effect of 
ibotenate on homomeric GLC-3 channels was similar to that on C. elegans GluClct2 and GluClp 
homo-oligomers, activating the GLC-3 channels at ImM, but producing weak, non-desensitising 
currents of a smaller amplitude and slower onset than glutamate.
5.3.2 GLC-3 channels are chloride selective
The permeability properties of the expressed channels (GLC-3) were selective for chloride ions, as 
indicated by the shift in reversal potential for L-glutamate when a percentage of the external chloride 
ions were substituted for monosodium gluconate. Reduction of the external NaCl concentration to 
54.9mM and its partial replacement by 45. ImM monosodium gluconate shifted the reversal potential 
(Ercv) for L-glutamate-sensitive currents from -16.6mV to 7.3mV, which is in the appropriate 
direction predicted by the Nemst equation. The current-voltage relationship for the GLC-3 channels 
also appear to be consistent with other C. elegans heteromeric (a & (3) and the homomeric channels, 
which exhibited outward rectification whether activated by L-glutamate or ivermectin (Cully et al., 
1994; Dent et al., 1997).
5.3.3. GLC-3 homomers are ivermectin-sensitive
The avermectins are capable of acting as potent agonists on invertebrate receptors of many different 
species (Cully et al., 1996a). The ability to irreversibly bind ivermectin, leading to channel opening, 
may be diagnostic for a  subunits of the C. elegans GluCl, as the GluClp subunit is not activated by 
these compounds (Cully et al., 1994). The complex pharmacology avermectins have on chloride ion 
channels across the invertebrate phyla has led some authors to propose that avermectins act at multiple 
sites (Scott and Duce, 1985). When applied at varying concentration, avermectins have 3 general 
effects, potentiation, direct gating and blockade.
Firstly, avermectins directly gate ligand-gated chloride channels. In this study, ivermectin increases 
chloride permeability in GLC-3 homo-oligomers, as with other C. elegans a  subunits (Table 5.1.) as 
GluClp subunits are not activated by these compounds (Cully et al., 1994). What appears to be 
characteristic among all expressed insect and nematode channels (GLC-3, GluClai, GluClct2 and 
DrosGluCla) and perhaps some native insect channels, is that the agonistic effect of ivermectin often 
appears to gate the channel very slowly and yet typically irreversibly. The time for maximal activation 
of ivermectin-sensitive currents was 28+18 seconds for GLC-3 homo-oligomers, compared to 18±1 
seconds for GluCla. The time course for GluCla and GluClp heteromers and poly (A)+ RNA was 
42±2 and 36±3 seconds respectively, which is much slower than that observed for homomeric 
channels (Cully et al., 1994). After the ivermectin-sensitive current was irreversibly activated, the 












Poly (A) RNA — — 104 1.5 36+3
G luCla — — 140+15 1.5+0.2 18+1
GluClp 0.038+20 1.9+0.2 — — —
G lua &  p 1.360+50 1.7+0.1 190+7 2.5+0.2 42+2
G luC la2 2.0+0.3 1.5 — — —
GILC-3 1.9+0.03 1.46+0.1 — — 28+18
DrosGluCIa 0.023 2.0 41 1.2 —
T able 5.1 EC50, Hill coefficients and activation times for ligands acting on C. elegans and Drosophila 
melanogaster subunits expressed in Xenopus oocytes (Cully et. al., 1992; 1994; 1996; Dent et. al., 
1997; 2000).
In support o f the electrophysiological data, binding studies have identified high affinity avermectin 
binding sites from at least two insect species (.Drosophila melanogaster and the locust Schistocerca 
americana) and two nematode species (C. elegans and Haemonchus con tortus) (Table 5.2, Rohrer et 
al., 1995). Interestingly, there appears to be vast differences in the species and tissue specific variation 
o f avermectin binding sites. Locust metathoracic ganglia and Drosophila adult head tissue possess an 
immensely enriched source o f avermectin binding sites (Bmax = 42pmol/mg) in comparison with C. 
elegans (Bmax = 0.46pmol/mg).
Kd (nM ) Bmax (pmol/mg)
Drosophila melanogaster
Adult heads 0.20 3.50
Adult bodies 0.34 0.22
Scistocerca americana
Metathoracic ganglia 0.16 42.00
Heads 0.27 3.50
Leg muscle 0.15 0.18
Caenorhabditis elegans
Mixed stages 0.24 0.40
Haemonchus contortus
L3 larvae 0.13 0.43
Table 5.2 Binding assay data of [ H] ivermectin (represented in: Cully & Paress, 1991; Rohrer et al., 
1992).
Interestingly, fipronil (a GABA-gated chloride channel blocker, (Cole et al., 1993), did not compete 
for the [3H]ivermectin binding sites in either locust S. americana metathoracic ganglia or Drosophila 
melanogaster head preparations (Moffatt, 1993). Similarly, glutamate also did not compete with 
[3H]ivermectin binding to nematode membranes (Cully and Paress, 1991; Schaeffer and Hains, 1989). 
However, Bermudez (1991) reported that both picrotoxin and ivermectin could reverse some of the 
binding effects of [35S] TBPS on locust GABA receptor membranes (Bermudez et al., 1991). This 
indicates that the binding site of avermectins is physically dissimilar to fipronil and glutamate binding 
sites and the blocking action may act near the picrotoxin-binding site within the M2 region of the 
channel.
The second effect of avermectins is the ability to block ligand-gated chloride channels. At higher 
concentrations (micromolar) avermectins have been shown to inhibit GABA-activated chloride 
currents in locust neuronal tissue (Bermudez et al., 1991), locust leg muscle (Duce and Scott, 1985), 
and GABA and IGluCl currents in Acaris suum preparations (Holden-Dye et al., 1988; Martin and 
Pennington, 1989). In this study, ivermectin showed no indication at any concentration to block 
glutamate-induced currents, which appears to be consistent for all the C. elegans IGluCl receptors 
expressed in oocytes.
The third effect of avermectins was observed from electrophysiological studies on Xenopus oocytes 
injected with cRNA. It was observed that oocytes injected with C. elegans recombinant RNA ct2 and 
cti & (3 heteromers, low concentration of avermectins (5nM) was found to potentiate glutamate- 
sensitive currents approximately 4-5 times the control response. In addition, in oocytes injected with 
total RNA, submaximal concentrations of avermectin slowed the rate of desensitisation of the 
glutamate response and shifted the Hill coefficient from 1.7 to 1 (Arena et al., 1992a). In contrast to 
this, the application of low concentration ivermectin (5nM) co-applied with submaximal concentration 
of glutamate, did not appear to substantially increase the glutamate-sensitive current in oocytes 
injected with C. elegans GLC-3 cRNA. Interestingly, the DrosGluCla subunit also failed to observe 
any significant potentiation of the glutamate-response (Cully et al., 1996a) following pretreatment 
with (IVMPO4) ivermectin phosphate (InM). A logical explanation for why avermectins potentiate 
some GluCls and not others is not known. It has been predicted (Cleland, 1996) that avermectin site of 
action is at or near the picrotoxin-binding site, since both picrotoxin and ivermectin inhibit [35S] TBPS 
(Bermudez et al., 1991) binding to locust GABA receptors and picrotoxin can reverse some of the 
effects of ivermectin (Fritz et al., 1979). Interestingly, two subunits DrosGluCla and GLC-3 that were 
not potentiated by ivermectin also appeared to be picrotoxin-resistant, providing additional evidence 
that ivermectin and picrotoxin may act at a similar site of action.
It might be that GLC-3 is only a minor component of the ivermectin receptors found in C. elegans, 
since Vassilatis et al. (1997b) concluded that the majority of [3H]-ivermectin binding sites present in 
membrane preparations could be accounted for by the GluClai and GluCla2 subunits. There is, 
however, a great deal that is unknown about the effects of ivermectin and its related compounds and it 
seems likely that further study of GLC-3 may be instructive.
5.3.4 The GLC-3 homomers arepicrotoxinin-insensitive
Picrotoxin is a potent convulsant agonist, produced by plants of the Menispermaceae family (Klunk et 
al., 1982) and is composed of equimolar amounts of picrotin and picrotoxinin (Etter et al., 1999). 
Only picrotoxinin is thought to be active as an antagonist (Curtis and Johnston, 1974) at the GABAa 
receptor (Lynch et al., 1995), where it has been described to be occasionally 50 times more potent 
than picrotin (Jarboe et al., 1968). However, in glycine receptors (Lynch et al., 1995) the two 
compounds have been found to be equipotent. In contrast, we have found both picrotoxinin and 
picrotin (data not shown) to be equally insensitive at antagonising C. elegans GLC-3 homo-oligomers 
at concentrations (ImM) sufficient to block other C. elegans GluCls (Cully et al., 1994). The only 
other picrotoxinin-resistant GluCls observed to date are in Leech Retzius cells (Mat-Jais et al., 1983) 
and Drosophila melanogaster, DrosGluCla, (Cully et al., 1996a). Picrotin showed minor antagonist 
activity against the homomeric C. elegans GluClp and GluCla channels, but picrotoxinin appears to 
be the active antagonist (Cully et al., 1994).
The mechanism of action of picrotoxinin is thought to involve complex channel blocking effects, 
which may be related to desensitisation and interaction with the M2 channel pore segment. In 
Drosophila RDL subunits a naturally occurring mutation in the residue of the second membrane 
spanning region (M2) (serine302 for alanine, Fig. 5.8) confers picrotoxinin, dieldrin and fipronil 
resistance (ffrench-Constant et al., 1993a; Pribilla et al., 1992; Zhang et al., 1994). Residue 302 of 
Drosophila Rdl corresponds to the same residue that is altered in rat glycinepi, glycinea, (Lynch et 
al., 1995; Pribilla et al., 1992), GluClp in C. elegans (position 279T) (Etter et al., 1999) and rat 
GABAaO, p 2, yi or y2 (Gurley et al., 1995; Wang et al., 1995). Figure 5.8 shows an alignment of the 
transmembrane II domains, from the ligand-gated anion channels, which indicate both naturally 
occurring and synthetic mutations of picrotoxin-insensitivity. These mutations are predicted to lie 
deep within the receptor pore (Olsen and Tobin, 1990; Smith and Olsen, 1995; Xu et al., 1995). 
However, the mechanism by which their mutations cause picrotoxin-insensitivity is not completely 
understood. Most authors are in agreement that the M2 mutation causes a block to the flow of chloride 
current through the channel pore (Etter et al., 1999; Gurley et al., 1995; Inoue and Akaike, 1988). In 
addition, this proposal is consistent with the observation from Gurley et al., (1995); Etter et al., 
(1999); Newland and Cull-Candy, (1992); that blocking of the current by picrotoxin is facilitated by
ligand binding. However, the mutation could be inducing this picrotoxin-sensitive block in one of 
many ways.
1. It is possible that picrotoxin could bind within the channel pore and physically obstruct the flow 
of ions (Zhang et al., 1994). This block of chloride ions could involve the drug physically 
blocking the channel pore or by inducing a conformational change that physically blocks 
conduction, alternatively picrotoxin could bind within the channel pore and prevent a 
conformational change from occurring, thus blocking conduction (Gurley et al., 1995; Zhang et 
a l , 1994).
2. Second, some authors propose that changing an amino acid away from the picrotoxin binding-site, 
but within the channel (ffrench-Constant et al, 1993a; Newland and Cull-Candy, 1992; Revah et 
al, 1991; Zhang et al, 1994) allows picrotoxin to act by stabilising the desensitised state of the 
GABAa receptor (i.e. keeping the channel in a closed state) from a site located within the pore of 
the channel. Interestingly, in support of this proposal Zhang et al, (1994) found that 
desensitisation appeared to be dramatically slower and often incomplete in the Rdl mutant.
3. A third possibility is that the channel pore mutation could disrupt the picrotoxin-binding site or 
prevent access of picrotoxin to its site of action (Gurley et al, 1995). Switching amino acids near 
the picrotoxin binding site may destabilise the conformation of the protein that binds the drug 
more tightly and therefore causing an alteration to the antagonist binding site (Zhang et al, 1994). 
However, despite a plethora of evidence from many different sources we cannot determine if 
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Figure 5.8 Alignment of various C. elegans and Drosophila Melanogaster L-glutamate receptor 
subunits with Rat GABAa and glycine a  sequences indicating the high degree o f homology in the M2 
region. Consensus sequence is boxed in black and channel mutations referred to in the text are 
highlighted in red. An asterisk denotes subunits conferring picrotoxin-insensitivity. Red shaded boxes 
of the sequence rat glycinePi are residues mutated to match the corresponding sequence of rat 
glycinea,. The naturally occurring amino acid threonine was substituted for Glu, Ala, Ser, Cys, Pro 
and Val producing mutations of GluClai M2 region (indicated by | ) .
5 .3 .5  C o n v u l s a n t  a n t a g o n i s t  e f f e c t s  o n  G L C - 3  h o m o - o l i g o m e r s
Experiments with non-competitive antagonists o f ionotropic chloride channels revealed some novel 
features o f the homomeric GLC-3 receptor. The GLC-3 channels are inhibited by BIDN and fipronil 
with IC 5oS of 0.22 and 11 pM respectively; this is the first report that any GluCl is sensitive to the 
actions of BIDN or a phenylpyrazole. The insecticidal activity o f these compounds is thought to target 
the convulsant binding site of both bicuculline-sensitive and bicuculline-insensitive GABA-gated 
chloride channels (Deng et al., 1993; Hosie et al., 1995b; Rauh et al., 1997b). This indicates that 
BIDN and fipronil may therefore share a common mechanism o f action, but act at quite different sites 
on the receptor channel complex. Naturally occurring mutations in residues o f the second membrane- 
spanning region (M2) o f RDL receptor subunits (serine3 0 2 for alanine) confers both picrotoxinin, 
BIDN, dieldrin and fipronil resistance (ffrench-Constant et al., 1993a; Gurley et al., 1995; Hosie et
al., 1995a; Pribilla et al., 1992; Wang et al., 1995; Zhang et al., 1995; Zhang et al., 1994). However, 
the sequences of the M2 regions of the C. elegans GluCl subunits (Fig. 5.8) are almost identical to 
each other and do not suggest any reason for the observed differences in fipronil and BIDN 
sensitivity. It is possible that residues outside the ion channel affect the antagonist sensitivity and 
specificity of the GluCl. Lynch et al., (1995) showed that mutations at the extracellular end of the M2 
of the mammalian glycine receptor a  subunit, notably alterations in lysine-274, transformed 
picrotoxin from an allosteric competitive antagonist to an allosteric potentiator at low (0.01 -  3 jiM) 
concentrations and to a non-competitive antagonist at higher (>3pM) concentrations.
Again, the sequence of this region of GLC-3 does not reveal any unusual features; in particular, the 
basic residue (K274) is conserved. In insect membranes [3H]-BIDN was displaced competitively by 
dieldrin but not by fipronil, picrotoxin, EBOB, TBPS or l-phenyl-4-t-butyl-2,6,7- 
trioxabicyclo[2.2.2]octane (TBOB) (Rauh et al., 1997b; Sattelle et al., 1995), indicating that BIDN 
probes a different site from the convulsant ligands (as represented by Fig. 5.9). In cockroach motor 
neuron preparations, (Sattelle et al., 1988) BIDN failed to inhibit nAChR or GABAB-like receptors 
indicating a preference for vertebrate and insect GABAa and C. elegans L-glutamate channel.
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Figure 5.9 Proposed models o f C. elegans L-glutamate (Horoszok et. al., 200) and insect GABA 
receptors (Cole et al., 1993; Hosie et al., 1995a).
At very low concentrations fipronil has been very effective at controlling insects (Colliot, 1992), but 
at the same time displaying good selectivity between invertebrates and mammals (Cole et al., 1993; 
Tomlin, 1994)). Fipronil selective toxicity is also indicated in radioligand binding assays, where the 
insecticide binds with a higher affinity to insect GABA receptors than vertebrate components. In rat 
brain membrane binding assays fipronil had no significant effects on [3H] muscimol (Abalis & 
Elderffawi, 1986), although it did displace [35S] TBPS, [3H]BIDN and [3H]EBOB with a low affinity 
(Cole et al., 1993). However, using membrane preparations from housefly head, fipronil failed to 
compete for [35S] TBPS (Olsen et al., 1989), [3H] BIDN and [3H] muscimol (Lunt et al., 1985). 
Clearly, however, fipronil did bind with a high affinity to the EBOB binding site (Gant et al., 1998), 
indicating that in insects, fipronil acts only at the EBOB binding site, which may be close to, but 
distinct, from the other two cyclodiene binding sites (TBPS and BIDN). Whereas in the vertebrate 
GABA-chloride channel, fipronil displaces all three cyclodienes (TBPS, EBOB and BIDN) at low 
affinities, suggesting they act at the same site. Clearly, however, the potencies of all 4 compounds 
(picrotoxin, BIDN, fipronil and dieldrin) are affected by the same mutation (A302S) in the RDL 
channel, suggesting that they either recognise a common feature of GABA receptor, or share a 
common mechanism of action (Hosie et al., 1995a).
The interesting pharmacology observed for GLC-3 indicates that this and other C. elegans GluCls 
may prove to be a valuable tool for studying the detailed interaction of non-competitive antagonists 
with ligand-gated chloride channels. In conclusion, we have identified two novel convulsant 
compounds acting at the L-glutamate receptor that show a similar potency for the L-glutamate-gated 
channels as the GABA-gated convulsant site. In particular, it will be interesting to determine whether 
or not other native and other recombinant GluCls are sensitive to fipronil, BIDN and related 
compounds. Detailed investigation of this latest member of the GluCl gene family using the advanced 
molecular genetic techniques available for C. elegans will also enhance our overall understanding of 
the nematode nervous system.
Chapter 6
Conclusions and future perspectives
6.1. Conclusions
Anthelmintics are an integral part of the agricultural industry, and the need to develop more efficient 
and selective compounds is ongoing. Most of the current anthelmintics have been found to target their 
actions on neurotransmitters involved in neuronal signalling of ion channels within the nervous 
system. In order to study the actions of these compounds, the identification of the neurotransmitters 
involved in neuronal signalling and the mechanism of interaction with the receptor subunit needs to be 
examined at the molecular level. The work described in this thesis has tried to address some of these 
fundamental issues.
The glutamate-gated chloride receptor has become established as the probable target for avermectin 
compounds, although the exact mode of action and the stoichiometry of the native GluCl receptors 
remain unknown. However, the successful completion of the C. elegans genome project allowed us to 
predict the total number of L-glutamate receptor subunits present within this organism. Using the 
polymerase chain reaction allowed direct amplification of a 1.4kb C. elegans GLC-3 receptor subunit 
cDNA, which displayed high amino acid identity (73-77%) with other GluCla subunits from 
nematodes, confirming that GLC-3 is also a member of the same amino-acid superfamily of receptor 
proteins.
Following the successful cloning of GLC-3, one of the principal aims of this project was to ascertain 
if GLC-3 homo-oligomers exhibited the same characteristic pharmacology as other GluCl receptor 
subunits. The GLC-3 homo-oligomers did resemble the pharmacological profile of other in vitro 
expressed GluCla subunits, and was distinctly dissimilar from the invertebrate GABAa and glycine 
receptors. Clearly, oocytes expressing GLC-3 homo-oligomers displayed robust, dose-dependent 
currents that were initiated by L-glutamate and smaller, non-desensitising currents from the L- 
glutamate analogue ibotenic acid, in addition to insensitivity to GABA, histamine, NMDA and 
glycine ligands. However, the in vitro pharmacology of the GluCls is quite distinct from that of the 
native channel. In general, L-glutamate, ibotenate and ivermectin activate both sets of receptors, but 
the apparent sensitivity of the recombinant homomers is far less than observed in native tissues. This 
suggests that native nematode receptors form heteromers of the GluCl receptors and it is plausible that 
unidentified subunit combinations exist.
The GLC-3 receptor subunits are striking in their similarity to other GluCla homomers, especially in 
their sensitivity to L-glutamate and ivermectin compounds, however, in earlier studies the only 
antagonist observed to inhibit either the ivermectin or the glutamate-gated currents have been 
picrotoxin and flufenamic acid (GABAb coupled antagonist). Of particular interest, was the finding
that two GABAa channel antagonists blocked, dose-dependently, L-glutamate-induced chloride 
currents from GLC-3 homo-oligomers, namely BIDN and the insecticide fipronil. The activity of 
these channel blockers has not been explored on native or other recombinant L-glutamate receptors, 
representing the first electrophysiological data on these antagonists.
All other known C. elegans GluCl receptor subunits expressed in oocytes (with the exception of 
GluCla) have either their L-glutamate or ivermectin currents blocked by picrotoxinin. In contrast, we 
have found picrotoxinin to be ineffective at antagonising L-glutamate-gated currents in GLC-3 homo- 
oligomers. An equivalent point mutation within the M2 domain at both GluClp from C. elegans and 
RDL (A301S) homo-oligomers from Drosophila have been shown to reduce picrotoxinin potency. 
However, the M2 sequence of the C. elegans GLC-3 subunit is almost identical to other GluCla 
subunits and do not suggest any reason for observed differences in picrotoxinin sensitivity. The GLC- 
3 homo-oligomer may prove to be a good subject for site-directed mutagenesis studies of the M2 
domain.
In this study immunocytochemical methods were used to characterise a member of the glutamate- 
gated chloride channels in nematodes. Polyclonal antibodies raised against GBR-2 GluCl receptor 
subunits to localised specific cells in the free-living species C. elegans. The avr-14 gene from C. 
elegans and Haemonchus contortus is alternatively spliced and encodes for two subunits, GBR-2A 
and GBR-2B. Despite the sequence conservation between Haemonchus and C. elegans GBR-2A and - 
2B subunits (88% and 83% respectively) the distribution of localisation was not completely 
conserved, clearly however, such high identity suggests that Haemonchus GBR-2 is the parasitic 
orthologue of C. elegans GBR-2 receptor subunits. The GBR-2 receptor subunits formed specific 
expression patterns (Fig. 3.5) in extrapharyngeal tissue in C. elegans and Haemonchus contortus, and 
subsequently motor nerve cords in Ascaris suum and Haemonchus contortus preparations. Subunits 
were also observed on 3 neuronal cell bodies observed in the corpus, metacorpus and terminal bulb 
regions of the C. elegans pharynx. From this pattern of immunoreactive neurons it is reasonable to 
assume that the GBR-2 subunits exist on the M3 motor neurons that innervate pm4 and pm5 muscle 
cells. Previous studies indicate IPSPs generated by the M3 motor neuron have been of an inhibitory 
glutamatergic transmission (Dent et al., 1997). I can, therefore, hypothesise that GBR-2 channels 
operate as pre-synaptic autoreceptors on the M3 neuron and are maybe indirectly involved in 
regulating glutamate release. In correlation to C. elegans GluCl(3 and a2 receptor subunits, it is 
plausible that GBR-2 are also involved in pharyngeal pumping, but do not co-assemble with GluCla2 
and (3 to form a native receptor. Previous studies have indicated the pharyngeal muscle and 
surrounding neurons to be the major site of action of ivermectin in free-living and parasitic species 
(Avery et al., 1997; Li et al., 1997; Raizen et al., 1995).
Using cloning, immunocytochemistry and electrophysiology techniques, this thesis attempts to 
provide a brief synopsis of our current understanding of the ivermectin-gated chloride channels and 
allows us to examine subunit configuration and anatomical localisation of the receptor as well as 
pharmacological characterisation. This study will also facilitate cloning of homologous ion channels 
from insects and parasitic nematodes allowing their genes to be used to establish a screening system 
for novel anthelmintic and insecticidal compounds and to identify addition drug binding distinct from 
the ivermectin binding-site.
6.2 Future work
To distinguish clearly between the expression of GBR-2 A and -2B polypeptides, subunit-specific 
antisera should be raised to unique intracellular loop regions. These results should indicate which 
subunits are present in the extrapharyngeal region and if the co-expression of GBR2-A and -2B exists. 
Future studies will also involve the immunolocalisation of GLC-3 receptor subunits in C. elegans, 
using polyclonal antibodies raised against the N-terminal subunit domain and reporter gene studies. 
This may provide some clues as to which subunits (if any) co-assemble in the native receptors.
In this study pharmacological characterisation of GLC-3 homo-oligomers to ivermectin and GABA 
convulsant antagonists was shown. However, this study involves just one a-subunit, it will be 
constructive to see if subsequent co-expression studies of GLC-3 with other subunits such as GluCla2 
and ai may lead to the assembly of more functional hetero-oligomeric receptors which may mimic the 
pharmacology of the native receptors. Although, as yet, there is no evidence that GLC-3, 012 and ai in 
any combination are hetero-oligomerically expressed in vivo. Clearly, a much more thorough in vivo 
and ex-vivo pharmacological investigation should be undertaken to identify the development of a new 
generation of anthelmintics, such as BIDN and fipronil which have been found to exert suitable 
toxicity properties on GLC-3 receptor subunits in recombinant expression studies.
With the aid of known sequence and subunit components and comprehensive physical maps of the C. 
elegans genome (Coulson et al., 1986), these studies will offer an important tool in determining 
anthelmintic-receptor interactions. Site-directed mutagenesis experiments of this functional homomer 
(GLC-3) will hopefully prove valuable in identifying key residues responsible for agonist and 
antagonist binding sites and improve on selectivity at the target site.
Appendices 7
Appendix 1
7.1  E s c h e r i c h i a  c o l i  g e n e t i c  m a r k e r s
M A R K ER D ESC R IPTIO N
Amy Amylase
Ara Mutation destroys ability to use arabinose
Cam' Chloramphenicol resistance
EndAl DNA specific endonuclease 1, mutation improves quality and quantity of 
miniprep
F Contains the F plasmid
GyrA46 DNA gyrase subunit A
HsdR{rkmk+) Ablates type 1 restriction but not methylation o f E.coli strain K
Lac Unable to utilise lactose
Laclq Overproduces the lac repressor protein
LacZ p-Galactosidase
LacZM15 Specific N-terminal deletion permitting a-complementation
ProAB Requires proline for growth
RecAl Recombination deficient
RelAl Permits RNA synthesis in absence o f protein synthesis
RpsL 30S ribosomal subunit S I2: mutation confers streptomycin resistance
SupE44 Suppressor of amber (UAG) mutations
Thi Requires thiamin (vitamin B1) for growth
TnlO(tetR) Contains the T N 10 transposon, conferring tetracycline resistance
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